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Preface 
Diet supplies the human body with the nutrients and energy sources that are 
required to maintain and sustain normal cell function. Apart from physical 
activity, a balanced diet is a key factor to maintain optimal health. The 
problem with Western diets is that there has been a major change in dietary 
habits since the beginning of the Agricultural Revolution (Cordain et al., 2005). 
With the greater availability of processed foods, the consumption of food that 
is high in fat has increased and an intake of vegetables and fibres has been 
reduced.  
 
Prior to the start of the agricultural revolution, the intake of polyunsaturated 
fatty acids (PUFA) n-6 and n-3 was maintained at a ratio of approximately 1:1 
(Simopoulos, 2006). However, with the modernization of cultures and the 
availability of processed foods the ratio has shifted in favour of n-6 fatty acids 
(FA), with an n-6/n-3 ratio of 15-20:1 (Simopoulos, 2006). These dietary FA 
imbalances have had a great influence on the increase of several diseases 
that includes cardiovascular disease, diabetes and some cancers (Das, 1995; 
Holmes et al., 1999). 
 
Diets high in fats such as the saturated and trans-fatty acids and low in n-3 
PUFA in particular have been associated with these diseased states 
(Simopoulos, 1999; Hughes-Fulford et al., 2001; Kromhout, 2001). Generally, 
FA such as the PUFA play an important role in maintaining cellular 
homeostasis with respect to optimising cell structure (i.e. lipid membrane fatty 
acid content) and function (i.e. secondary cell signalling messengers) (Benatti 
et al., 2004). FA, particularly the n-6 and n-3 PUFA affect cell structure and 
influence cellular processes such as proliferation, apoptosis and differentiation 
(Hilakivi-Clarke et al., 2004). These processes are regulated either directly by 
the FA or through conversion to metabolites such as the eicosanoids (Benatti 
et al., 2004). Furthermore, the oxidation of membranes PUFA by free radicals 
can also affect cell growth and/or development due to changes to the cellular 
oxidative status (Gago-Dominguez et al., 2007). This is of particular 
importance for the survival of cancer cells as their oxidative status is very low 
(Cheeseman et al., 1988).  
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Excessive amounts of n-6 PUFA and a high n-6/n-3 ratio, present in Western 
diets, have been found to enhance tumour growth in some cancers. Diets with 
a low n-6/n-3 PUFA content, however, could protect against further neoplastic 
development (Larsson et al., 2004). Studies have shown that diets 
supplemented with fish oil, which is high in n-3 PUFA eicosapentaenoic acid 
(C20:5n-3) and docosahexaenoic acid (C22:6n-3), reduces cell proliferation in 
some cancers (Aronson et al., 2001). One of the mechanisms by which n-3 
PUFA exert their protective effect might be through the cyclooxygenase-2 
(COX-2) pathway. The COX-2 enzyme is involved in the formation of 
prostanoids from free PUFA and converts n-6 PUFA such as arachidonic acid 
(C20:4n-6) into the 2-series prostanoids, while γ-linolenic acid (C18:3n-6) and 
the C20:5n-3 are converted into the 1- and 3-series prostanoids, respectively 
(Tapiero et al., 2002). The 2-series prostanoids promote cell proliferation and 
decrease apoptosis and the immune response, while the 1- and 3-series 
prostanoids inhibits tumourigenesis. Several mechanisms have been 
proposed to explain how n-3 PUFA especially fish FA C20:5n-3 and C22:6n-3 
could protect against cancer development. One mechanism is the competition 
between n-3 and n-6 FA for COX-2 activity, leading to decreased production 
of the 2-series prostanoids and an increase in 3-series products, inhibiting 
tumourgenesis (Hardman, 2002). Inclusion of C18:3n-6 in the diet also leads 
to the production of anti-inflammatory 1-series prostanoids that lead to further 
tumour cell growth inhibition (Fan and Chapkin, 1998). The n-3 and n-6 PUFA 
also vie for the desaturases and elongases that convert the precursors linoleic 
acid (C18:2n-6) into C20:4n-6 and α-linolenic acid (C18:3n-3) into C20:5n-3 
(Horrobin, 1993). Therefore a low ratio of n-6 to n-3 FA may lead to decreased 
production of C20:4n-6 and 2-series prostanoids. This mechanism can also 
account for the antitumourigenic effect of a high ratio of fish FA (C20:5n-3 and 
C22:6n-3) to C20:4n-6 in animal models (Dommels et al., 2002). 
 
With the membrane lipid pool being affected by the dietary intake of n-6 and 
n-3 PUFA, it has been suggested that the mechanisms by which high n-6 FA 
enhances tumour development can be modulated or manipulated through 
dietary intake of specific fatty acid combinations (Abel et al., 2004). Therefore, 
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lowering the n-6/n-3 fatty acid ratio could potentially reduce the risk of further 
cancer development by influencing cell survival. 
 
Research has shown that FA has both a detrimental and beneficial effect on 
the carcinogenesis process, depending on the saturation of the FA. Dietary fat 
intake impacts on the level of PUFA present in the cell membrane, and thus 
affect cellular structure and function. Membrane PUFA content affects the 
regulation of cell proliferation and apoptosis, and impacts on the oxidative 
status of a cell. As mentioned, all these parameters play an important role in 
neoplastic progression. Thus establishing a balance between n-6 and n-3 
PUFA content may determine the final outcome of cancer development. 
 
The current project evaluated the lipid profiles in colon polyps and surrounding 
mucosa. In addition the effect of different dietary fats with varying n-6/n-3 FA 
ratios was monitored on the lipid profiles of colon mucosa and red blood cell 
membranes in normal rats. In Chapter 1 the current knowledge pertaining to 
colon cancer, PUFA and their association with carcinogenesis as well as their 
role in cancer chemoprevention is reviewed.  Differences in the lipid profiles of 
colon polyps and surrounding mucosa and the role of a high n-6/n-3 ratio diet 
in the development of colon polyps will be critically discussed in Chapter 2.  
The incorporation and modulating effect of different dietary n-6/n-3 FA ratios 
on the lipid profile of rat colon mucosa and red blood cell (RBC) membranes 
are presented in Chapter 3. The modulating effect of the different dietary 
n-6/n-3 FA ratios will be assessed on the membrane cholesterol, 
phospholipids and FA content, as well as its effect on the extent of lipid 
peroxidation. As numerous studies utilise RBC as a biomarker for dietary fat 
intake, the lipid profile of colon mucosa and RBC membranes were compared 
to determine whether the membranes reflect a similar lipid pattern with 
respect to dietary fat intake. The main findings of the study will be integrated 
and summarized in Chapter 4, while supportive experimental procedures will 
be summarized in the Addendum section.  
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1. Introduction 
In all multicellular organisms maintenance of cellular homeostasis is vital for 
an individual to remain alive and healthy. Several factors impact on this 
dynamic equilibrium, one of which is diet. Our daily diet provides a source of 
energy and nutrients that assist in regulating cellular metabolic processes. 
Scientific evidence supports the view that alterations in diet have strong 
effects, both positive and negative, on health throughout life (WHO, 2003). 
Dietary adjustment may thus not only influence present health, but may 
determine whether or not an individual will develop diseases such as 
diabetes, cardiovascular disease and cancer much later in life. 
 
Research has shown that dietary fat in particular, plays an important role in 
human health and disease. Fat is a source of energy, but it is also a vital 
component of the cellular membrane structure, and is involved in many cell 
signalling pathways (Green and Tzagoloff, 1966; 
http://www.lipidlibrary.co.uk/Lipids/whatdo/index.htm, accessed 11 August 
2009). Mammals, including humans, can synthesize saturated and 
monounsaturated fatty acids (FA), but cannot synthesize the principle omega-
6 and omega-3 polyunsaturated fatty acids (PUFA), linoleic acid and α-
linolenic acid respectively (Hardman, 2004). These two FA are termed 
essential fatty acids and must be obtained from the diet (Horrobin, 1986). Both 
FA undergo desaturation and chain elongation to yield metabolically functional 
20- to 22-carbon FA. The omega-6 and omega-3 PUFA have a number of vital 
functions in the human body as structural lipids of cellular membranes 
modulating membrane fluidity, cellular interaction and signal transduction 
pathways (Hardman, 2004). Moreover, they play an important role in the 
regulation of inflammatory pathways and the immune system by acting as 
precursors for the synthesis of eicosanoids (Roynette et al., 2004). 
 
Carcinogenesis is regarded as a multi-step process, which is reflected by 
progressive genetic alterations that drive the transformation of normal cells 
into highly malignant derivatives (Grander, 1998). It has been well established 
that the characteristic features of cancer are accelerated cell proliferation, 
reduced apoptosis and the inhibition of cell differentiation, resulting from the 
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deregulation of signalling cascades. Stern et al. (1999) have postulated that 
the primary defect in carcinogenesis to be an architectural, organizational, and 
compositional change in the plasma membrane that results in the loss of 
homeostasis. Therefore, the suggested mechanisms by which dietary fat in 
the form of PUFA influence cancer development may be through its direct 
influence on lipid content in cell membranes, thereby affecting cell function. As 
tumours are dependent on host circulation for the type and amount of PUFA 
available, it should be possible to alter FA composition by dietary means. 
Thus dietary modulation of tumour membrane FA could alter the growth of 
tumour cells by influencing cell replication by interfering with components of 
the cell cycle, or by increasing cell death, either by cell necrosis or apoptosis 
(Field and Schley, 2004). 
 
One of these modulation mechanisms relates to the pattern of FA composition 
and their impact on eicosanoid production. Eicosanoids are the instigators of 
cellular inflammatory responses, with their production dependent on the PUFA 
composition in membranes (James et al., 2000). Therefore, the consumption 
of dietary PUFA impacts on the spectrum of eicosanoids produced by the cell, 
and thereby attenuates the biological effects of growth factor stimuli (Thies et 
al., 2001). Dysfunctions in eicosanoid metabolism have been associated with 
the development of specific cancers linked with an imbalanced PUFA intake, 
related to diets with a high n-6 and/or low n-3 PUFA content (Bartsch et al., 
1999). 
 
An additional mechanism by which PUFA impacts on the development of 
cancer is through its generation of free oxygen radicals and lipid peroxides. 
Data supports the notion that increased formation of reactive oxygen species 
(ROS) may play an important role in carcinogenesis (Waris and Ahsan, 2006). 
Numerous in vitro experiments show that ROS damages DNA, inducing 
premutagenic modifications of nucleotides and promoting oxidation of protein 
and lipids resulting in lipid peroxidation (Gago-Dominguez et al., 2005). Lipid 
peroxidation is a well known example of oxidative damage, a degenerative 
process that perturbs structure and/or function of the target system, often with 
cytopathological consequences. According to Özdemirler Erata et al. (2005), 
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oxidative stress plays an important role in the molecular mechanism of 
colorectal cancer. Degradation products formed may interfere with intracellular 
signalling cascades involved in cell replication and cell death (Udilova et al., 
2003). Lipid compositions of cellular membranes are associated with the 
sensitivity of cells towards lipid peroxidation. Hence, alterations in the FA 
composition may contribute to the peroxidative effect of FA such as 
docosahexaenoic acid (C22:6n-3) (Song et al., 2000). Various studies have 
shown that tumour development is promoted by a decrease in PUFA and lipid 
peroxidation (Galeotti et al., 1986; North et al., 1994). Research by Abel et al. 
(2001) indicated that decreased levels of long-chain PUFA in hepatocyte 
nodules are associated with decreased lipid peroxidation, impairing apoptosis 
and enhancing proliferation in these lesions. 
 
It is evident that PUFA have a profound effect on cellular function with regards 
to cell membrane regulation of metabolic processes. A full understanding of its 
regulatory capacity is therefore essential to elucidate their role on the 
development of cancer. This review aims to briefly debate the association 
between dietary fat and colon cancer development. The current knowledge on 
dietary PUFA and its biological functions in mammalian cells and its 
association with cancer development and chemoprevention will also be 
addressed. 
 
2. Cancer 
In healthy tissue, growth regulatory mechanisms endeavour to maintain 
cellular homeostasis. Homeostasis within a cell is regulated by the balance 
between proliferation, growth arrest and apoptosis (Evan and Vousden, 2001). 
When homeostasis is disturbed, either by an increased proliferation rate or a 
decrease in cell death, initiated or preneoplastic cells might progress into a 
tumour.  
 
Cancer is thus the product of malfunctions within the regulation of the cell 
cycle, such that injured or mutated cells that are normally killed are allowed to 
progress through the cell cycle, accumulating mutations (Foster, 2007). At 
least three important classes of genes play key roles in tumour initiation: 
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proto-oncogenes, tumour suppressor genes, and genes involved in DNA 
repair mechanisms. Mutations, amplifications or deletions in these genes may 
lead to decoupling of biological mechanisms involved in the regulation of 
normal cell growth and differentiation (Tysnes and Bjerkvig, 2007). 
Proto-oncogenes normally act at different levels of cell proliferation, but can 
promote tumour growth when mutated. Similarly, mutation of tumour 
suppressor genes (e.g. p53) would impair the inhibition of the cell cycle 
progression, thus facilitating abnormal growth (Foster, 2007). 
 
2.1 Cell cycle  
The cell cycle is a fundamental process in mammalian cells that enables them 
to grow and replicate (Fig. 1). Regulation of cell cycle progression is controlled 
by external factors, amongst which are nutrients and growth factors (Paul et 
al., 1978; Bohnsack and Hirschi, 2004). 
 
The cell cycle governs the fate of the cell and is the mechanism that interprets 
the growth-regulating signals received, deciding whether the cycle proceeds. 
The cell cycle consists of four phases: G1, S, G2 and M. Cells that are 
committed to replication move from G1 phase (the first gap) of the cycle, into 
the S (stationary) phase for DNA synthesis. The S phase is followed by the G2 
(the second gap) phase, where cells prepare for duplication in the M (mitosis) 
phase (Fig. 1). Progression through the cell cycle is dependent upon the 
integration of a large number of intra- and extra-cellular signals that integrate 
also with intrinsic genetic controls, resulting in several checkpoints in different 
phases of the cycle (Boonstra and Post, 2004). These checkpoints include the 
DNA damage checkpoints: S-checkpoint at G1/S and M-checkpoints at G2/M. 
At these checkpoints the progression through the cell cycle can be arrested to 
enable the cells to repair DNA upon damage caused by irradiation or a 
chemical carcinogen. Specific cellular mechanisms that control cell cycle 
progression and checkpoint progression through the intermitotic phases are 
deregulated in cancer (Golias et al., 2004). 
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Fig. 1 Cell cycle: the complete series of events from one cell division to the next. It is 
usually divided into the phase when DNA is replicated (S phase), the phase when the cell 
actually divides into two cells (M phase), the two intervening gap phases (G1 and G2), and 
a nondividing state called “quiescence” (G0). 
(http://en.wikipedia.org/wiki/Image:Cell_cycle.png, accessed 28 January 2008).  
 
 
2.2 Cell cycle control mechanisms disrupted in cancer 
2.2.1 Cell proliferation 
Regulatory pathways that control the proliferation response in normal cells are 
altered in most cancers. One class of mutations required for tumour 
development acts by short-circuiting the normally obligate requirement of 
somatic cells for external mitogenic signals (Evan and Vousden, 2001). A 
second class of growth deregulating mutations comprises those that target the 
regulatory checkpoints, such as the principle late G1-S checkpoint regulated 
by phosphorylated retinoblastoma (pRB) (Knudsen and Knudsen, 2006). 
Defects in this pathway include deletion of the RB genes itself and 
deregulation of the cyclin-dependent kinases (CDKs) that phosphorylate and 
functionally inactivate pRB. Uncontrolled cell proliferation associated with 
cancer depends on the dysfunction of at least one of these checkpoint 
pathways. 
 
2.2.2 Apoptosis 
Apoptosis is a form of cellular suicide used by multicellular organisms to 
eradicate cells in diverse physiological and pathological settings. This 
evolutionary conserved death process is important for normal tissue 
development and tissue homeostasis by regulating cell numbers and 
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eliminating damaged cells (Renehan et al., 2001). Deregulation of apoptosis is 
a key feature of cancer development. Defects in apoptosis allow damaged 
cells to live beyond their lifespan, accumulate genetic mutations and sustain 
growth under hypoxia and oxidative stress (Yu and Zhang, 2003). A mutation 
in the tumour suppressor gene p53, which is a critical regulator of apoptosis, 
is frequently observed in tumour cells. In the absence of p53, cells that have 
sustained DNA damage fail to arrest, and mutations are perpetuated, leading 
to genomic instability and cancerous promoting genetic alterations. Many of 
the signals that inactivate p53 are important during cancer initiation and 
promotion, because a loss of p53 creates a permissive environment in which 
there is inappropriate proliferation and survival (Zamzami and Kroemer, 
2005). 
 
2.2.3 Differentiation 
In most tissues, cells go through a process of terminal differentiation. This 
process serves as a transition stage between proliferation and cell death. By 
definition, differentiation is the process by which a cell matures and becomes 
capable of performing specific functions (Rudolph et al., 2001). Fully 
differentiated cells in constantly renewing tissue often lose their proliferative 
capability and have a defined relatively short life span. 
 
Rapid tissue renewal by terminal differentiation ensures effective elimination 
of damaged cells before they become neoplastic (Ding et al., 2001). Cells 
committed to terminal differentiation undergo a genetically programmed death 
process that exhibits features of apoptosis such as nuclear DNA 
fragmentation and increased Bax expression (Cai et al., 2004). In colon 
cancer, for example, the failure of intestinal epithelial cells to undergo normal 
differentiation, results in continuous DNA synthesis and cell proliferation 
(Lipkin, 1974). 
 
2.3 Colon cancer  
Cancer of the bowel is one of the leading causes of death in both men and 
women in industrialised Western countries (Dommels et al., 2002). Parkin et 
al. (2002) reported that colon and rectum cancer accounted for 1 million new 
 
 
 
 
 14
cases, approximately 9.4% of the total world population, with numbers not 
varying significantly between men and women (ratio 1.2:1). In terms of 
incidence, colorectal cancer ranks fourth in men and third in women globally.  
                                                                                                                                                       
The complexity of colon cancer development involves both genetic and 
environmental factors. Genetic dispositions, such as Familial Adenomatous 
Polyposis (FAP), increase the risk of developing colon cancer by the age of 21 
(Roynette et al., 2004). However, the prevalence of such predisposition is low 
and 90% of cases are due to exogenous factors, from which 50-80% are 
environmental (Bartsch et al., 1999). Among the environmental factors, dietary 
habits play a major role. Numerous reports have shown associations between 
diet and colon cancer (Ferguson, 2002; Le Marchand et al., 2002). A relation 
commonly found in epidemiological studies is an increase in risk associated 
with a high-fat, low fibre diet pattern (Singh and Fraser, 1998). 
 
2.3.1 Colon cancer development 
Colorectal cancer, commonly called colon cancer or bowel cancer, includes 
cancerous growths in the colon, rectum and appendix (Fig. 2). As with all 
cancers, colon cancer development is a multistage process involving genetic 
and epigenic defects that normally occur over a large part of the individual’s 
lifespan (Johnson, 2004). 
 
Fig. 2 Anatomy of the lower digestive tract - comprises the colon, small intestine and rectum 
(http://www.heartspring.net/images/colon01.gif, accessed 21 November 2007). 
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Colon cancer originates from the epithelial cells (colonocytes) that line the 
intestinal tract. The inner surface of the colon is lined with crypts; the fold of 
colonic epithelium that are continuously renewed by stem cell division 
(Komarova and Cheng, 2006). A dynamic balance between proliferation, 
differentiation and apoptosis maintains the steady state of cell growth of 
normal colonic epithelium. Stem daughter cells proliferate in the lower part of 
the crypt, move in tight cohort toward the upper crypt regions, gradually lose 
their capacity to divide and acquire the differentiated phenotype (Lamprecht 
and Lipkin, 2002). In normal colonic epithelium the size of the various 
functional compartments along the crypt axis are maintained within precise 
boundaries by multiple homeostatic signals. Disruption of these processes, for 
example by diet, can lead to colorectal carcinogenesis. 
 
The disease progresses through a series of clinical and histopathological 
stages ranging from single crypt lesions through small benign tumours 
(adenomatous polyps) to malignant cancers (carcinomas) (Fig. 3). The model 
of colorectal tumourigenesis includes several genetic changes that are 
required for cancer initiation and progression (Michor et al., 2005). 
Normal 
epithelium
Hyper 
proliferative 
epithelium 
Small 
adenoma
Large 
adenoma
Colon 
carcinoma
Fig. 3 Sequential histopathological changes in the colon that transform normal 
epithelium to invasive carcinoma during the development of colon cancer (adapted form 
Jänne and Mayer, 2000).
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2.3.2 Dietary risk factors associated with colon cancer development 
Several factors impact on the development of colon cancer. Genetic 
predispositions account for only a small percentage of colon cancer 
occurrences (Johnson, 2004). Research has shown that the prevalence of the 
disease’s development is largely related to dietary habits. 
 
2.3.2.1 Body fat and energy intake 
Energy intake among individuals is dependent on physical activity level, body 
size, metabolic efficiency and energy balance (Willet and Stampfer, 1986). 
The maintenance of a healthy body weight is determined by the ratio of 
energy intake to energy expenditure (Gunter and Leitzmann, 2006). An 
excess of energy input over energy output results in positive energy balance 
and leads to weight gain. 
 
For cancer of the colon, the increase in risk associated with excess body 
weight or increase in abdominal fat may be mediated by alterations in the 
metabolism of insulin and insulin-like growth factor-1 (IGF-1) (Bianchini et al., 
2002). A metabolic consequence of obesity, and specifically the accumulation 
of intra-abdominal fat, is the development of insulin resistance, which leads to 
an increase in secretion of insulin from the pancreas (Bianchini et al., 2002). 
Insulin resistance is believed to be the causal factor in metabolic perturbation. 
Specifically, insulin stimulates proliferation and reduces apoptosis in colorectal 
cancer cell lines (Koenuma et al., 1989), and promotes colon carcinogenesis 
in animal models (Tran et al., 1996). 
 
The relation between excess body weight and cancer risk suggest that excess 
energy is an important risk factor for development of cancer. Several 
physiological mechanisms have been postulated to explain the effects of 
energy balance and adiposity in cancer risk. These include increases in the 
endogenous production of reactive oxygen species (ROS) and oxidative DNA 
damage, alterations in carcinogen-metabolising enzymes, tissue homeostasis 
and alterations in endogenous hormone balance (Bianchini et al., 2002). 
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Increased energy availability may also contribute to colon carcinogenesis by 
stimulating reactive oxygen species production. An intracellular lipolytic 
environment rich in oxidizable substrates may result in the generation of lipid 
peroxidation products, depleted levels of antioxidants and an overall 
environment of oxidative stress (Draper & Bettger, 1994). High levels of ROS 
exert a toxic effect on biomolecules such as DNA, proteins and lipids, leading 
to the accumulation of oxidative damage in cells that deregulate redox-
sensitive metabolic and signalling pathways resulting in pathological 
conditions (Schrader and Fahimi, 2006). 
 
2.3.2.2 Dietary fat intake 
A large body of epidemiological evidence, together with data from animal and 
in vitro studies, strongly supports relationships between dietary constituents 
and the risk of specific cancers (Dommels et al., 2002; Zhang et al., 1996; 
Nano et al., 2003). Generally, vegetables and fruits, dietary fibres, and certain 
micronutrients appear to be protective against cancer (Jenkins et al., 2001), 
whereas fat, excessive calories and alcohol seem to increase the risk 
(Boffetta and Hashibe, 2006; Ferguson, 2002).  
 
Research suggests that a high intake of dietary fat plays a role in colorectal 
cancer development (Slattery et al., 1998; Salim et al., 2002). Studies 
demonstrate that not only the amount of fat, but also types of fat differing in 
FA composition are important determining factors in colon tumour 
development. Both saturated and unsaturated FA has been implicated in the 
carcinogenic process and has been shown to affect tumour growth, incidence 
and multiplicity (Rao et al., 2001, Reddy et al., 1991). A study links dietary n-6 
PUFA to increased risks for cancer of the colon, particularly in combination 
with low intake of n-3 PUFA or monounsaturated FA (Nkondjock et al., 2003).  
 
Several mechanisms have been proposed to explain the enhancement of 
colon cancer by n-6 PUFA, including the modulation of the immune response 
as a result of changes in the eicosanoid metabolism (Bartoli et al., 2000) and 
alterations of membrane structure and properties (Awad et al., 1996b). 
Laboratory studies have shown that high fat corn oil diets promotes colon 
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tumourigenesis in rats by up regulating cyclooxygenase-2 (COX-2), an 
enzyme that catalyzes the metabolism of n-6 and n-3 PUFA during 
prostaglandin biosynthesis (Singh et al., 1997). Increased intakes of n-6 FA 
such as linoleic acid and arachidonic acid elevate the biosynthesis of 2-series 
prostaglandins that enhances cell proliferation, a feature characteristic of 
cancer development (Benatti et al., 2004). Furthermore alterations to the 
membrane fatty content change the membrane-receptor and cell-to-cell 
communications resulting in abnormal and unregulated cell function. A study 
investigating the interaction of human colorectal carcinoma cells with Kupffer 
cells and extracellular matrix protein indicated that an increased membrane  
n-6 FA content decreased adherence to extracellular matrix protein, which 
may lead to increased cell motility and invasiveness (Meterissian et al., 1995). 
It has been shown that Kupffer cell binding precedes tumour cell phagocytosis 
and killing, thus decreased binding may improve tumour cell survival. 
 
In contrast, n-3 PUFA-enriched diets have been shown to reduce the 
development of colon tumours by reducing signalling pathways that enhance 
cell proliferation (Calviello et al., 2004). A study by Chang et al. (1998) 
suggested that fish oil rich in n-3 FA blocks the progression of colon cancer by 
increasing cell differentiation and apoptosis. The mechanism by which n-3 FA 
may lower the risk of cancer is through their suppressing effect on the 
biosynthesis of arachidonic-derived eicosanoids. This effect is achieved at 
several levels. First, high intakes of n-3 FA result in their incorporation into 
membrane phospholipids, where they partially replace arachidonic acid 
(Crawford et al., 2000). By decreasing the availability of arachidonic 
precursors, this substitution suppresses the biosynthesis of arachidonic 
derived eicosanoids in favour of those derived from n-3 FA (Larsson et al., 
2004). An increase in long chain n-3 FA such as eicosapentaenoic acid and 
docosahexaenoic acid in membranes may have antitumour effects by 
affecting gene expression or the activities of signal transduction molecules 
involved in the control of cell growth, differentiation and apoptosis (Larsson et 
al., 2004). 
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3. Polyunsaturated Fatty Acids (PUFA) 
Amongst dietary fats, the essential fatty acids (EFA) have been identified as 
essential nutrients (Cunnane, 2003). An essential nutrient is one that is 
needed for normal development and function of mammalian cells throughout 
the life cycle. Most vertebrates are capable of synthesizing FA containing 
either no (saturated) or one (monounsaturated) carbon-carbon double bond 
per mole. Dietary PUFA linoleic acid and α-linolenic acid are the sole sources 
of FA that cannot be synthesized by many animal species, including humans. 
 
The two principle dietary EFA linoleic acid (C18:2n-6) and α-linolenic acid 
(C18:3n-3) (Fig. 4) are the biosynthetic precursors of carbon-20 and 
carbon-22 PUFA with three to six double bonds that are formed via sequential 
desaturation and chain elongation steps. 
 
 
 
 
Fig. 4 Principle omega-3 and omega-6 EFA 
(http://www.scientificpsychic.com/fitness/fattyacids.html,  
accessed 26 March 2007).  
 
 
3.1 Nomenclature 
N-6 and n-3 FA are PUFA with two or more double bonds in the carbon atom 
chain. The distinction between omega-3 and omega-6 FA begins with 
structural dissimilarities. In designation of FA structure, numerical notation 
indicates the number of carbon atoms followed by the number of double 
bonds and an omega designation (ω- or n-) referring to the position of the first 
double bond from the methyl terminus (Jho et al., 2004). For example, 
C18:2n-6 has 18 C-atoms and two double bonds, with the first double bond at 
the 6th carbon atom counted from the methyl end.  C18:3n-3 has 18 C-atoms 
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and three double bonds, with the first bond at the 3rd carbon atom counted 
from the methyl group. C18:2n-6 is the parent compound of the n-6 family, 
whereas C18:3n-3 is the parent compound of the n-3 FA family. 
 
3.2 Dietary sources 
Vegetables are the main source of n-6 FA. The parent n-6 FA, C18:2n-6 is 
found in vegetable seeds and oils such as safflower, soybean, corn and 
sunflower (Table 1) (http://www.benbest.com/health/essfat.html, accessed 13 
June 2008). The marine food chain is based on the n-3 FA, which are present 
in plankton and algae on which the fish feed (Bartsch et al., 1999). Several 
species of marine fish, which include fatty fish such as salmon, tuna, herring, 
mackerel and anchovy, offer a rich dietary source of eicosapentaenoic acid 
(C20:5n-3) and docosahexaenoic acid (C22;6n-3). However, fish as a food 
source is not regularly included in the Western diet. Therefore, for the majority 
of the population, the alternative dietary source of long chain n-3 FA may be 
their precursor, C18:3n-3. This FA is found mainly in foods including perilla oil 
from the Asian beefsteak plant (Perilla frutescen), linseed oil, grapeseed oil, 
blackcurrent oil, flaxseed oil, borage oil, walnuts and green leafy vegetables 
such as purslane and spinach (Bartsch et al., 1999; Kurowska et al., 2003). 
 
3.3 Metabolism of PUFA 
Diet primarily provides EFA in the form of C18:2n-6 and C18:3n-3. In humans 
these 18-carbon precursors can be desaturated and elongated to more highly 
unsaturated members of their family, principally, arachidonic acid (C20:4n-6) 
and C20:5n-3. The liver is the primary site for EFA metabolism, although it 
does take place in other tissue as well (Pearce, 1983). 
 
The n-3 and n-6 FA are not metabolically interconvertible but share the same 
the same enzymes when desaturated and elongated (Cho et al., 1999). The 
first part of the metabolic pathway leading to the synthesis of metabolically 
functional PUFA of the n-3 and n-6 series takes place in the endoplasmic 
reticulum (Benatti et al., 2004). C18:2n-6 and C18:3n-3, undergo sequential 
alternating desaturation and elongation steps that are catalyzed by ∆6- and 
∆5-desaturase and FA elongase, (Fig. 5) (Benatti et al, 2004).  
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Table 1: FA percentages of commercially available dietary oils 
Food Palmitic acid Stearic acid Oleic acid Linoleic acid α-Linolenic acid
 C16:0 C18:0 C18:1n-9 C18:2n-6 C18:3n-3 
Perilla oil 6 2 17 15 61 
Flaxseed oil 3 7 21 16 53 
Menhaden 
herring oil (1) 19 4 13 1 1 
Canola oil 5 2 53 22 10 
Walnut oil 7 2 15 60 10 
Soybean oil  11 4 23 51 7 
Butter (2) 25 11 26 2 2 
Beef fat 29 20 42 2 0 
Palm oil 45 5 38 10 0 
Olive oil 14 3 71 10 0 
Corn oil 11 2 25 55 0 
Sunflower seed 
oil 6 4 24 65 0 
Borage oil (3) 11 4 16 39 0 
Evening 
primrose oil (4) 6 1 11 72 1 
Safflower oil 7 3 15 75 0 
(1) menhaden herring oil contains 1% EPA and 9% DHA 
(2) 30% of butter is saturated fat of chain length less than 16 (butyric acid. C4:0 has a 
“butter” flavour) 
(3) Borage oil contains 24% C18:3n-6 
(4) Evening primrose oil contains 10% C18:3n-6 
(Adapted from http://www.benbest.com/health/essfat.html, accessed 13 June 2008) 
  
C18:3n-3 is desaturated and elongated to C20:5n-3 and C22:6n-3. C18:2n-6 
is metabolized by ∆6-desaturation to form γ-linolenic acid (C18:3n-6), which is 
rapidly elongated to dihomo-γ-linolenic acid (C20:3n-6). C20:3n-6 can be 
further desaturated to C20:4n-6. However, due to the limited activity of 
∆5-desaturase in rodents and humans, only a small fraction of C20:3n-6 is 
converted to C20:4n-6 (Johnson et al., 1997). The synthesis outcome is 
dependent on competition between C18:3n-3, C18:2n-6 and some of their 
longer chain products for ∆6-desaturation, the influence of various hormones 
on desaturation activity, and negative feed-back regulation of long chain 
(LC)PUFA on both the ∆6- and ∆5-desaturases (Nakamura and Nara, 2004). 
 
The n-3 and n-6 FA are competitive inhibitors of each other’s metabolism. The 
competition is apparent at the desaturation step (Fig. 5), where a large 
amount of one type of FA will interfere with the metabolism of the other. With 
regards to FA metabolism, the rate limiting ∆6-desaturase enzyme is important 
in regulating the level of LCPUFA (Horrobin, 1993). It has been shown that the 
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∆6-desaturase enzyme is compromised by a decrease in activity in cancer 
cells and tumours (Horrobin, 1993). In effect, this results in low levels of 
LCPUFA in the cancer tissue. 
 
linoleic acid
C18:2n-6
α-linolenic acid
C18:3n-3
n-3 family n-6 family
steareadonic acid 
C18:4n-3
eicosatetraenoic acid
C20:4n-3
eicosapentaenoic acid
EPA C20:5n-3
docosapentaenoic acid
C22:5n-3
docosahexaenoic acid
C22:6n-3
γ-linolenic acid
C18:3n-6
dihomo γ-linolenic acid
C20:3n-6
arachidonic acid
C20:4n-6
docosatetraenoic acid
C22:4n-6
docosapentaenoic acid
C22:5n-6
∆6 desaturase
∆5 desaturase
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elongase
elongase
 
Fig. 5 Metabolism of EFA α-linolenic acid (n-3 FA) and linoleic acid (n-6 FA) to metabolically 
functional PUFA. (Adapted from Sprecher, 2002). 
           
 
3.4 Biological and functional effects of PUFA in the mammalian cell 
Membranes are of fundamental importance to cell structure and function. FA 
are the defining constituents of membrane lipids and are therefore responsible 
for their distinctive physical and metabolic properties. Any PUFA produced in 
the endoplasmic reticulum (ER) may be removed from the biosynthetic 
cascade and used for membrane lipid synthesis by enzymes localized in the 
ER (Sprecher, 2002).  
 
3.4.1 Components of membrane structure 
PUFA are important constituents of the phospholipids, where they appear to 
confer distinctive properties to the membrane, in particular by decreasing their 
rigidity. Phospholipids are the dominant lipids in all cell membranes. These 
glycerol based lipids contain side chains with variable FA contents namely, 
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phosphatidylserine (PS), phosphotidylethanolamine (PE), phosphatidylcholine 
(PC) and phosphatidylinositol (PI) (Juanéda et al., 1990) 
 
The phospholipids bilayer forms the basic structure of all membranes. 
Membrane phospholipids distribution is asymmetrical, with PC and 
sphingomyelin (SM) located in the outer leaflet, and PE and PS located in the 
inner leaflet (Deveaux, 1991). Most phospholipids contain a PUFA at the 
second carbon atom (sn-2 position) of the glyceride backbone and a saturated 
FA or monounsaturated FA at the sn-1 position. The presence of saturated 
and monounsaturated FA ensure that there is a correct balance between 
rigidity and flexibility.  
 
The FA composition of phospholipids determines biophysical (and functional) 
characteristics of membranes (e.g. membrane fluidity) (Burns et al., 1979), 
and influence the conformation and activity of many membrane associated 
enzymes and receptors involved in the second messenger system and cell 
signalling (Woutersen et al., 1999; Wiseman, 1996). With diet being a major 
source of FA, intake can modulate membrane FA composition and alter 
membrane associated functions (Yehuda et al, 2005).  
 
3.4.2 Functional properties of PUFA 
The importance of PUFA to health has been highlighted by studies reviewing 
FA deficiencies (Ruggieri et al., 1976; Holman et al., 1991). PUFA and their 
metabolites have two main physiological functions. Firstly PUFA are structural 
components of cellular membranes. In the retina and the brain, C20:5n-3 and 
C22:6n-3 is essential structural components (Crawford et al., 1978; 
SanGiovanni and Chew, 2005). PUFA confer distinctive properties to the 
membrane, in particular by decreasing their rigidity. Without the availability of 
PUFA, membranes will incorporate more saturated FA resulting in less fluid 
and unstable membranes.  
 
In addition, PUFA are involved in cholesterol transport and metabolism. 
Cholesterol is transported in the body largely in the form of fatty esters. Found 
in large amounts in plasma membranes, cholesterol also has a rigidifying 
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effect on the membrane by inhibiting the overall flexing motion of the acyl 
(hydrocarbon) chains (Petrache et al., 2005). Dietary intakes of PUFA of the 
n-6 series have been shown to lower plasma cholesterol (Horrobin and 
Manku, 1983). 
 
3.4.2.1 Eicosanoid production by PUFA substrates 
The role of EFA such as C18:2n-6 and C18:3n-3 obtained from plant 
ingredients in the diet is crucial. Without a source of these precursory FA, the 
production of eicosanoids would be compromised. In the mammalian 
organism eicosanoids are synthesized by every tissue and cell type and seem 
to be involved in the majority of physiological events. At the cellular level, they 
may act in a typical hormone-like manner by playing a role in normal 
metabolic processes (Tapiero et al., 2002). Metabolic activities influenced by 
eicosanoids include platelet aggregation, inflammation, haemorrhage, 
vasoconstriction, blood pressure and immune function (Benatti et al., 2004). 
 
 
Fig. 6 Arachidonic acid 
(http://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/prostag.htm, accessed 28 
February 2007) 
 
Most eicosanoids are derived from C20:4n-6 (Fig. 6) 
(http://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/prostag.htm, 
accessed 28 February 2007). In unstimulated cells, this 20-carbon FA is found 
to be sequestered in phospholipids from which it is released upon stimulation. 
As a consequence, the eicosanoids are produced only on demand. Thus, 
availability of these mediators is tightly controlled by the cellular 
concentrations and activities of the enzymes involved in their biosynthesis. 
These enzymes may be classified into four major groups, phospholipases for 
the signal induced release of C20:4n-6 from membrane phospholipids; 
prostaglandin endoperoxide synthases or cyclooxygenases (COX) for the 
metabolism of C20:4n-6 to prostanoids, i.e. prostaglandins, prostacyclins, and 
 
 
 
 
 25
thromboxanes; lipoxygenases (LOX) for the formation of hydroxylated 
eicosatetranoic acids (HETEs), leukotrienes etc. and cytochrome P450-
controlled monooxygenases for epoxidation and hydrolation of C20:4n-6 (Fig. 
7) (Marks et al., 2000). 
 
 
Fig. 7 Major enzymatic pathways involved in the formation of eicosanoids   from lipid FA 
(Marks et al., 2000).  
 
 
Other 20-carbon PUFA, such as C20:3n-6 and C20:5n-3 is also substrates for 
eicosanoid production cascades that parallel and compete with the C20:4n-6 
cascade. C20:5n-3 is a precursor of the prostaglandin of the 3-series, with 
three double bonds. The n-3 FA is converted by the same COX enzyme to the 
3-series endoperoxide PGH3, by way of PGG3, which can be further 
metabolised to PGE3 (Rose and Connolly, 1999). C20:3n-6 provides a third, 
less prominent cascade and yields prostaglandins of the 1-series. Although 
C20:3n-6 and C20:5n-3 is generally poorer substrates for prostaglandin 
synthase than C20:4n-6, they both compete for the enzyme binding site and 
can reduce the production of C20:4n-6-derived prostaglandins (Tocher et al., 
1997). Therefore, the supply of precursor PUFA for eicosanoid synthesis is 
directly related to the FA composition of membrane phospholipids which in 
turn is influenced by dietary PUFA intake and metabolism 
Prostaglandins occur at very low levels in nearly all-mammalian tissue. 
Prostaglandins have been found to exert a wide variety of pharmacological 
Phospholipids
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effects on humans and animals: PGE2 contraction and relaxation of smooth 
muscles of the uterus, PGE1 has vasodilatory properties, PGI2 reduces blood 
pressure and inhibits platelet aggregation by reducing calcium concentrations 
(Pai et al., 2002; Tapiero et al., 2002). These PUFA derivatives have also 
been shown to regulate cell processes such as mitosis, cell proliferation and 
cell adhesion (Rishikesh and Sadhana, 2003).  
 
3.4.2.2 PUFA modulates signal transductions 
PUFA released from membrane phospholipids by cellular phospholipases or 
exogenous sources are important signalling molecules (La et al., 2003). 
Research has shown that FA can act as second messengers or regulators of 
signal-transducing molecules, hereby regulating the transmission of signals 
from the extracellular environment (Sumida et al., 1993). The effects of PUFA 
on gene expression can be sustained for a time period dependent on its 
availability through the diet. In these cases, the PUFA acts like a hormone to 
control the activity or abundance of key transcription factors (Jump, 2004). 
 
PUFA effects on gene expression are cell specific and influenced by FA 
structure and metabolism. The molecular mechanism by which PUFA interact 
with the genome through several mechanisms is not fully understood. Studies 
suggest that these effects might be mediated by ligand-activated transcription 
factors. The peroxisome proliferators activated receptor (PPAR), a member of 
nuclear receptor supergene family of transcription factors, is suggested to be 
activated by PUFA. PPAR monitors the levels of nonesterified FA (Pawar and 
Jump, 2003). As such, FA binding to PPAR leads to changes in the 
transcription of many genes involved in lipid metabolism and storage.   
 
PUFA can cause protein phosphorylation, which is important for the activation 
or inhibition of enzymes involved in receptor mediated signal transduction 
pathways. Protein kinase C (PKC) phosphorylates target proteins in cells that 
regulate cellular proliferation and differentiation (Pajari et al., 1997). The 
activation of PKC is dependent on the lipid and FA composition of membrane 
phospholipids (Nishizuka, 1992). 
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3.4.2.3 Oxidative stress inducers 
Oxidative stress occurs when the production of oxidising agents, free radicals 
and reactive oxygen species (ROS) exceeds the antioxidant capacity of 
cellular antioxidants in a biological system (Schrader & Fahimi, 2006). This 
imbalance leads to tissue injuries and to the progression of degenerative 
diseases in humans such as cancer (Wijeratne & Cuppett, 2006). 
  
PUFA in membrane lipids containing two or more bonds, are opportune 
targets for free radicals. PUFAs create oxidative stress in biological systems 
as they under go lipid peroxidation, forming free radicals such as peroxyl and 
alkoxyl radicals. Although these lipid hydroperoxides are short-lived, their 
breakdown results in the formation of secondary products of lipid peroxidation 
(aldehydes such as malondialdehyde and 4-hydroxyalkenals) that are 
longer-lived and can attack a variety of cellular targets 
(http://findarticles.com/p/articles/mi_m0FDN/is_1_7/ai_83582815/, accessed 
24 September 2008).  
 
Lipid peroxidation is initiated by the attack on a FA or fatty acyl side chain of 
any chemical species that has sufficient reactivity to abstract a hydrogen atom 
from a methylenes carbon in the side chains. The greater the number double 
bonds in a FA side chain, the easier is the removal of a hydrogen atom, which 
is why PUFAs are particularly susceptible to peroxidation. The removal of a 
hydrogen atom from a PUFA double bond produces a reactive species that 
can propagate further reactions (Fig. 8).  
 
Products from this oxidative process may in turn react with DNA to form 
ethno- or malonaldehyde-derived DNA adducts that may cause misreplication 
during DNA synthesis (De Kok et al., 2003). The affected cell can try to repair 
this damage, which may involve exiting from the cell cycle and hence an 
anti-proliferative effect, or if damage is too severe cell death can occur 
(Diggle, 2002). Cell death can occur by necrosis, but lipid peroxidation can 
trigger the process of apoptosis, activating the intrinsic suicide pathway 
present within all cells (Gago-Dominguez et al., 2005). 
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Fig. 8  Schematic view of lipid peroxidation. Free radicals attack membrane 
lipids unsaturated FA, setting in motion a chain reaction which generates 
reactive species with the potential to cause cellular damage. 
(http://www.library.wur.nl/wda/dissertations/dis3424.pdf, accessed 7 March 
2006). 
 
3.5 PUFA and cancer development 
With the FA content of membranes playing an important role in normal cell 
function, clearly changes can have a profound effect on cellular functions such 
as signal transductions and membrane trafficking. Abnormalities in FA 
metabolism have been suggested to play a critical role in cancer 
development. Studies show that the impairment of ∆6-desaturase activity to be 
a characteristic feature of cancer cells (Horrobin, 1990). Impaired enzyme 
activity reduces the synthesis of the biologically functional LCPUFA. As a 
result, key membrane associated functions linked to membrane LCPUFA 
availability is affected. Consequently, these alterations play an important role 
in the abnormal cellular growth, which prevails in preneoplastic lesions. 
 
A causal relationship between cancer development and an abnormal over 
expression of eicosanoid forming enzymes has been implicated with a wide 
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variety of tumours (Accioly et al., 2008). After the release of C20:4n-6 from 
membrane phospholipids by phospholipases, it can be enzymatically oxidised 
to PGG2 and PGH2, the parent compounds of prostaglandins by 
cyclooxygenase (COX) (Whelan and McEntee, 2004). Formation of PGH2 is 
the committed step in the biosynthetic pathway. There are two COX isoforms, 
COX-1 and COX-2. COX-1 is constitutively expressed at low levels in most 
tissues and is thought to have cellular housekeeping function. COX-2 is not 
normally expressed in most tissues and is considered to be the inducible form 
of the enzyme. COX-2 has been detected in virtually all cancers, and its 
expression is variable and dependent on the stage of the neoplasia (Prescott 
and Fitzpatrick, 2000). Key events of tumour promotion such as cellular hyper 
proliferation and inhibition of programmed cell death have been found to be 
related to the pathological over expression of the pro-inflammatory enzyme 
COX-2. Genotoxic by-products of COX-2 catalyzed FA metabolism (such as 
active oxygen species, free radicals etc.) are suspected to contribute to 
genetic instability and thus to malignant progression of tumour cells.  
 
Two PGs, PGE2 and PGI2, derived from C20:4n-6 has been linked to 
colorectal cancer development. When PGs are produced, they act locally on 
cell-surface receptors in paracrine or autocrine manner to mediate their 
pathological effects (Cao and Prescott, 2000). PGE2 mediated tumourigenesis 
via 4 G-protein coupled receptors (EP 1-4) that modify intracellular calcium or 
cAMP (Hansen-Petrik et al., 2002). Cytoplasmic fluxes in either cAMP or 
calcium can have broad downstream effects on colorectal neoplasia; however 
the precise molecular mechanisms have yet to be clarified. PGI2 appears to 
mediate its protumourigenic effects via the activation of peroxismal 
proliferator-activated receptor-γ, which is up regulated in colorectal tumours, 
promoting tumourigenesis and inhibiting apoptosis (Whelan and McEntee, 
2004).  
It has been shown that several signal transduction systems including the PKC 
system are involved in the regulation of cell proliferation and this may play a 
role in fast growing cells. A key enzyme in this system is phospholipase C 
(PLC) which is a membrane bound enzyme that provides the second 
messengers for activation of PKC. In the human colon cell line, HT-29 
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adenocarcinoma cells, it has been shown that alterations of the membrane 
lipid content by the addition of EFA influences cell proliferation by modulating 
the activity of phospholipases (Awad et al.,1996a). PLC activity was shown to 
be much lower in cancer cells exposed to n-6 FA (C18:3n-6) compared to n-3 
FA (C18:3n-3, C20:5n-3 and C22:6n-3).  
 
Oxidative stress is considered to play a major role in carcinogenesis, with diet 
having a significant effect on the production of ROS (Kondo et al., 1994; 
Rainis et al., 2007). The unregulated or prolonged production of ROS has 
been linked to mutation (induced by oxidant-induced DNA damage), as well 
as modification of gene expression, which are characteristic of carcinogenesis 
(Bartsch and Nair, 2002). Owing to their structure, which is rich in double 
bonds, PUFA render cellular membranes vulnerable to damage from free 
radicals, resulting in a lipid peroxidation cascade. Under normal cellular 
conditions excessive ROS damage to lipid membranes can be prevented by 
cellular natural defences (Hiraishi et al., 1991). However, the role of 
oxy-radicals during the initiation and promotion stages of carcinogenesis has 
been suggested to resulting in a decreased PUFA content in the tumour 
subcellular membranes (Masotti et al., 1988; Dudeja and Brasitus, 1990). 
 
A reduction in tumour membranes degree of unsaturation is the most relevant 
rate-limiting factor of peroxidation. Membranes decrease in PUFA content has 
been linked to the activities of the FA metabolising enzymes such as 
∆6-desaturase, which is much lower in tumours (Hrelia et al., 1994). In Morris 
hepatoma cells, alterations to the membranes lipid composition, particularly 
regarding the degree of unsaturation and the loss of protective enzymes 
against oxygen radicals, such as superoxide dismutase (SOD), increased 
microsomal membranes resistance to lipid peroxidation (Galeotti et al., 1984). 
Increasing cellular peroxidation by enhancing membranes PUFA content can 
play a role in the control of cell proliferation by inhibiting cell growth and 
stimulating or enhancing apoptosis by (Bartsch et al., 1999). Thus, increasing 
membranes resistance to lipid peroxidation may play an important role in 
promoting neoplastic growth. 
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4. Chemoprevention of cancer using PUFA 
Chemoprevention by definition is the use of agents to slow the progression of, 
reverse, or inhibit carcinogenesis, thereby lowering the risk of developing 
invasive or clinically disease (Sun et al., 2004). The goal of any therapeutic 
strategy is to impact on the target cell within limited detrimental effect to 
normal cell function (Kasibhatia and Tseng, 2003). Suggested mechanisms of 
cancer prevention at a cellular level have been reported to be the promotion of 
differentiation, induction of apoptosis and inhibition of proliferation in tumour 
cells (Latham et al., 1999). 
 
As previously discussed, PUFA plays a critical role in cellular regulatory 
processes. Modulation of the FA content in membranes through dietary intake 
could thus be a plausible mechanism by which cancer progression could be 
delayed. 
 
4.1 n-3 PUFA 
Animal experiments and in vitro studies have highlighted that long chain, 
marine n-3 PUFA C20:5n-3 and C22:6n-3 is able to suppress the 
development of colon cancer (Davidson et al., 2004; Takahashi et al., 1997; 
Chen and Istfan, 2001). C20:5n-3 and C22:6n-3 ingested through the diet, 
enrich the membrane phospholipids pool, resulting in competition with n-6 
PUFA such as C20:4n-6 for ∆6-desaturase and COX enzymes, reducing 
eicosanoid biosynthesis (Larsson et al., 2004; McEntee and Whelan, 2002). 
Therefore, n-3 FA inhibits tumour development by competitive inhibition of 
C20:4n-6 metabolism, as well as by the unique opposing effects of n-3 
derived metabolites. 
 
The incorporation of n-3 FA into cells membrane phospholipids can alter 
membrane fluidity and modulate cell signalling (Mahèo et al., 2005). Due to 
low PUFA content in tumour cells, lipid peroxidation is low, providing a good 
environment for growth. Another possible mechanism by which dietary fish oil 
rich in n-3 LCPUFA such as C20:5n-3 and C22:6n-3  inhibit carcinogenesis is 
that n-3 PUFA may increase the accumulation of lipid peroxidation products in 
tumour cells, which may decrease cell proliferation and increase cell death 
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(Latham et al., 1999; Woutersen et al., 1999). Hong et al. (2002) showed that 
fish oil increases the oxidative stress levels in rat colonocytes. With the 
elevation of mitochondrial phospholipid unsaturation, an increase in ROS 
initiated an apoptotic cascade, which is suggested to inhibit colon cancer 
development. 
 
Overall, it appears that the n-3 FA achieve their anticancer effects by 
competitive inhibition of n-6 FA metabolism, which suggests that it is not the 
total amount of n-3 FA, but the balance of n-3 FA and n-6 FA that is important.  
 
4.2 n-6 PUFA: γ-linolenic acid (C18:3n-6) 
C18:3n-6 is metabolized to C20:3n-6, a precursor for the anti-inflammatory 
1-series prostaglandins. Dietary supplementation with C18:3n-6 has been 
shown to influence the production of eicosanoids by its interference with the 
metabolism of C20:4n-6 to bioactive metabolites (Johnson et al., 1997).  
Research suggests a link between the irritation caused by an inflammatory 
response and colon cancer development (Nakanishi and Rosenberg, 2006). 
Thus, as a preventive measure to the biosynthesis of tumour promoting 
C20:4n-6 metabolites, an increase in tissue C18:3n-6 attenuates their 
production. As C18:3n-6 bypasses the ∆6-desaturase, a key regulatory 
rate-limiting enzymatic step controlling the formation of PUFA, it may alleviate 
any decrease in the resultant long chain desaturated FA as noticed in cancer 
cells (Galeotti et al., 1984).  
 
In vitro studies have shown that C18:3n-6 can selectively kill tumour cells 
while causing little or no harm to normal cells.  Seegers et al. (1997) have 
shown that C18:3n-6 causes inhibition of cell progression and induces 
apoptosis in transformed cells. C18:3n-6 has the ability to inhibit both motility 
and invasiveness of human colon cancer cells by increasing the expression of 
E-cadherin, a cell-to-cell adhesion molecule that acts as a suppressor of 
metastasis (Jiang et al., 1997). 
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4.3 n-6/n-3 FA ratios 
The balance of EFA is important for good health and normal development. In 
Western industrialised countries diets contain levels of fat high in n-6 PUFA 
(e.g. corn oil), which are associated with tumour promotion (Wu et al., 2004). 
The development of breast cancer, for example, has been associated with the 
consumption of high n-6/n-3 PUFA ratios (Capone et al., 1997). It has been 
shown that dietary n-6 FA influences cancer development by affecting 
biochemical events that occur after the initiation of a cancerous cell, whereas 
the addition of n-3 FA to the diet can block the promoting effects of n-6 FA 
(Cave, 1997). It is therefore necessary to reduce the adverse effects of n-6 
PUFA and its metabolic products through dietary supplementation with n-3 
PUFA from fish and fish oils. 
 
However, studies suggest that the dietary n-6/n-3 PUFA ratio, rather than the 
quantity of n-3 PUFA is a key factor in the anti-tumour effect (Rose and 
Connolly, 1999). Intake of fish or fish oil FA C20:5n-3 and C22:6n-3 partially 
replaces the n-6 FA, especially C20:4n-6, in the membrane of all cells 
(Simopoulos, 2002). It is therefore possible that the ratio of n-6/n-3 PUFA 
entering the cellular pool from dietary sources can alter the ratio of eicosanoid 
precursor FA in membrane phospholipids.  
 
It is important to note that although the therapeutic strategy is to reduce the   
n-6 FA content in tumour membranes through supplementation with n-3 rich 
food, n-6 FA intake needs to be maintained in order for normal cell function to 
continue. Therefore, a balanced n-6/n-3 FA ratio is an important factor in 
terms of metabolic effects. Historically, before the advent of the agricultural 
revolution, the n-6/n-3 FA ratio was maintained at approximately 1:1. 
However, with the modernization of cultures and the availability of processed 
foods the ratio has shifted in favour of n-6 FA, with a n-6/n-3 ratio of 15-20:1 
(Simopoulos, 2002).  Thus strategies have been proposed that a lower n-6/n-3 
PUFA ratio is more desirable in reducing the risk of chronic diseases such as 
cancer.  
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When proposing a dietary intervention strategy for cancer therapies, the type 
of FA constituting the ratio is the critical factor to be considered. Cancer 
modulation studies indicate that low fat diets containing fish oil significantly 
decreases the n-6/n-3 PUFA ratio in plasma and gluteal adipose tissue in men 
with prostate cancer (Aronson et al., 2001). Administration of high doses of 
fish oil inhibits ∆6-desaturation and reduces the n-6 FA content in tumour 
membranes. In association with dietary C18:3n-6, the reduction by fish oil of 
the levels of n-6 derived FA can be maintained at an optimal level to 
compensate for normal cell functions. In cancer cells ∆5- and ∆6-desaturase 
activity is impaired, thus C18:3n-6 is elongated to C20:3n-6 without further 
desaturation to C20:4n-6. This could explain why C18:3n-6 supplementation 
may attenuate C20:4n-6 metabolism in some cells (Johnson et al., 1997).  
Thus C20:5n-3 given with C18:3n-6 raises the levels of the desirable 
C20:5n-3 and C20:3n-6, without raising C20:4n-6 (Nassar et al., 1986; 
Horrobin et al., 1984).  
 
Abnormal EFA metabolism, such as the inability of ∆6-desaturase to 
synthesize C18:3n-6 and C20:3n-6, or an overproduction of the undesirable 
2-series eicosanoids from C20:4n-6, has been linked to the development of 
many chronic degenerative diseases including cancers. This defect can thus 
be potentially overcome by dietary supplementation with a mixture of 
C18:3n-6-rich oil (e.g. borage oil) and C20:5n-3-rich fish oil. Research has 
shown that C18:3n-6 supplementation can bypass the pathologically defective 
∆6-desaturase activity and elevate the formation of C20:3n-6 and 
subsequently the synthesis of the desirable 1-series eicosanoids (Fan and 
Chapkin, 1998). C20:5n-3 supplementation meanwhile increases tissue 
C20:5n-3 levels, which not only suppress the C20:4n-6 levels, but also 
reduces the synthesis of 2-series eicosanoids with their undesirable effects. In 
addition, C20:5n-3 also suppresses the conversion of C20:3n-6 to C20:4n-6, 
increases the ratio of C20:3n-6 to C20:4n-6 in tissue and plasma 
phospholipids, and hence increases the formation of 1-series eicosanoids. 
Thus dietary supplementation with the proper combinations of C18:3n-6 and 
C20:5n-3 could modulate the synthesis of 1-, 2- and 3-series eicosanoids. 
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Subsequently, a balanced eicosanoid metabolism may reduce the 
development of cancer. 
 
In addition to modulating eicosanoid production, dietary intakes of low n-6/n-3 
FA ratios increase membranes PUFA content (Abel et al., 2004). Due to the 
relative increase of PUFA, particularly the n-3 LCPUFA C20:5n-3 and 
C22:6n-3, membranes are more susceptible to lipid peroxidation (Song et al., 
2000). An increase in lipid peroxidation increases the oxidative stress levels 
within cells due to the production of lipid oxidative products, which have 
deleterious effects due to stimulating apoptosis (Lotem et al., 1996).  
 
In cancer cells the level of lipid peroxidation is low due to a reduction in 
membrane PUFA content (Cheeseman et al., 1988). Thus, by specifically 
increasing membranes n-3 LCPUFA through dietary fat intake, cancer cells 
are made more susceptible to oxidative damage and are therefore stimulated 
to undergo apoptosis due to an increase in oxidative stress (Narayanan et al., 
2001). The study by Abel et al. (2004) illustrated that low dietary n-6/n-3 FA 
ratios not only alter membranes FA profile in hepatocyte nodules, but also 
increased susceptibility to lipid peroxidation. By increasing the oxidative stress 
within cancer cells, processes regulating apoptosis could be stimulated 
(Latham et al., 1999). This strategy utilizing low dietary n-6/n-3 FA ratios to 
modulate membranes lipid profile could be useful tool in the chemoprevention 
of cancer.     
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Abstract 
Several abnormal conditions, including some cancers, have been associated 
with changes in the membrane lipid and FA composition. Dietary fat serves as 
a major source of lipids and FA, particularly the polyunsaturated fatty acids 
(PUFA), n-6 and n-3. High intakes of n-6 PUFA have been linked to the 
development of colon cancer in association with low n-3 PUFA intake. 
Therefore understanding the differences in the lipid and FA profiles between 
cancer and normal cells in the colon, and the role diet plays in these factors 
may be invaluable in understanding their role in carcinogenesis. This study 
compares the lipid profile of azoxymethane (AOM) induced colon polyps to 
that of the surrounding mucosa tissue in rats fed a diet high in n-6 PUFA. 
Male Fischer rats were fed the AIN-76A diet containing sunflower oil that has 
high n-6 PUFA content for a period of nine months. Results indicate that the 
lipid and FA content of the colon polyps differs significantly from the 
surrounding mucosa. Colon polyps had an increase in membrane 
phopholipids phosphatidylcholine (PC) and phosphatidylethanolamine (PE). 
Changes in membrane fluidity were indicated by the decrease (p<0.05) in the 
PC/PE and cholesterol/phospholipids (chol/PL) ratios, and increase (p<0.05) 
in the polyunsaturated FA/saturated FA (P/S) ratio. Metabolism of FA was 
significantly altered in the polyps favouring n-6 FA metabolism and the 
production of prostaglandin E2. No clear indication of impaired ∆6-desauturase 
enzyme activity was noticed. Increases in the n-6 PUFA content could be a 
reflection of the dietary FA intake that increases FA incorporation in the 
polyps.  Changes in the FA parameters of the polyps, particularly an increase 
in C20:4n-6 and the n6/n3 ratio have been shown to contribute to the rapid 
growth of cancer tissue. These lipid changes associated with the development 
of colon polyps could provide unique targets for developing strategies in 
chemoprevention by dietary manipulation. 
 
Keywords: colon polyps, membrane lipid profile, n-6 polyunsaturated fatty 
acids 
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2.1 Introduction 
Fatty acids (FA) as integral components of cell membranes play an important 
role in normal cell function. Membrane FA profiles influences cell structure 
with regards to membrane phospholipid composition, membrane fluidity and 
the activity of membrane enzymes and receptors (Goldberg and Zidovetzki, 
1997; Lund et al., 1999). In addition, FA act as signalling molecules involved 
in cell proliferation and/or apoptosis (Hwang and Rhee, 1999; Artwohl et al., 
2004).  
 
Studies have indicated that the altered lipid content of tumour tissue appears 
to play an important role in the process of carcinogenesis (Eriksson and 
Andersson, 1992). With tissue phospholipids being metabolically active and 
providing a dynamic reservoir of long-chain polyunsaturated fatty acids, 
alterations of the membrane FA content of tumour cells may play an important 
role in their altered growth characteristic (Jones et al., 2003).   
 
Although the role of individual FA in human cancer development is still poorly 
understood, animal studies have shown that diets containing high levels of n-6 
polyunsaturated fatty acids (PUFA) increase the incidence of chemically 
induced colonic tumours in rats (Reddy et al., 1991). Several studies indicate 
that diets high in lard, beef tallow, or corn oil, fat sources that have a high 
saturated fat and n-6 PUFA content increase the concentration of colonic 
luminal secondary bile acids (Craven et al., 1987; Chapkin et al., 1993). 
Secondary bile salts have been shown to induce cell proliferation and to act 
as promoters in colon carcinogenesis (Bull et al., 1993). In humans the high 
consumption of n-6 PUFA have been shown to increase the formation of 
exocyclic DNA adducts in white blood cells (Nair et al., 1997). These 
biomarkers of lipid peroxidation-derived DNA damage have been utilized to 
identify the links between increased intakes of dietary n-6 PUFA, DNA 
damage and the elevated risk for cancers of the breast, colon and prostate. 
 
Several mechanisms have been proposed to implicate n-6 PUFA involvement 
in the promotion of cancer development. One of these mechanisms is 
associated with the production of eicosanoids derived from PUFA substrates 
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(Tapiero et al., 2002). With the dietary intake and metabolism of dietary n-6 
PUFA such as linoleic acid, the availability of the metabolically active long 
chain PUFA, arachidonic acid (C20:4n-6) increases (Nicholson et al., 1991). 
C20:4n-6 derived metabolites serve as precursors for the synthesis of the 
short-lived 2-series prostaglandins (PG) that act in an autocrine or paracrine 
manner to convey their biological effects. Evidence linking the effects of 
dietary fat on mammary carcinogenesis to PG synthesis derives mainly from 
the observation that non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the 
promoting effects of diets rich in n-6 PUFA (Carter et al., 1983; Cunningham 
et al., 1997). PG synthesis, particularly of the 2-series, also suppresses the 
immune response and may thereby promote cancer development (Marnett, 
1992).  
 
With the lipid FA content of cell membranes playing an important role in 
maintaining cellular structure and function, the characterization of lipid 
alterations associated with tumour development would be of importance. The 
present investigation evaluated the differences in the lipid profiles of 
cancerous tissue and surrounding tissue in a colon cancer animal model with 
rats fed a diet high in n-6 PUFA. 
 
2.2 Methods and materials 
2.2.1 Chemicals 
Azoxymethane (AOM), sodium pentobarbital, perchloric acid, methanol and 
chloroform, fluorescing agent 2,5-bis-(5’-tert-butylbenz-oxazolyl-[2’])thiophene 
(i.e. BBOT), butylated hydroxytoluene (BHT), sodium hydroxide (NaOH), 
malachite green and the phospholipid standards were obtained from Sigma-
Aldrich.  Acetic acid, petroleum ether, boric acid, sodium carbonate (Na2CO3), 
sodium tartrate, copper sulphate (CuSO4.5H2O) and silica thin layer 
chromatography plates were supplied by Merck (Darmstadt, Germany). 
Sulphuric acid was obtained from BDH/Merck (Poole, England), sodium 
dodecyl sulphate from Fluka (Darmstdat, Germany) and bovine serum 
albumin (BSA) from Mees Laboratories (South Africa). The sunflower oil was 
supplied by RFS Catering Supplies (Milnerton, South Africa). 
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2.2.2 Induction of colon polyps 
The Ethics Committee of the Medical Research Council of South Africa 
approved the use of laboratory animals in this study. Starting at 7 weeks of 
age (approximately 150 g body weight), male Fischer rats (n=13) were 
injected i.p. with 15 mg/kg azoxymethane (AOM) once a week for three 
consecutive weeks.  The rat body weights were determined three times 
weekly. 
 
2.2.3 Animals and treatment 
The animals were housed individually in wire-bottomed cages under 
controlled lighting (12 hr cycles) and temperature (23-25°C) with free access 
to water. All rats were fed the AIN-76A diet (AIN, 1977) containing sunflower 
oil as a fat source for 9 months following the AOM treatment. The FA profile of 
sunflower oil is summarized in Table 1. Nine (9) months after initiation, all the 
rats were euthanized by injection (i.p.) with sodium pentobarbital (0.15 ml /100 
g body weight). The colon from each rat was removed and opened 
longitudinally. The macroscopic polyps were excised and the surrounding 
epithelial mucosa collected by scraping the inner surface with a microscope 
glass slide. The polyps and surrounding mucosa samples were frozen in liquid 
nitrogen and stored at -80 °C until analyzed.  
 
2.2.4 Lipid extraction 
For the colon polyp and surrounding mucosa lipid extraction, the tissue was 
ground to a fine powder in liquid nitrogen. A sub fraction of the mucosa 
powder (10-30 mg) was taken for protein analyses while the remaining sample 
(50-100 mg) mucosa samples were used for the lipid extractions. Lipids were 
extracted from the colon polyps and mucosa with chloroform/methanol (CM; 
2:1; v/v) containing 0.01% butylated hydroxytoluene (BHT) as antioxidant. 
Briefly, the method adapted from Folch et al. (1957): polyp and surrounding 
mucosa tissue previously ground to a fine powder in liquid nitrogen, were 
weighed (80-100 mg) and resuspended in 0.5 ml saline and the lipids were 
extracted with 12 ml CM. The CM mixture was filtered (sinterglass filters using 
Whatman glass microfibre filters, Cat N, 1820 866, Whatman International, 
Ltd, Maidstone, England), and the filtrate was evaporated to dryness in vacuo 
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at 40 °C. The extract was, transferred to glass culture tubes (5 x 2 ml CM), 
washed with saline saturated with CM (1 ml), and stored at 4 °C under 
nitrogen until analyzed.  
 
Table 1: Fatty acid content (%of total FA) of sunflower oil. 
Fatty acid % of total FA 
C14:0 0.07±0.01 
C16:0 6.68±0.18 
C17:0 0.04±0.02 
C18:0 4.45±0.07 
C20:0 0.29±0.02 
C22:0 0.75±0.06 
C24:0 0.25±0.01 
SATS total 12.53±0.37 
  
C16:1 0.06±0.02 
C18:1 25.17±0.50 
C20:1 0.21±0.01 
C22:1 0.02±0.01 
C24:1 0.05±0.01 
MUFA total 25.50±0.55 
  
C18:2n-6 62.25±0.76 
C18:3n-6 <0.01 
C20:2n-6 0.02±0.01 
C20:3n-6 <0.01 
C20:4n-6 <0.01 
C22:4n-6 <0.01 
C22:5n-6 <0.01 
n-6 total 62.31±0.77 
  
C18:3n-3 0.25±0.01 
C20:3n-3 <0.01 
C20:5n-3 <0.01 
C22:5n-3 <0.01 
C22:6n-3 <0.01 
n-3 total 0.25±0.01 
  
n-6/n-3 249.24±1.64 
PUFA 62.56±0.78 
P/S ratio 4.99±2.11 
n=2; SATS = saturated fatty acids; MUFA = monounsaturated 
fatty acids; PUFA = polyunsaturated fatty acids; P/S = 
PUFA/SATS. 
  
 
2.2.5 Thin layer chromatography (TLC) 
The lipid extracts were fractionated by thin layer chromatography (TLC). Lipid 
extracts (i.e. 30 μl spot per sample) were applied on 2 separate silica (10 x 20 
mm) TLC plates for fatty acids (FA) and phospholipids analyses, respectively. 
The plates were developed using the solvent chloroform: methanol: petroleum 
ether: acetic acid: boric acid (40:20:30:10:1.8; v/v/v/v/w) containing the 
fluorescent agent 2,5-bis-(5’-tert-butylbenz-oxazolyl-[2’])thiophene (i.e. 
BBOT), for 90 minutes (Addendum 1). The plates were dried under nitrogen 
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gas and phospholipids visualized under UV light. The lipid fractions PC and 
PE were identified against phospholipid standards. 
 
2.2.6 Fatty acid analyses 
For FA analyses the phospholipid fractions, PC and PE, were scraped off the 
TLC plates and transmethylated with 2 ml methanol/18 M sulphuric acid (95:5; 
v/v) at 70 °C for 2 hrs (Benadé et al., 1988), and the resultant FA methyl 
esters (FAME) extracted with hexane and distilled water (v/v, 2:1). The 
hexane (top layer) was removed and dried under nitrogen gas in a water bath 
(37 °C) and the samples dissolved in hexane prior to analyses by gas 
chromatography. The FAME were analyzed by gas chromatography on a 
Varian 3300 gas Chromatograph equipped with 30 m fused silica BPX-70 
capillary columns (SGE, USA) of 0.32 mm internal diameter (Addendum 2). 
The individual FAME were identified by comparison of the retention times to 
those of a standard FA mixture containing C14:0 to C24:1 (Nu-Chek-Prep, 
MN, USA) (Addendum 3). Results for individual FA were quantified using an 
internal standard (C17:0) and expressed both quantitatively (i.e. μg FA/mg 
protein) and qualitatively as a percentage of the total FA (Addendum 3).  
 
2.2.7 Phospholipid determination 
The phospholipids fractions PC and PE were determined colorimetrically 
based on the method according to Itaya and Ui (1966). Briefly, PC and PE 
fractions were separated by TLC (see section 2.2.5), and digested in 
perchloric acid (i.e. PC: 400 μl; PE: 300 μl) on a 170 °C heating block for two 
hours. After digestion, distilled water was added to the samples at a ratio of 5: 
1. Samples were vortexed and centrifuged at 500 rpm for 15 minutes and 250 
μl of the samples were transferred to clean tubes. A volume of 1 ml of 
phospholipid reagent (Addendum 4) containing malachite green, ammonium 
molbydate and tween at a ratio of 15:5:1 was added to each sample, and 
incubated at room temperature for 20 minutes, and the colour development 
measured spectrophotometrically at 660 nm and referenced against a 
phosphate standard curve. 
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2.2.8 Cholesterol determination 
The cholesterol content of the polyps and surrounding mucosa samples was 
determined by an enzymatic iodide method using cholesterin-oxidase and 
cholesterin-esterase (Richmond, 1973). Briefly, to 20 μl lipid CMS extract (see 
section 2.2.4) a volume of 50 μl chloroform:methanol (2:1 v/v) was added per 
sample and vortexed. Peroxide free Triton X-100 (300 μl) was added, 
vortexed and evaporated to clearness under nitrogen gas. Cholesterol reagent 
(1.7 ml) (Addendum 5) was added to each sample and vortexed. The 
cholesterol reagent B (20 μl) was added to 1 ml of the lipid sample solution 
transferred into clean glass tubes, and vortexed. To the remaining 1 ml 
cholesterol sample solution 20 μl 3 M NaCl was added and vortexed. After a 
30-minute incubation at room temperature, the absorbance was measured at 
365 nm with samples being referenced against the corresponding blank. 
Cholesterol content of the polyp and surrounding mucosa were quantified 
from a cholesterol standard curve. The cholesterol/phospholipid molar ratio 
(chol/PL) was calculated by using the combined PC and PE concentrations 
representing the main membrane phospholipids. 
 
2.2.9 Protein determination 
Powdered polyp and colon mucosa preparations (10-15 mg) from the liquid 
nitrogen homogenization step (see section 2.2.4) were solubilised in a 0.5 N 
NaOH 5% sodium dodecyl sulphate (SDS) solution at 37 °C for 48 hrs in a 
shaking water bath. The protein content was determined by using a modified 
Lowry method (Markwell et al., 1978; Addendum 6A). Briefly, solution 1 
containing 5% SDS + 0.5 N NaOH; solution 2 containing Na2CO3 (2%), 
sodium tartrate (0.16%) and solution 3, CuSO4.5H2O (4%), was prepared. 
Solubilised polyps and surrounding mucosa protein sample volumes ranging 
from 75-200 μl were dissolved with distilled water to a total volume of 200 μl. 
Solution 1 (300 μl) was added to each sample and vortexed. Solution 4 (1.5 
ml) consisting of 100 parts of solution 2 and 1 part of solution 3 was added to 
each sample then vortexed. Folin-Ciocalteu reagent (150 μl) diluted to a 1:1 
ratio with distilled water was added to each sample, vortexed, and samples 
incubated in a 37 °C water bath for 45 minutes. The absorbencies of the 
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samples were determined spectrophotometrically at 660 nm. Polyps and 
surrounding mucosa protein content were quantified against a BSA (0.5 
mg/ml) standard curve.  
 
2.2.10 Statistical analyses 
Statistical analyses (ANOVA) of the colon polyps and surrounding mucosa 
tissue mean fatty acid profile, phospholipids and cholesterol contents were 
conducted. For the FA the qualitative (i.e. percentage of total FA) and 
quantitative (μg FA/mg protein) value was determined as well. All the 
statistical analyses were carried out using the analyses of variance. The 
Students-T distribution Test was used to determine the significant differences 
between the means of the control (i.e. surrounding tissue/colon mucosa) and 
experimental (i.e. colon polyps) groups. Values were considered significantly 
different if p<0.05. 
 
2.3 Results 
2.3.1 Dietary oil fatty acid content (Table 1) 
The sunflower oil diet’s FA content consisted mainly of C18:1n-9 (25.17%) 
and C18:2n-6 (62.25%), with an n-6/n-3 FA ratio of approximately 250:1. The 
total PUFA content was (62.56%) with a PUFA/SATS (P/S) ratio of 4.99. 
 
2.3.2 Phospholipids and cholesterol content 
The PC and PE phospholipid fractions (Fig. 1A) increased significantly in the 
polyp tissue when compared to the surrounding mucosa. However, the 
increase in PE was much greater than PC, resulting in a significantly 
decreased (p<0.05) PC/PE ratio in the polyp tissue (Fig. 1B). The cholesterol 
content (Fig. 1C) of the polyp tissue decreased significantly (p<0.05) in 
comparison to the surrounding with a concomitant decrease (p<0.05) in the 
cholesterol/phospholipid ratio (Fig. 1D). 
 
2.3.3 Fatty acids 
The qualitative (i.e. % of total FA) and quantitative (i.e. μg FA/mg protein) fatty 
acid composition of the polyp vs. surrounding tissues in the PC and PE 
fractions are summarized in Table 2. 
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2.3.3.1 Saturated FA (SATS) 
Qualitative: (i) PC: The total SATS level was significantly reduced (p<0.05) in 
the colon polyps. This notable change was mainly because of decreases in 
C14:0, C16:0, C20:0 and C22:0. Polyp C18:0 and C24:0 content increased 
significantly (p<0.05) when compared to surrounding tissue. (ii) PE: A 
significant decrease in total SATS in the polyp PE fraction occurred as a result 
of reduced levels of C14:0, C16:0, C22:0 and C24:0, while no effect was 
noticed for C18:0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Comparative phospholipids and cholesterol (i.e. μg/mg protein) analyses of colon 
polyps and surrounding mucosa tissue. Results are the means (n=13) ± standard 
deviation. (A) Membrane phospholipids content, (B) PC/PE ratio, (C) Cholesterol 
content and (D) Cholesterol/Phospholipid (chol/PL) ratio. If letters (lowercase) on 
columns differ, then p<0.05. The chol/PL molar ratio was calculated from the sum of 
PC and PE which constitute the two major phospholipids fractions in rat tissue. PC = 
phosphatidylcholine, PE = phosphatidylethanolamine. 
 
Quantitative: (i) PC: The total SATS content was significantly increased 
(p<0.05) in the polyp tissue largely due to an increase in C16:0, C18:0, C22:0 
and C24:0. The fatty acid C20:0 content decreased significantly when 
0
5
10
15
20
25
30
polyp surrounding
C
ho
le
st
er
ol
 
(μg
/m
g 
pr
ot
ei
n)
C
ho
le
st
er
ol
 
(μg
/m
g 
pr
ot
ei
n)
a
b
C
0
10
20
30
40
50
PC PE
Ph
os
ph
ol
ip
id
s
(μg
/m
g 
pr
ot
ei
n)
Ph
os
ph
ol
ip
id
s
(μg
/m
g 
pr
ot
ei
n)
a
a
b
b
A
0
2
4
6
8
10
polyp surrounding
PC
/P
E 
ra
tio
PC
/P
E 
ra
tio
a
b
0
0.4
0.8
1.2
1.6
2
polyp surrounding
ch
ol
/P
L
ch
ol
/P
L
a
b
B
D
polyp
surrounding
 
 
 
 
 60
compared to the surrounding tissue. (ii) PE: In the polyps there was a 
significant increase in SATS levels as a result of an increase in C18:0, C20:0 
and C24:0. Levels of C14:0 was significantly reduced (p<0.05) in the polyp 
tissue. 
 
2.3.3.2 Monounsaturated FA (MUFA) 
Qualitative: (i) PC: The total MUFA increased in the polyps largely due to 
significant increases (p<0.05) in C16:1, C20:1 and C24:1. The C22:1 content 
decreased significantly in comparison to the surrounding tissue. A marginal 
increase (p<0.1) in C18:1 was observed in the polyps when compared to the 
surrounding mucosa. (ii) PE: Total polyp MUFA decreased only due to a 
significant decrease (p<0.05) in C16:1 and C18:1. 
 
Quantitative: (i) PC: In comparison to the surrounding tissue, the total MUFA 
content in polyps increased significantly due to increased levels of C16:1, 
C18:1, C20:1 and C24:1 (p<0.05). (ii) PE: Total MUFA increased due to a 
significant increase in C24:1, while C18:1 and C20:1 was only marginally 
(p<0.1) increased. 
 
2.3.3.3 Polyunsaturated FA (PUFA) 
(a) n-6 PUFA 
Qualitative: (i) PC: The total n-6 PUFA content in the polyp tissue increased 
significantly with increases in C18:2n-6, C20:2n-6, C20:4n-6, C22:2n-6, 
C22:4n-6 and C22:5n-6 (p<0.05). (ii) PE: Significantly increased levels of 
C20:4n-6 and C22:4n-6 resulted in a higher total n-6 PUFA content in the 
polyps (p<0.05). However, the C18:2n-6 content was significantly decreased 
(p<0.05) in comparison to the surrounding tissue, while C20:3n-6 was 
marginally (p<0.1) decreased. 
 
Quantitative: (i) PC: Significant increases (p<0.05) in polyp C18:2 n-6, 
C18:3n-6, C20:2n-6, C20:3n-6, C20:4n-6, C22:4n-6 and C22:5n-6 content 
increased the total n-6 PUFA. (ii) PE: Comparative to the surrounding tissue, 
the polyps n-6 PUFA composition increased in C18:2n-6, C20:2n-6, C20:4n-6, 
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C22:2n-6 and C22:4n-6 content significantly (p<0.05), resulting in a significant 
increased total n-6 PUFA level. 
 
(b) n-3 PUFA 
Qualitative: (i) PC: The total n-3 PUFA content increased significantly due to 
an increase in C20:5n-3 (p<0.05) in the polyps. (ii) PE: In the polyps C22:5n-3 
increased significantly (p<0.05), whereas C20:5n-3 decreased significantly 
resulting in no change in the total n-3 PUFA level. 
 
Quantitative: (i) PC: Levels of C20:5n-3, C22:5n-3 and C22:6n-3 increased 
significantly in the colon polyps (p<0.05), thereby increasing membrane total n-3 
PUFA content. (ii) PE: The total n-3 PUFA composition of polyps increased 
mainly due to increased levels of C22:5n-3 (p<0.05) and C22:6n-3 (p<0.1). 
 
(c) Total PUFA and total long chain (LC) PUFA 
Qualitative: In both PC and PE phospholipid fractions the total PUFA content 
increased significantly in the colon polyps when compared to the surrounding 
tissue. The n-6 and n-3 long chain (LC) PUFA levels also increased 
significantly (p<0.05) within the polyp, hereby increasing the total LC PUFA 
content. 
 
Quantitative: Polyps had a much higher total PUFA content (p<0.05) in 
comparison to the surrounding tissue in both PC and PE fractions. Significant 
increases (p<0.05) in n-3 and n-6 LC PUFA increased the levels of total LC 
PUFA in polyp membranes. 
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Table 2: Rat colon polyp and surrounding mucosa fatty acid content (% and μg FA/m protein) 
 
 
Fatty Acid 
                                  % of total fatty acids                                                 μg FA/mg protein 
                        PC                        PE                       PC                      PE
Polyp Surrounding Polyp Surrounding Polyp Surrounding Polyp Surrounding
C14:0 0.40±0.19a 0.99±0.44b 0.25±0.11a 1.29±0.89b 0.85±0.34 0.89±0.44 0.26±0.12a 0.52±0.18b 
C16:0 32.92±3.18a 46.15±7.62b 12.93±2.82a 21.89±6.98b 54.79±7.99a 41.95±8.42b 13.02±2.71 13.00±2.71 
C18:0 28.76±3.69a 21.65±4.18b 21.85±1.36 22.72±1.83 48.57±11.26a 19.54±3.16b 24.78±3.15a 15.33±5.50b 
C20:0 1.74±0.48a 5.55±1.71b 2.24±0.77 2.59±0.38 2.69±0.91a 4.88±1.23b 2.34±1.07# 1.62±0.60# 
C22:0 1.26±0.18a 1.61±0.44b 0.75±0.08a 1.26±0.26b 2.03±0.44a 1.34±0.31b 0.81±0.16 0.77±0.27 
C24:0 1.46±0.24a 1.00±0.26b 0.57±0.16a 0.77±0.27b 2.24±0.36a 0.88±0.25 0.60±0.15a 0.45±0.16b 
SATS Total 66.43±2.60a 76.71±6.63b 38.46±3.42a 50.09±8.71b 102.12±10.58a 63.21±6.70 42.62±4.58a 31.06±6.83b 
         
C16:1 0.57±0.21a 0.38±0.17b 0.50±0.19a 0.79±0.34b 1.07±0.38a 0.30±0.13b 0.52±0.15 0.50±0.15 
C18:1 16.31±1.67# 13.60±4.23# 14.32±1.65a 17.24±1.64b 25.03±4.48a 13.37±3.57b 17.34±3.16# 13.69±4.75# 
C20:1 0.75±0.13a 0.32±0.12b 0.51±0.21 0.56±0.16 1.21±0.27a 0.28±0.11b 0.56±0.23# 0.38±0.11# 
C22:1 0.12±0.04a 0.28±0.07b 0.12±0.04 0.15±0.04 0.19±0.08 0.24±0.06 0.14±0.04 0.13±0.05 
C24:1 0.68±0.20a 0.31±0.11b 0.23±0.09 0.20±0.07 1.13±0.32a 0.28±0.10b 0.22±0.05a 0.13±0.05b 
MUFA Total 18.24±1.76# 15.51±3.75# 15.56±1.81 18.96±1.21 28.40±4.92a 14.35±3.62b 18.70±3.32a 14.65±5.01b 
         
C18:2n-6 4.40±0.72a 2.52±0.79b 5.65±0.58a 6.26±0.67b 8.02±2.08a 2.21±0.74b 6.15±1.02a 3.90±1.50b 
C18:3n-6 0.23±0.09 0.23±0.13 0.22±0.02 0.38±0.22 0.33±0.08a 0.21±0.12b 0.24±0.02 0.18±0.07 
C20:2n-6 0.83±0.25a 0.52±0.16b 0.77±0.21 0.80±0.15 1.29±0.32a 0.46±0.15b 0.83±0.24a 0.54±0.17b 
C20:3n-6 0.87±0.43 0.66±0.22 1.45±0.59# 1.88±0.53# 1.52±0.94a 0.59±0.20b 1.66±0.82 1.44±0.74 
C20:4n6 5.58±0.90a 2.02±1.13b 23.51±2.46a 14.29±4.92b 9.80±2.99a 1.60±0.85b 28.03±4.30a 14.75±6.74b 
C22:2n-6 0.24±0.13a 0.37±0.06b 0.29±0.07 0.29±0.06 0.38±0.20 0.33±0.07 0.31±0.08a 0.18±0.08b 
C22:4n-6 0.98±0.22a 0.30±0.12b 11.44±1.82a 2.84±0.98b 1.50±0.36a 0.26±0.10b 13.36±2.49a 2.43±0.97b 
C22:5n-6 0.33±0.05a 0.22±0.08b 1.46±0.24 1.73±0.51 0.49±0.09a 0.19±0.08b 1.65±0.06 1.25±0.61 
n-6 Total 13.77±1.37a 6.70±1.73b 44.61±3.92a 28.10±7.79 23.19±3.78a 5.87±1.47b 52.69±7.15a 28.26±6.75b 
         
C18:3n-3 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 
C20:5n-3 0.54±0.10a 0.25±0.08b 0.22±0.04a 0.33±0.07b 0.88±0.25a 0.22±0.07b 0.24±0.05 0.27±0.08 
C22:5n-3 0.21±0.10 0.22±0.08 0.60±0.10a 0.23±0.03b 0.44±0.13a 0.20±0.06 0.68±0.15a 0.21±0.07b 
C22:6n-3 0.25±0.08# 0.19±0.07# 0.95±0.17 1.13±0.33 0.39±0.12a 0.17±0.06b 1.01±0.34 0.87±0.41 
n-3 Total 0.98±0.14a 0.65±0.15b 1.70±0.34 1.64±0.43 1.66±0.57a 0.56±0.15b 1.85±0.60a 1.23±0.62b 
         
PUFA 14.75±1.38a 7.37±1.77b 46.31±4.10a 29.59±7.94b 24.85±4.24a 6.44±1.52b 54.75±7.35a 29.90±6.71b 
n-6 LC PUFA 8.78±1.24a 4.17±1.51b 38.80±3.84a 21.17±7.77b 14.93±3.45a 3.49±1.08b 46.02±6.83a 24.00±6.90b 
n-3 LC PUFA 0.98±0.14a 0.65±0.15b 1.70±0.34 1.64±0.43 1.66±0.57a 0.56±0.15b 1.85±0.60a 1.23±0.62b 
Total LC PUFA 9.77±1.26a 4.85±1.56 40.50±4.01a 23.20±7.95b 16.68±3.38a 4.08±1.13b 48.08±7.03a 25.64±6.90b 
Values (n=13) are means ± SD of the relative and absolute fatty acid contents of colon polyps and surrounding tissue. Means followed by the same letter 
(lowercase) do not differ.  If letters differ, then p<0.05, while marginal effects are represented by #. PC=phosphatidylcholine; PE=phosphatidylethanolamine; 
SATS= saturated fatty acids; MUFA=monounsaturated fatty acids; PUFA= polyunsaturated fatty acids; LC PUFA= long-chain PUFA.
 
 
 
 
 63
2.3.3.4 Membrane FA ratios 
PC: The polyunsaturated/saturated (P/S) FA ratio increased significantly 
(p<0.05) when compared to the surrounding tissue (Table 3). The 
C20:4n-6/C20:5n-3 and n-6/n-3 ratios also tended to increase, although not 
significantly.  
 
PE: The C20:4n-6/C20:5n-3, n-6/n-3, P/S and delta-6 desaturase 
substrate/product (∆6 S/P) ratios increased significantly (p<0.05) in the PC 
and PE phospholipid fractions of the colon polyps (Table 3).  
 
The C20:4n6 PC/PE ratio (Fig. 2A and 2B) significantly (p<0.05) increased in 
the colon polyps. The qualitative (%) and quantitative (μg) content of C20:4n-6 
tended to increase in the PC phospholipid fraction of the polyp compared to 
the surrounding mucosa (Table 4). In phospholipid PE, the C20:4n-6 content 
was much higher in the polyps, with both percentage of total FA and μg 
FA/mg. 
 
 
Table 3: Quantitative (μg FA/mg protein) fatty acid ratios of rat colon polyps 
  and surrounding mucosa tissue. 
             
FA Ratios 
PC PE 
polyp surrounding polyp surrounding 
C20:4n-6/C20:5n-3 11.85±2.13 8.54±4.88 112.46±25.41a 48.41±27.37b 
n-6/n-3 14.26±3.38 10.33±3.03 26.08±3.61a 20.83±4.28b 
P/S 0.22±0.03a 0.10±0.03b 1.24±0.17a 0.76±0.18b 
∆6 S/P (%)* 6.67±1.88a 4.79±2.22b 7.75±2.29a 3.25±0.89b 
Values (n=13) are means ± SD of the fatty acid ratios of colon polyps and surrounding tissue.   Means 
followed by the same letter (lowercase) do not differ.  If letters differ, then p<0.05. C20:4n-6/C20:5n-3= 
arachidonic acid/eicosapentaenoic acid ratio; P/S= polyunsaturated fatty acid/saturated acid ratio; ∆6 S/P 
=delta-6-desaturase substrate/product ratio. * Relative FA values were used to calculate ratio. 
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Fig. 2 PC/PE ratio of C20:4n-6 content in the polyp and surrounding mucosa tissues. If letters 
(lowercase) on columns differ, then p<0.05. 
 
 
Table 4: Qualitative (% of total FA) and quantitative (μg FA/mg protein)  
    content of the comparative C20:4n-6 content in the PC and PE    
    phospholipid fractions of the polyp versus surrounding tissue ratio. 
 
Phospholipid C20:4n-6-polyp/surr ratio 
PC (% of total FA) 1.94±0.69 
PE (% of total FA) 1.47±0.28 
PC (μg FA/mg protein) 5.19±1.75 
PE (μg FA/mg protein) 2.28±1.02 
Values (n=13) are means ± SD of the colon polyp/surrounding tissue ratio of the C20:4n-6 qualitative (% 
of total FA) and quantitative (μg FA/mg protein) content. PC= phosphatidylcholine and PE= 
phosphatidylethanolamine. 
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2.4 Discussion  
FA form the building blocks of lipids that provide cell structure and regulate 
membrane functions that include mediating receptor signalling cascades, 
cell-to-cell interactions and membrane fluidity (Clandinin et al, 1991, Lund et 
al., 1999). Changes in the FA compositions of cells have been attributed to 
several pathological conditions including some cancers (Dommels et al., 
2002). Thus understanding the differences in FA profiles between cancer and 
healthy cells may be invaluable in understanding their role in carcinogenesis. 
The aim of this investigation was therefore to compare the lipid profile of colon 
polyps and surrounding mucosa tissue in rats fed a diet high in n-6 
polyunsaturated FA.  
 
Results from the current study show that the development of colon polyps is 
associated with a distinctly different lipid pattern. In terms of membrane 
phospholipid content, the colon polyps display a significant increase in the 
levels of PC and PE when compared to the surrounding mucosa. Increases in 
PC and PE content could be a prerequisite for the process of cell growth and 
division (Pasternak and Bergeron, 1970). In normal colonic mucosa, epithelial 
cells proliferate rapidly within the basal proliferative zone of the crypts (Lipkin, 
1973). Within this zone cells divide providing a constant source of new cells 
every 4-8 day. The increase in polyp phospholipid content could thus reflect 
the need for membrane constituents, such as phospholipids, to generate more 
cells. Increased proliferation and expansion of the basal proliferative zone in 
colon mucosa have been associated with a high risk of developing colon 
cancer (Newmark et al., 1991). Thus, the differences in the phospholipids 
profiles between the polyps and surrounding mucosa phospholipids content 
could be associated with increased cell turnover due to alterations in cell 
growth regulatory mechanisms.  
  
Changes in the PC/PE ratio, the cholesterol/phospholipid molar ratio (chol/PL) 
and the degree of unsaturation (P/S ratio) are important in maintaining 
membrane fluidity (Owen et al., 1982).  Membrane fluidity plays a determining 
role in membrane functions such as activity of membrane-associated 
enzymes and receptors involved in a wide range of functions regarding cell 
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signaling pathways (Peck, 1994). As PC and PE constitute almost 90% of the 
total phospholipids, the ratio of PC to PE provides a sensitive indicator of 
changes in the phospholipids content of membranes (Williams et al., 1998). 
Both PC and PE increased significantly in the polyps, while the PC/PE ratio 
decreased significantly in the colon polyps due to a higher increase in PE. An 
increase in PC content has a “fluidizing” effect on membranes due to the large 
choline head group reducing the tight packaging between the phospholipid 
head groups (Soulages and Brenner, 1989; Eskin et al., 2006; Hamai et al., 
2006). Furthermore, the reduction of the polyp cholesterol content and 
concomitant increase in phospholipids resulted in lowering the chol/PL ratio. 
As a result, the polyp membranes are less rigid due to the loss of 
cholesterol-associated inhibition of the overall motion of the acyl 
(hydrocarbon) chains (Petrache et al., 2005). An increase in membrane 
unsaturation with respect to long chain PUFA content was indicated by the 
elevated P/S ratio, also suggest an increase in membrane fluidity. Alterations 
in the above mentioned membrane fluidity parameters could potentially 
change the cell growth kinetics in order to sustain the altered growth pattern in 
the polyps. 
  
Tissue membrane phospholipids maintain a consistent pattern of fatty acid 
composition, yet within a limited range, exhibit responsiveness to changes in 
the availability of circulating FA (Lands, 1991), and therefore the diet. In terms 
of fatty acid content, the alterations observed were significantly different 
between the two phospholipid fractions, PC and PE, in the polyp tissue. 
Quantitatively (μg FA/mg protein) the total SATS content increases 
significantly in both PC and PE when compared to the surrounding mucosa 
tissue. In PC the SATS levels are much higher due to increases in C16:0 and 
C18:0, while only C18:0 increased in PE. Despite the quantitative increase in 
SATS, qualitatively (% of total FA) C16:0 decreased in both phospholipid 
fractions, while increasing C18:0 in PC. The SATS content have been 
implicated to play an important role in tumourigenesis. In primary mouse 
embryonic fibroblasts Zeng et al. (2008) observed that C16:0 and C18:0 
compromised the expression of the pro-apoptotic genes p21 and Bax in 
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response to DNA damage. With the resultant decrease and increase in C16:0 
and C18:0, respectively, it could be hypothesized that they, by negatively 
regulating the DNA damage response pathway may promote cell 
transformation. In this context, it appears that the increased availability of 
SATS in precancerous/cancer cells may contribute to tumour growth and 
potentially stimulate polyp development. Saturated FA also appears to 
modulate cancer cells programmed death. In MDA-MB-231 breast cancer 
cells, free fatty acid palmitate (C16:0) induces apoptosis by reducing the 
mitochondrial membrane potential that allows for the release of the cytosolic 
pro-apoptotic factor cytochrome c (Hardy et al., 2003). Therefore, it appears 
that depending on cell type, changes in C16:0 and C18:0 membrane levels 
influences apoptosis and cell survival.                    
 
MUFA increased significantly in both PC and PE phospholipids in the polyps 
mainly due to an increase in C16:1n-7, C18:1n-9 and C24:1n-9. Of these FA, 
C18:1n-9 has been implicated to play a role in activating key cellular functions 
that promote the progression of the neoplastic phenotype. In this regard the 
C18:1n-9 membrane content seems to play a role in the activation of protein 
kinase C (PKC), an enzyme that promotes cellular proliferation in tissues 
(Craven and DeRubertis, 1987; Khan et al., 1992).  It would appear that one 
of the mechanisms utilized to promote polyp development may be through 
increased C18:1n-9 stimulation of PKC. Incidentally, increases in this 
enzyme’s activity has been linked the increased risk of colon cancer (Craven 
et al., 1987; Blobe et al., 1994).  
 
When comparing the differences in polyp FA content with the surrounding 
mucosa, the total PUFA content increased significantly in both the PC and PE 
lipid fractions. The differences between the surrounding mucosa and polyps 
PUFA content could therefore be linked to changes in the mechanisms 
regulating the metabolism of the essential FA. The metabolism of FA is a 
critical factor for the cell to maintain its membrane structure and function. 
Cells are dependent on ∆6- and ∆5- desaturases for the synthesis of long 
chain polyunsaturated FA (LCPUFA), which are mainly esterified into 
phospholipids and contribute to maintaining membrane fluidity. ∆6-desaturase 
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is the rate-limiting enzyme that catalyzes the first reaction of both n-3 and n-6 
PUFA synthesis. In rat liver, Cho et al. (1999) observed that ∆6-desaturase 
expression increases when animals are fed diets deficient in FA, while PUFA 
added to the diet decreases the enzyme activity. In the colon polyps, the 
∆6-desaturase-substrate/product (∆6 S/P) ratio, which is a reflection of 
∆6-desaturase activity, is increased significantly in both PC and PE, hereby 
suggesting a decrease in enzyme activity.  However when considering the 
high level of LCPUFA in both PC and PE it would appear that the 
∆6-desaturase is not altered or impaired in the polyps and that the tentative 
increased substrate level could be related to negative product feedback 
regulation of the enzyme (Nakamura et al., 2000). This is also in agreement 
with the high level of the n-3 and specifically the n-6 LCPUFA in the PC and 
PE phospholipid fractions of the polyps. Of interest is the significantly increase 
in C20:4n-6 in both PC and PE fraction which again argued against an 
impaired ∆6-desaturase. In intestinal tumourigenesis, Hansen-Petrik et al. 
(2002) indicated that selective ∆6-desaturase inhibition resulted in 36-37% 
fewer tumours in Apc(Min/+) mice and a 35% decrease in primary tumour size 
in nude mice bearing HT-29 colon cancer cell xenographs.  
 
C20:4n-6 is an important FA in maintaining normal cellular homeostasis 
because of the multiple roles it plays, (i) structurally as part of membrane 
phospholipids, (ii) functionally as a precursor to the 2-series eicosanoids and 
(iii) as an intermediate involved in signal transduction pathways regulating cell 
proliferation and apoptosis (Khan et al., 1995).  In this study, the colon polyps 
had a significantly higher C20:4n-6 content in both lipid fractions compared to 
the surrounding tissue. An increase in the C20:4n-6 content of rat colonic 
mucosal phospholipids has been shown to be associated with increased rates 
of cell proliferation (Lee et al., 1993). FA such as C20:4n-6 may differentially 
influence carcinogenesis via their metabolism into various prostaglandins 
(PGs) as it has been reported that PGE2 protects colonocytes from 
programmed cell death by activating anti-apoptotic genes (Wang et al., 2004). 
This is significant because apoptosis is progressively suppressed during the 
development of colon cancer (Bedi et al., 1995). Therefore, modifications of 
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membrane phospholipid FA may play a critical role in the regulation of several 
cell signalling pathways related to the development of cancer. 
 
The polyps have a much higher level of n-6 PUFA (C18:2n-6, C20:4n-6, 
C22:4n-6, C22:5n-6) than n-3 FA in both phospholipid fractions resulting in a 
significant increase in the n-6/n-3 ratio, specifically in PE. In the colon polyps 
the relative C20:5n-3 content was lower than C20:4n6, as indicated by a 
significant (p<0.05) increased C20:4n-6/C20:5n-3 ratio. Competitive effects 
exist between the C20:4n-6 and C20:5n-3 fatty acid precursor substrates of 
COX-2. Thus, increasing membrane C20:5n-3 could lead to competitive 
inhibition of C20:4n-6 metabolism as well as the production of metabolites 
such as PGE3 (Rose and Connolly, 1999). These metabolites are less 
biologically active than the corresponding C20:4n-6 derived metabolites such 
as PGE2 (Fischer, 1997). Since C20:4n-6 synthesis and its subsequent 
conversion to prostaglandins contribute significantly to the growth of intestinal 
tumours, modulation of the C20:4n-6 metabolic cascade should inhibit 
carcinogenesis.  
 
The increase in the polyp C20:4n-6/C20:5n-3, C20:4n-6 PC/PE and 
C20:4n-6-polyp/surrounding ratios suggest that in connection with high n-6 
PUFA dietary intake, the production of 2-series prostaglandins stimulus could 
be increased. Therefore, regulation of C20:4n-6 metabolism as well as 
membrane content plays an important role in determining cell survival 
parameters. The increased C20:4n-6-polyp/surr ratio showed that there was a 
shift in the concentration of C20:4n-6, towards the polyps. When considering 
the C20:4n-6 membrane distribution or gradient a significant shift is noticed 
towards PC as indicated by the increased C20:4n-6 PC/PE ratio despite the 
fact that C20:4n-6 content is significantly higher in the PE phospholipid 
fraction. The shift in membrane content of C20:4n-6 has implications with 
regards to the metabolic availability of C20:4n-6 that may affect cell survival 
parameters associated with the promotion of tumour growth (Chen and 
Hughes-Fulford, 2000). Of interest is the finding in rat liver carcinogenesis 
where the C20:4n-6 PC/PE ratio was decreased in hepatocyte nodules due to 
an increased level of PE (Abel et al., 2001). This altered pattern was 
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implicated in the altered growth characteristics of these lesions. The 
differences between the two tissue compartments could be related to the 
proliferative status with the liver being the more quiescent in nature (Mabuchi 
et al., 2004).  Despite these differences, C20:4n-6 seems to be a major factor 
determining the altered growth properties of cancerous lesions.  
 
The FA content of the sunflower oil diet used in the present study consisted 
mainly of the essential FA C18:2n-6, which is the precursory n-6 FA substrate 
that undergoes rapid elongated and desaturation to produce C20:4n-6 
(Sprecher and Chen, 1999). Consequently, the increase in membrane n-6 
LCPUFA, particularly C18:2n-6 and C20:4n-6 in the polyps could be a 
reflection of the dietary fat.  Although C20:4n-6 is essential for normal cell 
functioning (Johnson et al., 1986; Martin-Venegas et al., 2006), a high dietary 
level of C18:2n-6 has been implicated in colon carcinogenesis. Therefore, 
dietary strategies to reduce excessive C18:2n-6 intake needs to be adopted. 
In this regard dietary intake of n-3 PUFA has been shown to reduce the 
availability of C18:2n-6 in membrane phospholipids (Liou et al., 2007). 
Therefore, with increased intake of n-3 FA, the availability of the 
elongation-desaturation product C20:4n-6 may be reduced. N-3 LCPUFA, 
have been suggested to play a protective role in colorectal cancer 
development by inhibiting the cyclooxygenase-2 (COX-2) enzyme and the 
production of C20:4n-6 derived eicosanoids (Singh et al., 1997). This 
suggests that n-3 FA may play an important role in the prevention of polyp 
development by reducing the differences in the C20:4n-6 PC/PE and 
polyp/surrounding ratios.  
 
2.5 Conclusions 
The present study suggests that alterations in lipid metabolism in the colon 
are likely to play an important role in its neoplastic development. The dynamic 
state of the lipid bilayer would allow the manipulation of the lipid content by 
dietary means. Hereby, the type of FA available for the maintenance of 
membrane fluidity and the synthesis of prostaglandins, for example, may be 
determining factors required for persistent cellular transformation into the 
malignant phenotype. Changes in the colon polyp’s cholesterol, phospholipid 
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and FA profiles could provide unique targets for developing strategies in 
chemoprevention by means of dietary manipulation. 
 
2.6 References 
? Abel, S., Smuts, C.M., de Villiers, C. and Gelderblom, W.C.A. (2001). 
Changes in essential fatty acid patterns associated with normal liver 
regeneration and the progression of the hepatocyte nodules in rat 
hepatocarcinogenesis. Carcinogenesis, 22: 795-804.  
? AIN. (1977). American Institute of Nutrition Report of the American 
Institute of Nutrition ad hoc committee on standards for nutritional 
studies. J. Nutr., 107:1340-1348. 
? Artwohl, M., Roden, M., Waldhäusl, W., Freudenthaler, A. and 
Baumgartner-Parzer, S.M. (2004). Free fatty acids trigger apoptosis 
and inhibit cell cycle progression in human vascular endothelial cells. 
FASEB J, 18: 146-148.  
? Bedi, A., Pasricha, P.J., Akhtar, A.J., Barber, J.P., Bedi, G.C., 
Giardiello, F.M., Zehnbauer, B.A., Hamilton, S.R. and Jones, R.J. 
(1995). Inhibition of apoptosis during development of colorectal cancer. 
Cancer Res., 55: 1811-1816. 
? Benadé, A.J.S., Fincham, J.E C., Smuts, C.M M., Lai Tung, M.T., 
Chalton, D., Kruger, M., Weight, M.J., Daubitzer, A.K., and Tichelaar, 
H.Y. (1988). Plasma low density lipoprotein composition in relation to 
atherosclerosis in nutritionally defined Vervet monkeys. 
Atherosclerosis, 74:157-168. 
? Blobe, G.C., Obeid, L.M. and Hannun, Y.A. (1994). Regulation of 
protein kinase C and role in cancer biology. Cancer Metastasis Rev., 
13: 411-431. 
? Bull, A.W., Marnett, L.J., Dawe, E.J. and Nigro, N.D. (1993). 
Stimulation of deoxythymidine incorporation in the colon of rats treated 
intrarectally with bile salts and fats. Carcinogenesis, 4: 207-210. 
? Carter, C.A., Milholland, R.J., Shea, W. and Ip, M.M. (1983). Effect of 
the prostaglandin synthase inhibitor indomethacin on 
7,12-dimethyl-benz(α)anthracene induced mammary tumorigenesis in 
rats fed different levels of fat. Cancer Res., 43: 3559-3562. 
 
 
 
 
 72
? Chapkin, R.S., Gao, J., Lee, D-Y.K. and Lupton, J.R. (1993). Dietary 
fibres and fats alter rat colon protein kinase C activity: correlation to cell 
proliferation. J. Nutr., 123: 649-655. 
? Chen, Y. and Hughes-Fulford, M. (2000). Prostaglandin E2 and the 
protein kinase A pathway mediate arachidonic acid induction of c-fos in 
human prostate cancer cells. Br. J. Cancer, 82: 2000-2006. 
? Cho, H.P., Nakamura, M.T., Clarke, S.D. (1999). Cloning, expression 
and nutritional regulation of the mammalian delta-5 desaturase. J. Biol. 
Chem., 274: 471-477. 
? Clandinin, M.T., Cheema, S., Field, C.J., Garg, M.L., Venkatraman, J. 
and Clandinin, T.R. (1991). Dietary fat: exogenous determination of 
membrane structure and cell function.  FASEB J., 5: 2761-2769. 
? Craven, P.A. and DeRubertis, F.R. (1987). Subcellular distribution of 
protein kinase C in rat colon epithelial cells with different proliferative 
activities. Cancer Res., 47: 3434-3438. 
? Craven, P.A., Pfanstial, J. and DeRuberts, F.R. (1987). Role of 
activation of protein kinase C in the stimulation of colonic epithelial 
proliferation and reactive oxygen formation by bile salt. J. Clin. Invest., 
79: 532-541. 
? Cunningham, D.C., Harrison, L.Y. and Schultz, T.D. (1997). 
Proliferative response of normal human mammary and MCF-7 breast 
cancer cells to linoleic acid, conjugated linoleic and eicosanoid 
synthesis inhibitors in culture. Anticancer Res., 17: 197-204. 
? Dommels, Y.E.M., Alink, G.M., van Bladeren, P.J. and van Ommen, B. 
(2002). Dietary n-6 and n-3 polyunsaturated fatty acids and colorectal 
carcinogenesis: results from cultured colon cells, animal models and 
human studies. Environ. Toxicol. Pharmacol., 11:297-308. 
? Eriksson, L.C. and Andersson, G.N. (1992). Membrane biochemistry 
and chemical hepatogenesis. Crit. Rev. Biochem. Mol. Biol., 27: 1-55.  
? Eskin, N.A.M., Snait, T. and Tamir, S. (2006). Dictionary of 
nutraceuticals and functional foods. CRC Press, pg 338. 
? Fischer, S.M. (1997). Prostaglandins and cancer. Front. Biosci., 2: 
482-500. 
 
 
 
 
 73
? Folch, J., Lees, M. and Sloane Stanley, G.H. (1957). A simple method 
for the isolation and purification of total lipids from animal tissue. J. Biol. 
Biochem., 226: 497-509. 
? Goldberg, E.M. and Zidovetzki, R. (1997). Effects of dipalmitoylglycerol 
and FA on membrane structure and protein kinase C activity. Biophys. 
J., 73: 2603-2614. 
? Hamai, C., Yang, T., Kataoka, S., Cremer, P.S. and Musser, S.M. 
(2006). Effect of average phospholipid curvature on supported bilayer 
formation on glass by vesicle fusion. Biophys. J., 90: 1241-1248. 
? Hansen-Petrik, M.B., McEntee, M.F., Johnson, B.T., Obukowicz, M.G., 
Masferrer, J., Zweifel, B., Chui, C.H. and Whelan, J. (2002).  Selective 
inhibition of delta-6 desaturase impedes intestinal tumorigenesis. 
Cancer Lett., 25: 157-162. 
? Hardy, S., El-Assaad, W., Przybytkowski, E., Joly, E., Prentki, M. and 
Langlier, Y. (2003). Saturated fatty acid induced apoptosis in 
MDA-MB-231 breast cancer cells. J. Biol. Chem., 22: 31861-31870. 
? Hwang, D. and Rhee, S.H. (1999). Receptor-mediated signaling 
pathways: potential targets of modulation by dietary fatty acids. Am. J. 
Clin. Nutr., 70: 546-556. 
? Itaya, K. and Ui, M. (1966). A new micromethod for the colorimetric 
determination of inorganic phosphate. Clin Chim. Acta, 14: 361-366. 
? Johnson, H.M., Russell, J.K. and Torres, B.A. (1986). Second 
messenger role of arachidonic acid and its metabolites in 
interferon-gamma production. J. Immunol., 137: 3053-3056. 
? Jones, R., Adel-Alvarez, L.A., Alvarez, O.R., Broaddus, R., Das, S. 
(2003). Arachidonic acid and colorectal carcinogenesis. Mol. Cell. 
Biochem., 253: 141-149. 
? Khan, W.A., Blobe, G.C. and Hannun, Y.A. (1992). Activation of protein 
kinase C by oleic acid. J. Biol. Chem., 267: 3605-3612. 
? Khan, W.A., Blobe, G.C. and Hannun, Y.A. (1995).  Arachidonic acid as 
second messengers and the role of protein kinase C. Cell Signaling, 
7:171-184.  
? Lands, W.E.M. (1991). Biosynthesis of prostaglandins. Ann. Rev. Nutr., 
11: 41-60. 
 
 
 
 
 74
? Lee, D.-Y., Lupton, F.R., Aukema, H.M. and Chapkin, R.S. (1993). 
Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell 
proliferation. J. Nutr., 123: 1808-1817. 
? Liou, Y.A., King, D.J., Zibrik, D. and Innis, S.M. (2007). Decreasing 
linoleic acid with constant α-linolenic acid in dietary fats increases (n-3) 
eiscosapentaenoic acid in plasma phospholipids in healthy men. J. 
Nutr., 137: 945-952. 
? Lipkin, M. (1973). Proliferation and differentiation of gastrointestinal 
cells. Physiol. Rev., 53: 891-915. 
? Lund, E.K., Harvey, L.J., Ladha, S., Clark, D.C. and Johnson, I.T. 
(1999). Effects of dietary fish oil supplementation on the phospholipids 
composition and fluidity of cell membranes from human volunteers. 
Ann. Nutr. Metab., 43: 290-300. 
? Mabuchi, A., Mullaney, I., Sheard, P.W., Hessian, P.A., Beth L. Mallard, 
B.L, Michael N. Tawadrous, M.N., Arthur Zimmermann, A., Senoo, H. 
and M. Wheatley, A.M. (2004). Role of hepatic stellate cell/hepatocyte 
interaction and activation of hepatic stellate cells in the early phase of 
liver regeneration in the rat. J. Hepatology, 40: 910-916. 
? Markwell, M.K., Haas, S.M. Bieber, L.L. and Tolbert, N.E. (1978). A 
modification of the Lowry procedure to simplify protein determination in 
membrane and lipoprotein samples. Anal. Chem., 87: 206-210. 
? Marnett, L.J. (1992). Aspirin and the potential role of prostaglandins in 
colon cancer. Cancer Res., 52: 5575-5589. 
? Martin-Venegas, R., Roig-Pèrez, S., Ferrer, R. and Moreno, J.J.  
(2006). Arachidonic acid cascade and epithelial barrier function during 
Caco-2 cell differentiation. J. Lipid Res., 47: 1416-1423.  
? Nair, J., Vaca, C.E., Velic, I., Mutanen, M., Valista, L.M. and Bartsch, 
H. (1997). High dietary ω-6 polyunsaturated fatty acids drastically 
increase the formation of ethno-DNA based adducts in white blood 
cells of female subjects. Cancer Epidemiol. Biomark. Prev., 6: 597-601. 
? Nakamura, M.T., Cho, H.P. and Clark, S.D. (2000). Regulation of 
hepatic ∆-6 desaturase expression and its role in the polyunsaturated 
 
 
 
 
 75
fatty acid inhibition of fatty acid synthase gene expression in mice. J. 
Nutr., 130: 1561-1565.  
? Newmark, H.L., Lipkin, M. and Maheshwan, M. (1991). Colonic 
hyperproliferation induced in rats and mice by nutritional-stress diets 
containing four components of a human Western-style diet. Am. J. Clin 
Nutr., 54: 209s-214S. 
? Nicholson, M.L., Neoptolemos, J.P., Clayton, H.A., Talbot, I.C. and 
Bell, P.R.F. (1991) Increased cell membrane arachidonic acid in 
experimental colorectal tumors. Gut, 32: 413-418. 
? Owen, J.S., Bruckdorfer, K.R., day, R.C. and McIntyre, N. (1982). 
Decreased erythrocyte membrane fluidity and altered lipid composition 
in human liver disease. J. Lipid Res., 23: 124-132. 
? Pasternak, C.A. and Bergeron, J.J.M. (1970). Turnover of mammalian 
phospholipids. Stable and unstable components in neoplastic mast 
cells. Biochem. J., 119: 473-480.  
? Peck, M.D. (1994). Interactions of lipids with immune function I: 
Biochemical effects of dietary lipids on plasma membranes. J. Nutr. 
Biochem., 5: 466-478.  
? Petrache, H.I., Harris, D. and Parsegian, V.A. (2005). Alteration of lipid 
membrane rigidity by cholesterol and its metabolic precursors. 
Macromol. Symp., 219: 39-50. 
? Reddy, B.S., Burill, C. and Rigotty J. (1991). Effects of diets high in ω-3 
and ω-6 fatty acids on initiation and postinitiation stages of colon 
carcinogenesis.  Cancer Res., 51: 487-491. 
? Richmond, W. (1973). Preparation and properties of a cholesterol 
oxidase from Nocardia sp. and its application to the enzymatic assay of 
the total cholesterol in serum. Clin. Chem., 19: 1350-1356. 
? Rose, D.P. and Connolly, J.M. (1999). Omega-3 fatty acids and cancer 
chemopreventive agents. Pharmacol. Ther, 83: 217-44. 
? Singh J, Hamid R, Reddy BS. (1997). Dietary fat and colon cancer: 
modulation of cyclooxygenase-2 by types and amount of dietary fat 
during the postinitiation stage of colon carcinogenesis. Cancer Res., 
15: 3465-3470. 
 
 
 
 
 76
? Soulages, J.L. and Brenner, R.R. (1998). Interactions among 
phospholipids of guinea pig rough micrososmes: effect of fat deficiency. 
Mol. Cell. Biochem., 90: 127-136. 
? Sprecher, H. and Chen, Q. (1999). Polyunsaturated fatty acid 
synthesis: a microsomal peroxisomal process. Prost. Leuko. Essen. 
Fatty Acids, 60: 317-321. 
? Tapiero, H., Nguyen, G., Couvreur, P. and Tew, K.D. (2002). 
Polyunsaturated fatty acids (PUFA) and eicosanoids in human health 
and pathologies. Biomed. Pharmacother., 56: 215-222.  
? Wang, D., Wang, h., Shi, Q., Katkuri, S., Walhi, W., Desverqne, B., 
Das, S.K., Dey, S.K. and DuBois, R.N. (2004). Prostaglandin E(2) 
promotes colorectal adenoma growth via transactivation of the nuclear 
peroxisome proliferator-activated receptor delta. Cancer cell, 6: 
285-295. 
? Williams, E.E., May, B.D., Stillwell, W. and Jenski, L.J. (1998). 
Docosahexaenoic acid (DHA) alters the phospholipid molecular 
species composition of membranous vesicles exfoliated from the 
surface of a murine leukemia cell line. Biochim. Biophys. Acta, 1418: 
185-196. 
? Zeng, L., Wu, G-Z., Goh, K.J., Lee, Y.M., Ng, C.C., You, A.B., Wang, 
J., Jia, D., Hao, A., Yu, Q. and Li, B. (2008). Saturated fatty acids 
modulate cell response to DNA damage: Implication for their role in 
tumorigenesis. PloSONE, 3: 1-9. 
 
 
 
 
 77
 
 
    
 
 
 
 
 
 
 
CHAPTER 3 
 
LIPID MODULATION OF RAT COLON MUCOSA AND 
RED BLOOD CELL MEMBRANES BY DIETARY FAT 
WITH VARYING N-6/N-3 FATTY ACID RATIOS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78
Abstract 
This study investigated the effects of different dietary n-6/n-3 fatty acid (FA) 
ratios on the lipid profile of rat colon mucosa and red blood cell (RBC) 
membranes. Sunflower, fish and borage oils were utilized to vary the diets 
n-6/n-3 FA ratio. The lipid profiles of the colon mucosa and RBC membranes 
responded differently to the dietary FA presumably due to functional and 
proliferative properties. Fish oil reduced membrane phospholipid 
phosphatidylethanoamine (PE) in the mucosa, while increasing 
phosphatidylcholine (PC) and PE in the RBC membranes. Borage oil 
significantly reduced the PC/PE ratio in the mucosa, while fish oil increased 
the ratio in both membranes. The dietary FA significantly altered the 
membranes fluidity due to modifications to the fluidity lipid parameters 
including cholesterol/phospholipid ratio, PC/PE and 
polyunsaturated/saturated (P/S) ratios. Differential effects of fish and borage 
oil on the saturated and monounsaturated FA levels suggest that they may be 
involved in regulating cell survival responses. Modulation of the membrane 
lipid profiles by the different FA ratio diets particularly those using fish oil 
content, showed a reduction in the membrane n-6/n-3 ratio due to a higher 
n-3 long chain (LC) PUFA content. Borage oil exhibited a similar effect 
although to a lesser extent while it also increased in the n-6 FA level. Both 
dietary oils reduced the C20:4n-6/C20:5n-3 ratio suggesting a reduced 
production of the prostaglandin 2 series. The n-6/n-3 interactions are also 
reflected by variations in the membrane incorporation of LCPUFA, which is 
orchestrated by a reduced ∆6-desaturase activity as well as negative 
feedback regulation by FA product of the enzyme. The combination of fish 
and borage oil in the diet either counteracted or enhanced the individual 
effects exerted by the oils. The intake of fish and borage oil was associated 
with an elevation in lipid peroxidation presumably due to an increase in 
LCPUFA. This study suggests that a low n-6/n-3 PUFA ratio diet could 
potentially be used as a cancer therapeutic tool due to its ability to alter 
prostaglandin synthesis and enhance the susceptibility to lipid peroxidation. 
 
Keywords: dietary n-6/n-3 ratios, modulation, lipid peroxidation, colon 
mucosa, red blood cells, membrane 
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3.1 Introduction  
Dietary intakes of n-6 and n-3 polyunsaturated fatty acids (PUFA) have 
received considerable attention as key modulators of health (Sumida et al., 
1993; Sessler and Ntambi, 1998). Both PUFA families are readily incorporated 
into cell membrane phospholipids, where they influence the physical and 
functional properties of membranes. In western cultures the consumption of 
foods rich in n-6 PUFA (e.g. plant based fats: vegetable oils) exceeds that of 
n-3 rich foods such as fish and fish oils (Simopoulos, 2006). Studies suggest 
that this dietary pattern facilitates the development of cancers of the breast, 
colon and prostate (Reddy and Sugie, 1988; 
http://www.eurekalert.org/pub_releases/2006-02/uoc--ofc012706.php, 
accessed 21 October 2008; Thiébaut et al., 2009). It has been suggested that 
a critical balance between membrane n-6 and n-3 PUFA content and their 
interactions determines whether cells are transformed into an abnormal state 
(Simopoulos, 2006). Therefore, with diet playing a key role in neoplastic 
transformations, it is reasonable to assume that exposure to specific dietary n-
6/n-3 fatty acid (FA) ratios could potentially modulate or prevent the 
development of colon cancer (Campos et al., 2005). 
 
Health benefits associated with the intake of fish oil and borage oil have been 
extensively studied (Horrobin, 1992; Engler et al., 1998; Belch and Hill, 2000; 
Kris-Etherton et al., 2002; Das, 2008). Fish oils, specifically from fish such as 
mackerel and salmon, are rich in the n-3 long chain (LC) PUFA, 
eicosapentaenoic acid (C20:5n-3) and docosahexaenoic acid (C22:6n-3) 
(Covington, 2004). In contrast, borage oil is rich in the n-6 PUFA, γ-linolenic 
acid (C18:3n-6).  Both classes of PUFA derived from these oils are readily 
incorporated into the phospholipids of cell membranes of all tissue types, 
such as the colon (Gee et al., 1999) and liver (Palombo et al., 1993). 
Alterations in membrane FA composition as a result of PUFA incorporation 
may lead to changes in membrane fluidity and membrane mediated function 
and cell signaling e.g. eicosanoids, lipid secondary messengers, signalling 
proteins (Benatti et al., 2004).  
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Intakes of n-3 LCPUFA through the consumption of fish or fish oil reduces the 
risk of colon cancer by inducing apoptotic pathways that suppress further cell 
growth (Narayanan et al., 2001; Courtney et al., 2007). Many of the clinical 
effects of C18:3n-6 supplementation has been attributed to its capacity to 
block the metabolism of arachidonic acid (C20:4n-6) to bioactive eicosanoids 
(Johnson et al., 1997). The problem, however, is that the metabolism of 
C18:3n-6 by elongase and Δ5-desaturase activities also generates 
dihomo-γ-linolenic acid (C20:3n-6), which is a potential precursor of C20:4n-6 
(Sprecher, 2000). Studies suggest using combined ratios of fish oil and 
borage oil (i.e. C20:5n-3 and C18:3n-6) to minimize the production of 
C20:4n-6 (Barham et al., 2000). Hereby, pro-inflammatory processes 
involving C20:4n-6 derived metabolites, the eicosanoids, which may 
potentially lead to disease development (e.g. cancer), may be reduced by n-3 
LCPUFA intake (Takahashi et al., 1987). 
 
In addition to modulating eicosanoid production, membrane incorporation of 
LCPUFA, particularly the n-3 FA, enhances susceptibility to free radical 
damage that leads to oxidative stress (Song and Miyazawa, 2001). Lipid 
peroxidation (LPO) is a cellular process utilized by cells to regulate cell 
numbers by stimulating mechanisms that lead to growth inhibition and cell 
death (apoptosis) (Girotti, 1998). With regard to cancer, the level of LPO is 
very low due to reduced membrane PUFA content (Horrobin, 1990). The 
reduced membrane susceptibility to LPO is likely to play an important role in 
the abnormal growth, which prevails in preneoplastic lesions (Biasi et al., 
2002). Therefore, dietary intakes of specific FA, such as the n-3 LCPUFA, 
have been suggested to inhibit further cancer development through the 
enhancement of LPO induced cell growth inhibition (Chen and Istfan, 2001; 
Abel et al., 2004). 
 
The objective of the present study was to investigate the effect of the intake of 
dietary fats with specific n-6/n-3 FA ratios on the lipid profiles of normal rat 
colon mucosa and red blood cell membranes. The effect of membrane FA 
changes on the susceptibility to LPO was also monitored. 
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3.2 Materials and methods 
3.2.1 Chemicals 
N-3 FA rich fish oil (EPA-55) was obtained from Equazen UK Ltd (St 
Petersburg Place, London, UK). Borage oil, rich in C18:3n-6 was obtained 
from Créde Natural Oils (Strand, South Africa). Sunflower oil was supplied by 
RFS Catering Supplies (Milnerton, South Africa). Perchloric acid, methanol 
and chloroform, fluorescing agent 2,5-bis-(5’-tert-butylbenz-oxazolyl-
[2’])thiophene (i.e. BBOT), butylated hydroxytoluene (BHT), sodium hydroxide 
(NaOH), sodium phosphate monobasic monohydrate (NaH2PO4), sodium 
phosphate dibasic anhydrous (Na2HPO4), sodium chloride (NaCl) and 
malachite green were supplied by Sigma-Aldrich. Silica TLC plates, acetic 
acid, petroleum ether, boric acid, sodium carbonate (Na2CO3), sodium tartrate 
and copper sulphate (CuSO4.5H2O) was obtained from Merck (Darmstadt, 
Germany). Sulphuric acid was supplied by BDH/Merck (Poole, England). 
Sodium dodecyl sulphate (SDS) was supplied by Fluka (Germany), bovine 
serum albumin (BSA) by Mees Laboratories (South Africa) and BCA 
(bicinchoninic acid) by Separations (South Africa). 
 
3.2.2 Preparation of diets 
A rat diet (AIN-93) (Reeves et al., 1997) with a total fat content of 5% (w/w) 
was used throughout the experiment with commercially bought sunflower oil 
being used as a common fat source in all the diets. For the experimental ratio 
diets, the AIN-93 diet fat content was modified with fish oil and borage oil to 
obtain fats with varying n-6/n-3 FA ratios for the duration of the experiment. 
The experimental fat sources consisted of: (1): sunflower oil only (S diet; 
n-6/n-3=250:1), (2): sunflower oil supplemented with fish oil (SF diet; n-6/n-3= 
12:1), (3): sunflower oil supplemented with borage oil (SB diet; n-6/n-3= 30:1) 
and (4): sunflower oil supplemented with fish oil and borage oil (SBF diet; 
n-6/n-3 = 12:1). The FA profile of the dietary oil mixtures were analyzed using 
gas chromatography (Varian 4600) and the exact n-6/n-3 FA ratios (Table 1, 
page 89) calculated. The diets were kept at -20 °C under nitrogen until use. 
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3.2.3 Animals and treatment 
The Ethics Committee of the Medical Research Council of South Africa 
approved the use of laboratory animals in this study. At weaning (body weight 
50 g), male Fischer rats (n=48) were divided and housed individually in 
wire-bottomed cages under controlled lighting (12 hr cycles) and temperature 
(23 -25°C) with free access to water. The animals were fed ad libitum the 
AIN-93 diet (Reeves et al., 1997), with sunflower oil as a fat source (5%) for a 
period of three weeks. 
 
After the three weeks, at a body weight of 150 g, the animals were divided into 
four groups (n=9 per dietary group), and placed on their respective dietary 
groups (diet S, SF, SB and SBF). Body weights were measured once a week, 
while feed intakes were recorded bi-weekly. Animals were terminated by 
sodium pentobarbital injection i.p after four months exposure to the 
experimental ratio diets. The colon was excised, opened longitudinally and the 
epithelial mucosa collected by scraping the inner surface with a microscope 
glass slide. The mucosa sample were frozen in liquid nitrogen and stored at 
-80 °C until analysed. Blood samples were collected from the abdominal aorta 
into heparin-coated blood vials. 
 
3.2.4 Preparation of RBC membranes 
Immediately after termination, packed RBC was obtained by centrifugation of 
the blood at 3000 rpm for 10 min at 4 °C. After the removal of the plasma and 
the buffy coat by aspiration, cells were washed three times with a 0.9% NaCl 
solution. For the preparation of hemoglobin-free ghosts, a slightly modified 
method of Dodge et al (1963) was followed. Hemolysis of the washed RBC 
was performed in 5 mM sodium phosphate buffer (pH 8.0) and pellets were 
obtained by centrifugation at 15 000 rpm for 20 min at 4 °C. The hemolysis 
process was repeated 3 times until the pellet was a pale pink colour. The RBC 
membranes were finally suspended in 2 ml of the buffer and stored at -80 °C 
until analyzed. 
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3.2.5 Lipid extraction 
Lipids were extracted from the phosphate buffer RBC membrane solution (≥2 
mg protein) with chloroform/-methanol (CM; 2:1; v/v) containing 0.01% 
butylated hydroxytoluene (BHT) as antioxidant (Folch et al., 1957). The 
tissue:CM ratio was approximately 20:1. The samples were extracted using a 
rotary shaker for 20 minutes. Saline saturated chloroform-methanol-saline 
(CMS 86:14:1 v/v/v) was added to the RBC solution, vortexed (60s) and 
centrifuged at 500 rpm for 15 minutes. The bottom CM layer was removed 
and transferred into a round bottom flask. The CM (10 ml) extraction step was 
repeated twice. The collected CM extracts were evaporated on a rota-vapor at 
40 °C, and transferred with 5x2ml CMS to glass culture-tubes. Saturated CMS 
(1 ml) was added, vortexed and centrifuged at 500rpm for 15 min. The top 
layer (saline) was removed, and samples stored under nitrogen at 4 °C until 
analyzed. 
 
For the colon mucosa lipid extraction, the tissue was ground to a fine powder 
in liquid nitrogen. A sub fraction of the mucosa powder (10-30 mg) was taken 
for protein analyses. The remaining mucosa samples were weighed (15-80 
mg) and resuspended in 0.5 ml saline and the lipids were extracted with 12 ml 
CM. The sample was filtered (sinterglass filters using Whatman glass 
microfibre filters, Cat N, 1820 866, Whatman International, Ltd, Maidstone, 
England) and the filtrate evaporated to dryness in vacuo at 40 °C, and 
transferred to glass culture tubes. The extract was treated with saline 
saturated with CMS as described above, and stored at 4 °C under nitrogen 
until analysed.  
 
3.2.6 Thin layer chromatography (TLC) 
The lipid extracts from the mucosa and RBC ghosts were fractionated by thin 
layer chromatography (TLC) as described in Chapter 2. The major 
phospholipids fractions PC and PE were collected for phospholipid and FA 
analysis. Phospholipids were identified against a phospholipid standard 
mixture containing PC, PE, sphingomyelin (SM), phosphatidylserine (PS) and 
phosphatidyl inositol (PI). 
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3.2.7 Fatty acid analysis 
For FA analyses the phospholipid fractions, phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE), were collected and transmethylated with 2 ml 
methanol/18 M sulphuric acid (95:5; v/v) at 70 °C for 2 hrs (Benadé et al., 
1988). The resultant FA methyl esters (FAME) extracted with hexane and 
distilled water (v/v, 2:1). The hexane (top layer) was removed and dried under 
nitrogen gas in a water bath (37 °C). The dried samples were dissolved in 
hexane and analyzed by gas chromatography on a Varian 3300 gas 
Chromatograph equipped with 30 m fused silica BPX-70 capillary columns 
(SGE, USA) of 0.32 mm internal diameter (Addendum 2). The individual 
FAME were identified by comparison of the retention times to those of a 
standard FA mixture containing C14:0 to C24:1 (Nu-Chek-Prep, MN, USA) 
(Addendum 3). Individual FA was quantified using C17:0 as an internal 
standard and expressed as μg FA/mg protein as well qualitatively as a 
percentage of the total fatty acids (Addendum 3). 
 
3.2.8 Cholesterol and phospholipid determination 
Cholesterol and phospholipids contents were determined as described in 
Chapter 2. Briefly, the cholesterol content of the rat mucosa and RBC 
samples (i.e. 20 μl of CMS lipid extracted samples) was determined by an 
enzymatic iodide method using cholesterin-oxidase and cholesterin-esterase 
(Richmond, 1973). The phospholipid concentrations of PC and PE were 
determined colorimetrically based on the method according to Itaya and Ui 
(1966). 
 
3.2.9 RBC membranes and mucosa protein determination 
The protein content of the RBC membranes was determined using a 
bicinchoninic acid reaction (Kaushal and Barnes, 1986; Addendum 6B). 
Briefly, RBC membrane proteins were solubilized in a 2% SDS 20 mM NaCO3 
2 mM EDTA solution at a ratio of 1:10. Solubilised RBC protein sample 
volumes ranging from 40-80 μl were diluted in distilled water to a final volume 
of 600 μl. A protein determining reagent, containing bicinchoninic acid (BCA) 
detection reagent and 4% CuSO4.5H2O (50:1), was added to the samples at a 
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volume of 400 μl. The samples were vortexed and incubated in a 60 °C water 
bath for 1 hr and the absorbance measured at 562 nm. Samples were 
quantified against a BSA (0.1 mg/ml) standard curve. The protein content of 
the mucosa samples was determined according to a modified Lowry method 
(Markwell et al., 1978) as described in Chapter 2.  
 
3.2.10 Determination of conjugated dienes 
The extent of lipid peroxidation was determined by measuring the levels of 
conjugated dienes (CD) according to the method of Hu et al. (1989). Firstly for 
the tissue homogenate preparation, mucosa samples were homogenized on 
ice in 19 volumes of 1.15% potassium chloride in 0.01 mM phosphate buffer 
(pH 7.4) using Teflon motorized Dounce (i.e. dounce approx. 10x). A sample 
volume of 100 μl was removed for protein determination and the remaining 
volume (1.9 ml) stored at -80 °C until required. The protein content of the 
mucosa homogenates was determined according to the Kaushal and Barnes 
(1986) method as described above. Mucosa homogenate and RBC ghost 
membranes containing approximately 2 mg of protein were used for the 
assay. For sample preparation, 2.5 mM ferrous sulphate (200 μl) was added 
to the reactions and incubated in a shaking water bath at 37 °C for one hour. 
Chloroform-methanol (CM, 1:2, v/v) (vortex 60 sec), then chloroform (vortex 
30 sec), and finally saline saturated CM (vortex 30 sec) were added to the 
samples at a ratio of 3:1:1 and samples centrifuged at 1000xg for 10 minutes 
at 4 °C. The bottom layer was transferred to clean glass culture-tubes 
Samples were re-extracted with chloroform. The extracts were dried under N2 
gas in a 37 °C water bath, hexane (1 ml) was added, and absorbencies read 
at 233 nm. Lipid peroxidation was expressed as nmol/mg protein CD 
equivalents, using the molar extinction coefficient 27000 M-1cm-1 (Hu et al., 
1989). 
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3.2.11 Statistical analyses 
(a) Feed intake and body weight gain 
 
Feed intake 
A mixed effects regression model was used with FISH, BORAGE and MONTH 
(time of measurement) as the fixed effects covariates. The covariance 
structure of the repeated measurements residuals within each rat was 
modelled by a first order autoregressive process. Interaction terms between 
the various fixed effects were introduced and they were kept based on their 
improvement of the model fit. The FISH*BORAGE and also the FISH*MONTH 
interaction (difference in slopes) were tested since this would indicate an 
intervention (FISH) effect. 
• The Satterthwaite degrees of freedom specification was used for the 
fixed effects testing. 
• Proc Mixed in SAS Version 9.1 was used for the regression modeling. 
 
Least Squares Means (LSMeans) were used to estimate treatment (FISH) 
effects the time (WEEK) effect at weeks 2, 4, 6, 8, 10, 12 and 14 based on the 
mean response model. Time (WEEK) comparisons and 95% confidence 
intervals for the effects and differences were obtained. 
 
Body weight gain 
A mixed effects regression model was used with FISH, BORAGE, WEEK 
(time of measurement) and the baseline weight as the fixed effects covariates. 
The random effects model within each rat was based on the time of 
measurement and the baseline response. The covariance structure of the 
repeated measurements residuals within each rat was modelled by a first 
order autoregressive process. After starting with only linear time effects in 
both the fixed and random components of the model the introduction of a 
quadratic time effect in both produced a dramatic improvement in the model fit 
based on Akaike Criterion (AIC). Interaction terms between the various fixed 
effects were introduced (especially FISH*BORAGE) and they were kept based 
on their improvement of the model fit. The FISH*WEEK and BORAGE*WEEK 
interactions (difference in slopes) were tested since this would indicate an 
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intervention (FISH and /or BORAGE) effect since the randomization ensured 
that the four groups started at the same mean baseline weight. 
• The Satterthwaite degrees of freedom specification was used for the 
fixed effects testing. 
• Proc Mixed in SAS Version 9.1 was used for the regression modeling. 
 
Least Squares Means (LSMeans) were used to estimate treatment (FISH 
and/or BORAGE) effects at weeks 1 to 18 based on the mean response 
models. This was done to capture the time dependent FISH and/or BORAGE 
effects. Treatment (FISH and/or BORAGE) comparisons and 95% confidence 
intervals for the effects and differences were obtained. 
 
(b) Lipid profile and extent of lipid peroxidation 
The data was analyzed using a 2-way ANOVA as the data had a 2 x 2 
factorial design. The GLM procedure (SAS, Version 9.1) was used to test for 
interactions and main effects. Where the interaction effect was significant 
(tested first), confidence limits for the differences of LS-Means were used to 
measure the effects of all the multiple comparisons in the interaction term 
(different combinations of factors with each-other). Each of the main effects 
was tested separately in a 1-way ANOVA using the F-test. Where no 
interaction effect was observed the main effect was directly obtained from the 
2-way ANOVA. Statistical significance was considered at p<0.05. 
 
3.3 Results 
 
The statistical analyses of the data examined determined whether any 
significant interaction (2-way ANOVA) between the fish and borage oil 
contents of the diets influenced the lipid parameters and the extent of lipid 
peroxidation present in the rat mucosa and RBC membranes. Where 
fish/borage oil interaction occurred, the confidence limits (p<0.05) were 
determined to measure the effects of all the multiple comparisons in the 
interaction term for interactions between diets: (a) S and SB, (b) S and SF, (c) 
S and SBF, (d) SB and SF, (e) SB and SBF, and lastly (f) SF and SBF. In 
addition, the main effect of the fish and borage oils were also determined to 
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indicate whether the fish oil or borage oil content in the diets had a significant 
(p<0.01 or p<0.05) effect overall, not specific to any diet. 
 
3.3.1 Fatty acid content of dietary oils (Table 1) 
The sunflower oil (S) diet consisted mainly of C18:1n-9 (25.17%) and 
C18:2n-6 (62.25%), with an n-6/n-3 FA ratio of approximately 250:1. The total 
PUFA content was (62.56%) with a PUFA/SATS (P/S) ratio of 4.99. Fish oil 
(F) contained C18:1n-9 (2.63%), C18:2n-6 (1%), C18:3n-3 (0.86%), C20:5n-3 
(73.01%) and C22:6n-3 (11.65%), with a total PUFA content of 89.29%. The 
fish oil had an n-6/n-3 ratio of 0.02 and a P/S ratio 38.32. Borage oil consisted 
mainly of C18:1n-9 (17.9%), C18:2n-6 (33.76%) and C18:3n-6 (19.32%), with 
a total PUFA percentage of 57.51. The borage oil had an n-6/n-3 ratio of 
14.98 and a P/S ratio of 3.77. 
 
The sunflower and fish oil (SF) diet contained C18:1n-9 (18%) C18:2n-6 
(61.25%), C18:3n-3 (0.13%), C20:5n-3 (4.40%) and C22:6n-3 (0.53%), with 
an n-6/n-3 FA ratio of 12:1. SF had a P/S ratio of 4.90 and a total PUFA of 
66.85%. The SB diet contained C18:1n-9 (19%), C18:2n-6 (54.63%), and 
C18:3n-6 (6.70%), with an n-6/n-3 FA ratio at approximately 30:1. SB 
consisted of 64.15% PUFA, and a P/S ratio of 4.7. The combination diet 
containing both fish and borage oil (SBF), predominantly consisted of 
C18:1n-9 (18.8%), C18:2n-6 (56.63%), C18:3n-6 (4.98%), C18:3n-3 (1.01), 
C20:5n-3 (3.62%) and C22:6n-3 (0.42%). The SBF diet had an n-6/n-3 ratio of 
approximately 12:1, a total PUFA 67.05% and P/S ratio of 5.4. 
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Table 1: FA content of the oils (% of total FA) used in the experimental diets. 
           
Fatty 
Acids 
Dietary oils 
S F B SF SB SBF 
C14:0 0.07±0.01 0.21±0.03 0.09±0.01 0.22±0.04 0.12±0.04 0.08±0.01 
C16:0 6.68±0.18 0.98±0.12 9.86±0.25 6.22±0.03 7.47±0.15 6.80±0.41 
C17:0 0.04±0.02 <0.01 0.26±0.08 0.23±0.07 0.13±0.06 0.09±0.01 
C18:0 4.45±0.07 0.75±0.10 4.48±0.09 5.87±0.01 4.90±0.01 4.53±0.01 
C20:0 0.29±0.02 <0.01 0.39±0.02 0.34±0.01 0.32±0.03 0.31±0.01 
C22:0 0.75±0.06 <0.01 0.23±0.07 0.56±0.08 0.54±0.09 0.59±0.09 
C24:0 0.25±0.01 0.39±0.01 <0.01 0.16±0.04 0.18±0.01 0.16±0.01 
SATS total 12.53±0.37 2.33±0.26 15.31±0.52 13.63±0.28 13.66±0.39 12.56±0.55 
       
C16:1 0.06±0.02 0.70±0.03 0.11±0.04 0.15±0.03 0.10±0.01 0.12±0.01 
C18:1 25.17±0.50 2.63±0.41 17.90±0.55 18.85±0.61 19.72±0.05 18.83±0.08 
C20:1 0.21±0.01 0.30±0.02 4.34±0.54 0.23±0.07 1.45±0.07 1.23±0.38 
C22:1 0.02±0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
C24:1 0.05±0.01 <0.01 2.15±0.28 <0.01 0.83±0.27 0.49±0.03 
MUFA total 25.50±0.55 3.63±0.46 24.50±1.41 19.23±0.71 22.45± 20.67±0.50 
       
C18:2n-6 62.25±0.76 1.00±0.01 33.76±0.84 61.25±0.14 54.63±0.25 54.28±3.31 
C18:3n-6 <0.01 0.67±0.01 19.32±0.14 <0.01 6.70±0.08 5.97±1.41 
C20:2n-6 0.02±0.01 <0.01 0.83±0.26 0.26±0.02 0.61±0.04 0.08±0.03 
C20:3n-6 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
C20:4n-6 <0.01 <0.01 <0.01 0.22±0.01 <0.01 0.18±0.02 
C22:4n-6 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
C22:5n-6 <0.01 0.39±0.01 <0.01 <0.01 <0.01 <0.01 
n-6 total 62.31±0.77 2.06±0.03 53.91±1.24 61.73±0.17 61.94±0.37 61.84±4.77 
       
C18:3n-3 0.25±0.01 0.86±0.11 3.60±0.01 0.13±0.05 1.27±0.01 1.19±0.25 
C20:3n-3 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
C20:5n-3 <0.01 73.01±0.41 <0.01 4.40±0.24 <0.01 3.52±0.12 
C22:5n-3 <0.01 1.71±0.39 <0.01 <0.01 0.33±0.04 0.16±0.01 
C22:6n-3 <0.01 11.65±0.65 <0.01 0.53±0.18 <0.01 0.49±0.10 
n-3 total 0.25±0.01 87.23±1.56 3.60±0.01 5.06±0.47 2.21±0.05 5.36±0.48 
       
n-6/n-3 249.24±1.64 0.02±0.01 14.98±3.88 12.20±0.36 28.03±7.4 11.54±1.24 
PUFA 62.56±0.78 89.29±1.59 57.51±1.25 66.79±0.64 64.15±0.42 67.20±5.25 
P/S ratio 4.99±2.11 38.32±6.12 3.76±0.17 4.90±0.89 4.70±1.08 5.35±0.25 
Value are means ±SD of two determinations. SATS = saturated fatty acids; MUFA = monounsaturated 
fatty acids; PUFA = polyunsaturated fatty acids; P/S = PUFA/SATS. S = sunflower oil; F = fish oil; B = 
borage oil; SF = sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage 
oil + fish oil. 
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3.3.2 Feed intake and weight gain 
 (a) Daily feed intake 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1  Daily feed intake profiles over a period of 14 weeks 
 
No significant fish/borage oil interaction was observed. A significant time 
effect (WEEK) was observed. Rats of all four dietary groups significantly 
(p<0.01) decreased their feed intake from week 2 to week 12, except for the 
group on the SB diet that was increased between week 12 to week 14. 
 
(b) Daily fatty acid intake 
The intake of specific dietary n-6 and n-3 FA quantities correlated with the 
dietary oils FA composition (Fig 2). All the diets provided a high percentage of 
the n-6 FA, C18:2n-6 (Fig 2A), With the S diet, rats consumed between 0.5 
mg C18:3n-3/100 g BW, with trace quantities (<0.1 mg/100 g BW) of 
C18:3n-6, C20:4n-6, C20:5n-3 and C22:6n-3 (Fig 2B). The SF diet 
predominantly provided the animals with n-3 FA, EPA (C20:5n-3), in quantities 
of approximately 9 mg/100 g body weight (BW) with minor quantities (<1 
mg/100 g BW) of C20:4n-6 and C22:6n-3 (Fig 2C). Fat intake with the SB diet 
mainly provided the rats with n-6 FA C18:3n-6 (approximately 13 mg/100 g 
BW) and n-3 FA C18:3n-3 (approximately 2 mg/100 g BW) (Fig 2D). 
Consumption of the SBF diet increased the rats’ intake of C18:3n-6, C20:5n-3 
and C18:3n-3 predominantly with low levels of C22:6n-3 (Fig 2E). 
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Fig. 2 Fatty acid intake (mg/100 g BW/day) in relation to the different n-6/n-3 FA ratio diets. 
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(c) Body weight gain 
No interaction was observed indicating that the body weight gain profile 
between fish and borage oils were similar (Fig.3). However, individually both 
fish and borage oils had significant main effects over time. Fish oil resulted in 
significantly (p<0.01) higher weight gain from week 12 onwards as compared 
to the control and this effect increased linearly over time (Fig. 4A). Although a 
significant main effect for the borage oil (Fig.4B) was observed resulting in a 
higher body weight gain, this effect decreased linearly over time. The linear 
decrease was only significant (p<0.05) from week 15 onwards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Body weight gain of rats fed diets supplemented with fish oil and/or borage oil to obtain 
varying n-6/n-3 FA ratios. 
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4A             4B 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Effect of fish oil (A) and borage oil (B) on rat weight gain. 
 
 
3.3.3 Cholesterol and phospholipid content (Table 2) 
3.3.3.1 Cholesterol 
The fish and borage oil diets had no significant interaction or main effects on 
the cholesterol content in neither the colon mucosa nor the RBC membranes. 
In the colon mucosa, however the SBF diet tended to increase the level.  
 
3.3.3.2 PC and PE phospholipid content 
Mucosa membranes: No significant fish/borage interaction was noticed. PC 
tended to be decreased by the SF and SB diets while PE tended to be 
decreased and increased by the SF and SB diets respectively. The decrease 
in PC and PE by the SBF diet was similar to the SF diet. Overall, main effects 
showed a decrease (p<0.05) in PE by fish oils.  
 
RBC membranes: No significant fish/borage oil interaction was observed. PC 
and PE phospholipid content tended to increase with all the ratio diets SF and 
SBF. The SBF diet increased the RBC PC, while the PE content was similar 
to the level observed with the SF diet. Overall, the fish oil main effect resulted 
in an increase (p<0.01) in the PC and PE phospholipids. 
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3.3.3.3 PC/PE ratio 
Mucosa membranes: No significant fish/borage oil interaction was noticed. 
The SF and SB diets tended to increase and decrease the ratio, respectively, 
while the SBF diet tended to counteract the SB diet’s reducing effects. 
Overall, fish and borage oil exhibited significant main effects by increasing 
(p<0.05) and decreasing (p<0.01) the ratio, respectively. 
 
RBC membranes: No significant fish/borage oil interaction was observed. 
The SF diet tended to increase the ratio, with the SBF diet having a greater 
increasing effect. As a main effect fish oil increased the PC/PE ratio. 
 
3.3.3.4 Chol/PL ratio 
Mucosa membranes: No significant fish/borage oil interaction or any main 
effects were noticed. However, the ratio tended to decrease with the SB diet, 
while increasing with the SBF diet.  
 
RBC membranes: Significant (p<0.01) fish/borage oil interaction was noticed. 
Both the SF and SB diets significantly decreased (p<0.05) the chol/PL ratio. 
Overall, the fish and borage oils have significant main effects by reducing 
(p<0.05) the chol/PL ratio in the RBC membranes.
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Table 2: Comparative effect of the varying n-6/n-3 FA ratio oil diets on the cholesterol and phospholipids (PC and PE) content of  
    the rat colon mucosa and red blood cell membranes.               
 
Values are means (n =4 -9) ± SD of the cholesterol and phospholipid content expressed in μg (cholesterol or phosphate) per mg protein. Diets: S = sunflower oil only; SF = 
sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil. Phospholipids: PC = phosphatidylcholine; PE = phosphatidylethanolamine; 
chol/PL = cholesterol/phospholipids ratio.  Significant fish/borage oil interaction at p<0.05 (superscript) specified by the same letter.  Main effects due to the presence of fish 
oil (F) or borage oil (B) on the lipid profiles: increase =↑, decrease =↓, no effect = –. Significant main effects of F/B indicated by * = p<0.01 and # = p<0.05.  
 
 
 
Lipid 
Profile 
Colon mucosa Red blood cell membranes 
S SF SB SBF Main Effects S SF SB SBF Main Effects 
 
Cholesterol 
(μg chol/mg 
protein 
 
54.24±13.43 55.53±15.12 48.22±16.23 72.45±7.25 – 0.003±0.001 0.003±0.001 0.003±0.001 0.003±0.001 – 
PC 335.67±75.89 280.40±71.70 214.75±63.68 318.21±59.42 – 2.00±0.64 3.37±0.50 2.29±0.84 3.64±0.67 F * ↑ 
PE 
(μg Pi/mg protein) 
216.18±65.31 140.57±40.41 260.29±33.11 168.94±28.86 F * ↓ 0.66±0.17 1.02±0.22 0.76±0.30 0.96±0.37 F * ↑ 
PC/PE 
(Molar) 
1.97±0.38 2.56±1.03 1.18±0.57 1.78±0.04 F # ↑, B * ↓ 2.73±0.48 3.24±0.76 2.93±0.46 3.80±0.66 F * ↑ 
 
chol/PL 
(Molar) 
 
0.31±0.19 0.28±0.13 0.22±0.08 0.32±0.07 – 0.003±0.001abc 0.001±0.001b 0.002±0.001a 0.001±0.001c F * ↓,  B # ↓ 
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3.3.4 Fatty acids  
The FA content of the phospholipids was expressed qualitatively (%) and 
quantitatively (μg). 
 
3.3.4.1 Saturated fatty acids (SATS) (Table 3) 
 Mucosa PC (%): No significant fish/borage oil interaction or main effects 
were observed.  
 
Mucosa PC (μg): No significant fish/borage oil interaction or overall main fish 
or borage oil effects were observed.  
 
Mucosa PE (%): No significant fish/borage oil interaction was observed. 
However, the SF diet tended to increase total SATS, in contrast to a decrease 
with the SB diet. The SBF diet reduced the total SATS. Overall, main effects 
produced by fish oil increased (p<0.01) the total SATS due to a significant 
increase (p<0.01) in C18:0, as well as a marked increase in C14:0, C16:0 and 
C20:0. Borage oil, however, counteracted this effect by reducing (p<0.01) the 
total SATS as a result of a decrease (p<0.01) in C16:0. Borage oil significantly 
(p<0.05) increased C20:0. 
 
Mucosa PE (μg):  Significant fish/borage oil interaction was only observed for 
C18:0. The SB diet reduced (p<0.05) C18:0 significantly when compared to 
both the S and SF diets. The SBF diet counteracted these effects, with the 
fish oil increasing C18:0 above the level observed with the SB diet. Overall, 
fish oil had a significant main effect (p<0.05) resulting in an increase in total 
SATS content due to increases in C14:0, C16:0 and C20:0. However, borage 
oil countered these effects by significantly reducing (p<0.01) the levels of 
C14:0, C16:0 and total SATS. 
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Table 3: Saturated fatty acid composition (% total fatty acids and μg fatty acid/mg protein) of the membrane phospholipids PC 
                                   and PE in rat colon mucosa and red blood cell membranes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means (n = 4-9) ± SD of the qualitative (%) and quantitative (μg FA/mg protein) fatty acid content of rat colon mucosa and RBC membranes. Diets: S = sunflower oil only; SF = sunflower 
 oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil; PC= phosphatidylcholine; PE = phosphatidylethanolamine; SATS= saturated fatty acids. Significant fish/borage oil 
interaction indicated by significant differences between 2 dietary groups at p<0.05 (superscript) as shown by the same letters. Main effects due to the presence of the fish (F) or borage (B) oils indicated by: 
increase = ↑, decrease = ↓, no effect = –. Significant main effects specified by * = p<0.01 and # = p<0.05. Where both F and B have significant main effects at p<0.01 or p<0.05, the value highlighted in bold  
has the highest main effect.
Fatty Acids 
Qualitative (% of total fatty acids) Quantitative (μg FA/mg  protein) 
S SF SB SBF Main 
effects 
S SF SB SBF Main 
effects 
Mucosa PC           
C14:0 0.85± 0.38 0.43± 0.18 0.39± 0.22 0.18± 0.01 – 2.10±1.24 0.85± 0.75 0.62± 0.47 <0.01 –
C16:0 25.33± 1.57 23.29± 2.92 22.20± 4.44 22.62± 3.33 – 45.83± 7.82 33.35± 8.17 34.01± 18.45 41.29± 11.48 –
C18:0 8.31± 1.55 9.16± 1.75 11.07± 3.77 8.58± 1.04 – 17.39± 6.83 14.47± 3.98 12.82± 5.30 15.40± 2.72 –
C20:0 0.71± 0.25 0.76± 0.24 0.65±0.07 0.90± 0.33 – 1.41± 0.32 2.89± 2.19 1.28± 0.45 1.59± 0.56 –
C22:0 0.54± 0.12 0.56± 0.04 0.49±0.11 0.58± 0.13 – 1.14± 0.24 0.77± 0.03 0.79± 0.51 1.09± 0.45 –
C24:0 0.31± 0.09 0.44± 0.10 0.29±0.10 0.33± 0.05 – 0.68± 0.11 0.68± 0.17 0.52± 0.40 0.62± 0.15 –
Total SATS 34.38± 5.09 34.31± 3.98 34.48±1.67 32.83± 4.16 – 67.84± 14.54 50.58± 12.16 36.62± 19.36 59.52± 13.97 –
           
Mucosa PE 
C14:0 
 
0.20± 0.07 
 
0.38± 0.27 
 
0.16± 0.00 
 
0.07± 0.01 
–  
0.26± 0.09 
 
1.07± 0.54 
 
0.17± 0.07 
 
0.08± 0.01 
 
B * ↓ 
C16:0 9.60± 1.58 11.89± 2.45 5.82± 2.10 6.90± 1.67 B * ↓ 12.36± 2.43 14.11± 4.57 4.14± 2.80 7.99± 2.14 B * ↓ 
C18:0 14.54± 0.56 17.74± 3.65 12.72± 2.95 16.49± 1.15 F * ↑ 20.54± 6.26a 20.69± 7.32b 5.29± 1.76abc 19.32± 5.37c – 
C20:0 0.44± 0.14 0.49± 0.09 0.65± 0.10 0.64± 0.32 B # ↑ 0.68± 0.35 0.99± 0.79 0.46± 0.27 0.74± 0.49 – 
C22:0 0.69± 0.23 0.64± 0.15 0.82± 0.15 0.66± 0.11 – 0.97± 0.42 0.63± 0.20 0.55± 0.24 0.80± 0.29 – 
C24:0 <0.01 <0.01 <0.01 <0.01 – <0.01 <0.01 <0.01 <0.01  
Total SATS 25.39± 1.30 30.97±5.87 20.07± 3.35 24.74± 1.95 F * ↑, B * ↓ 34.74± 9.18 36.68± 12.54 8.73± 3.36 28.91± 6.92 F # ↑, B * ↓ 
 
RBC PC 
          
C14:0 <0.01 0.36±0.11 0.25±0.19 0.33±0.07 – 0.07±0.06ab 0.02±0.01b <0.01a 0.03±0.02 – 
C16:0 12.05±1.54a 19.34±4.18ab 16.54±2.44 12.74±4.22b – 0.30±0.07a 0.80±0.19ab 0.50±0.13bc 0.37±0.11c F # ↑ 
C18:0 10.27±1.12ab 17.10±3.63b 14.94±2.08a 13.13±3.54 – 0.29±0.11a 0.65±0.26ab 0.43±0.15 0.32±0.05b F # ↑ 
C20:0 0.37±0.30 0.58±0.17 0.24±0.09 0.40±0.22 – 0.03±0.01 0.20±0.01 0.01±0.01 0.04±0.05 – 
C22:0 0.11±0.02 0.16±0.08 0.32±0.19 0.25±0.11 B # ↑ <0.01 <0.01 <0.01 <0.01 – 
C24:0 0.33±0.23 0.25±0.04 0.22±0.07 0.21±0.05 – 0.02±0.00a 0.01±0.01 <0.01a 0.01±0.00 B # ↓ 
Total SATS 21.33±3.26abc 38.36±4.60bd 29.71±2.72a 28.16±6.39cd F * ↑ 0.55±0.12 1.48±0.35 0.92±0.29 1.38±0.93 F * ↑ 
 
RBC PE 
          
C14:0 0.34±0.03 0.91±0.82 0.49±0.35 0.67±0.37 – <0.01 0.02±0.02 <0.01 0.02±0.02 – 
C16:0 5.49±1.19 6.18±2.31 7.98±2.75a 3.30±0.71a – 0.06±0.01 0.10±0.04 0.11±0.06 0.08±0.05 – 
C18:0 7.63±2.41 10.54±5.36a 7.80±1.93 4.82±1.92a – 0.07±0.02 0.22±0.15 0.09±0.03 0.24±0.15 F * ↑ 
C20:0 0.58±0.14a 0.20±0.04a 0.24±0.12 0.27±0.10 B # ↓ <0.01 <0.01 <0.01 <0.01 – 
C22:0 0.41±0.02 0.51±0.24 0.53±0.29 0.40±0.04 – <0.01 <0.01 <0.01 0.03±0.03 – 
C24:0 <0.01 0.28±0.14 0.29±0.22 0.28±0.22 – <0.01 <0.01 <0.01 <0.01 – 
Total SATS 14.19±4.12 22.07±11.38a 17.73±5.75 9.06±2.08a – 0.15±0.03 0.21±0.13 0.20±0.07 0.25±0.17 – 
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RBC PC (%): Significant fish/borage oil interaction affected the total SATS, 
C16:0 and C18:0. The SF and SB diets increased (p<0.05) C16:0, C18:0 and 
total SATS, with the SF diet having the greater effect. The SBF diet decreased 
(p<0.05) C16:0 and total SATS in comparison to the level observed with the 
SB diet, where borage oil tended to counter the effect of the SF diet. Overall, 
the presence of fish oil had a significant main effect (p<0.01) resulting in an 
increased total SATS, due to increases in C16:0 and C18:0, while borage oil 
significantly (p<0.05) increased the level of C22:0.  
 
RBC PC (μg): Significant fish/borage oil interaction influenced the membrane 
content of C14:0, C16:0, C18:0 and C24:0. The SF diet significantly increased 
(p<0.05) C16:0 and C18:0, while decreasing (p<0.05) C14:0. The SB diet 
significantly reduced (p<0.05) C14:0 and C24:0 compared to the S, while 
C16:0 decreased (p<0.05) to a level below that observed with the SF diet. The 
SBF diet decreased (p<0.05) C16:0 and C18:0 due to borage oil countering 
the increasing effects caused by the fish oil. Overall, fish oil significantly 
increased the total SATS by increasing C16:0 (p<0.05) and C18:0 (p<0.05), 
while borage oil significantly reduced (p<0.05) C24:0. 
 
RBC PE (%): Significant fish/borage oil interaction influenced the total SATS, 
C16:0, C18:0 and C20:0. The SF diet tended to increase C14:0, C18:0 and 
C24:0, while significantly (p<0.05) decreasing C20:0, resulting in an increase 
in total SATS. The SB diet significantly (p<0.05) increased C16:0 in 
comparison to the SBF diet. The SBF diet significantly (p<0.05) decreased the 
total SATS largely due to reductions in C18:0 (p<0.05). Overall, only borage 
oil had a significant main effect (p<0.05) resulting in a decrease in C20:0. 
 
RBC PE (μg): No significant fish/borage oil interaction was observed.  Fish oil, 
overall, had a significant main effect (p<0.01) that resulted in an increase in 
C18:0. 
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3.3.4.2 Monounsaturated fatty acids (MUFA) (Table 4) 
Mucosa PC (%): The MUFA was not affected by any significant fish/borage oil 
interaction. The SF and SBF diets tended to increase the level of C18:1n-9. 
Overall, no significant fish oil or borage oil main effects were observed. 
 
Mucosa PC (μg): No significant fish/borage oil interaction influenced the 
MUFA content. The SB diet tended to increase C18:1n-9 while the SBF diet 
favoured an increase in C18:1n-9, mainly due to the influence of the borage 
oil. Overall, borage oil significantly increased the total MUFA as a main effect 
due to the increased (p<0.01) C18:1n-9 level. 
 
Mucosa PE (%): No significant fish/borage oil interaction influenced the 
MUFA. Overall, fish oil had a significant main effect by increasing (p<0.05) 
C18:1n-9, whilst borage oil resulted in a decrease (p<0.01) in C16:1 and an 
increase (p<0.01) in C20:1. 
 
Mucosa PE (μg): Fish/borage oil interaction significantly influenced the total 
MUFA and C18:1n-9 content. The SB diet significantly decreased (p<0.05) the 
total MUFA due to a decrease (p<0.05) in C18:1n-9. With the combination diet 
SBF, the total MUFA and C18:1n-9 increased (p<0.05) significantly due to the 
fish oil countering the reducing effect observed with the SB diet. Overall, the 
fish and borage oils did not have any significant main effects on the MUFA 
content. 
 
RBC PC (%): Significant (p<0.05) fish/borage oil interaction altered the total 
MUFA. Individually, both the SF and SB diets significantly (p<0.05) increased 
the total MUFA mainly due to a marked increase in C18:1n-9. Overall, no fish 
or borage oil main effects were observed. 
 
RBC PC (μg): Significant fish/borage oil interaction was observed to alter the 
levels of 18:1n-9, with the SF diet significantly (p<0.05) increasing the content 
in relation to the S diet. Overall, main effects produced by fish oil significantly 
increased C18:1n-9 (p<0.05). 
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Table 4: Monounsaturated fatty acid composition (% total fatty acids and μg fatty acid/mg protein) of the membrane     
phospholipids PC and PE in rat colon mucosa and red blood cell membranes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means (n = 4-9) ± SD of the qualitative (%) and quantitative (μg FA/mg protein) fatty acid content of rat colon mucosa and RBC membranes. Diets: S = sunflower oil only; SF = sunflower 
oil + fish  oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil; PC=phosphatidylcholine; PE=phosphatidylethanolamine; MUFA= monounsaturated fatty acids. Significant 
fish/borage oil interaction indicated by significant differences between 2 dietary groups at p<0.05 (superscript) as shown by the same letters. Main effects due to the presence of the fish (F) or 
borage (B) oils indicated by: increase =↑, decrease = ↓,  no effect = –. 
Fatty Acids 
Qualitative (% of total fatty acids) Quantitative (μg FA/mg protein) 
S SF SB SBF Main 
effects 
S SF SB SBF Main 
effects 
Mucosa  PC 
          
C16:1 1.23±.0.28 0.91± 0.12 0.86± 0.58 1.01± 0.26 – 2.09± 0.83 0.91± 0.38 1.43± 1.34 1.95± 0.89 – 
C18:1n-9 12.72± 1.09 13.01± 1.17 12.11± 2.24 14.07± 1.12 – 19.22± 6.73 14.18± 4.09 24.94± 5.89 26.18± 7.60 B * ↑ 
C20:1 0.45± 0.09 0.48± 0.12 0.49± 0.12 0.51± 0.09 – 0.83± 0.48 1.20± 1.11 0.84± 0.45 0.96± 0.34 – 
C22:1 0.20±.0.07 0.21± 0.05 0.15± 0.04 0.20± 0.08 – 0.48± 0.23 0.86± 0.68 0.33± 0.13 0.41± 0.23 – 
C24:1 0.20± 0.12 0.23± 0.01 0.14± 0.12 0.06± 0.03 – 0.41± 0.25 1.09± 1.11 0.13± 0.02 0.10± 0.02 – 
Total MUFA 20.45± 1.27 20.00± 1.24 20.01± 2.77 21.88± 1.59 – 23.74± 16.84 23 .32± 4.78 36.49±4.31 36.81±9.89 B # ↑ 
           
Mucosa PE           
C16:1 0.42± 0.13 0.50± 0.13 0.27± 0.14 0.25± 0.07 B * ↓ 0.51± 0.11 0.91± 0.72 0.24± 0.30 0.31± 0.09 – 
C18:1n-9 7.92± 0.69 9.09± 1.57 7.61± 1.98 9.24± 0.35 F # ↑ 11.03± 3.43a 9.69± 3.36 2.45± 0.99ab 11.03± 2.86b – 
C20:1 0.19± 0.03 0.15± 0.04 0.36± 0.04 0.30± 0.13 B * ↑ 0.27± 0.08 0.15± 0.02 0.24± 0.13 0.40± 0.17 – 
C22:1 0.24± 0.14 0.30± 0.16 0.23± 0.03 0.15± 0.02 – 0.35± 0.24 0.58± 0.48 0.58± 0.48 0.18± 0.08 – 
C24:1 0.31± 0.10 <0.01 0.17± 0.07 <0.01 – 0.44± 0.19 <0.01 0.17± 0.01 <0.01 – 
Total MUFA 11.22± 1.68 12.23± 1.54 9.15±5.19 13.01± 0.72 – 16.48± 4.90a 13.17± 3.79 6.11± 0.87ab 15.71± 4.03b – 
           
RBC PC           
C16:1 0.23±0.17 0.26±0.08 0.21±0.06 0.36±0.23 – 0.01±0.01 0.01±0.00 <00.1 0.01±0.01 – 
C18:1n9 3.00±0.85 4.15±1.13 3.57±0.51 3.73±0.96 – 0.07±0.01a 0.16±0.04a 0.11±0.04 0.11±0.04 F # ↑ 
C20:1 <0.01 0.19±0.06 0.11±0.04 0.14±0.05 – <0.01 <0.01 <0.01 <0.01 – 
C22:1 0.15±0.07 0.04±0.03a 0.07±0.00 0.17±0.06a – <0.01 <0.01 <0.01 <0.01 – 
C24:1 <0.01 <0.01 <0.01 <0.01 – <0.01 <0.01 <0.01 <0.01 – 
Total MUFA 4.09±0.68ab 5.83±0.81b 5.64±0.70a 5.40±1.51 – 0.18±0.11 0.22±0.07 0.17±0.06 0.27±0.17 – 
 
RBC PE 
          
C16:1 <0.01 0.29±0.07 0.22±0.10 0.33±0.14 – <0.01 <0.01 <0.01 0.01±0.00 – 
C18:1n-9 3.06±0.73a 5.54±2.50a 4.69±0.97 4.10±1.76 – 0.03±0.01 0.11±0.08 0.07±0.04 0.09±0.06 F # ↑ 
C20:1 0.93±0.54 0.22±0.00 0.21±0.11 0.64±0.54 – 0.02±0.02 <0.01 <0.01 <0.01 – 
C22:1 <0.01 <0.01 <0.01 <0.01 – <0.01 <0.01 <0.01 <0.01 – 
C24:1 <0.01 <0.01 0.96±0.22 2.10±0.62 – <0.01 <0.01 0.01±0.00 0.03±0.02 – 
Total MUFA 5.37±1.37 6.43±2.03 7.34±1.41 7.09±2.83 – 0.06±0.02 0.11±0.05 0.10±0.04 0.15±0.07 B * ↑ 
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RBC PE (%): Only C18:1n-9 was significantly affected by a fish/borage oil 
interaction. The SF diet increased (p<0.05) C18:1n-9. Diets SF, SB and SBF 
tended to increase the total MUFA mainly due to increases in C18:1n-9. 
However, neither fish nor borage oil exhibited any overall main effects. 
  
RBC PE (μg): The RBC membranes MUFA content was not influenced by any 
fish/borage oil interaction. However, overall borage oil significantly (p<0.01) 
increased the total MUFA, while fish oil significantly (p<0.05) increased 
C18:1n-9.  
 
3.3.4.3 Polyunsaturated fatty acids (PUFA)  
(a) n-6 PUFA (Table 5) 
Mucosa PC (%): No significant fish/borage interactions were observed to 
influence the total membrane n-6 PUFA content. The SF diet tended to 
increase total n-6 PUFA, C18:2n-6 and C20:3n-6 while reducing C22:5n-6.  
The SB diet tended to reduce C18:2n-6, while increasing C20:3n-6 and 
C20:4n-6 in comparison to the S diet. C20:4n-6 tended to be increased by the 
SBF diet due to borage oil countering fish oil’s decreasing effect. Overall, fish 
oil significantly increased C18:2n-6 (p<0.01) and the total n-6 PUFA (p<0.05).  
 
Mucosa PC (μg): No significant fish/borage oil interactions were observed to 
influence the n-6 PUFA content. However, the SF diet tended to increase 
C18:3n-6, C20:2n-6 and C22:2n-6, while reducing C18:2n-6 and C20:4n-6, 
compared to the S diet. A similar result was detected with the SB diet, with the 
diet also reducing C18:2n-6 and C22:4n-6, while increasing C20:4n-6 and 
total n-6 PUFA. The SBF diet tended to decrease C18:3n-6, C20:3n-6 and 
C20:2n-6 by cancelling the individual increasing effects of the two oils.  
C18:2n-6 and C20:4n-6 was increased with the SBF diet, due to the 
enhancing effect of borage oil. No fish oil neither borage oil main effects were 
observed. 
 
Mucosa PE (%): Significant fish/borage oil interaction was observed to 
influence the n-6 fatty acids. The SB diet tended to increase C18:3n-6, 
C20:3n-6 and C20:4n-6, while the SBF diet had a similar effect. Overall main 
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borage oil effects significantly increased (p<0.01) C20:3n-6, C20:4n-6 and 
C22:4n-6 resulting in an increase (p<0.05) in total n-6 PUFA, while C20:2n-6 
and C22:2n-6 was reduced (p<0.05). The fish oil mainly reduced (p<0.01) 
C22:4n-6 and C22:5n-6. 
 
Mucosa PE (μg): C20:2n-6 and C22:5n-6 content was significantly altered by 
fish/borage oil interactions. The SF diet increased C20:2n-6 significantly 
(p<0.05), but lowered (p<0.05) C22:5n-6 with a resultant decrease in total n-6 
PUFA compared to the S diet.  SF tended to decrease C18:2n-6, C20:4n-6, 
C22:4n-6 and C22:5n-6 while 18:3n-6 was increased. The SB diet significantly 
(p<0.05) reduced C20:2n-6 and C22:5n-6 in comparison to the SF and S 
diets, respectively, while C18:3n-6 and C20:4n-6 tended to increase, with 
C18:2n-6 and C22:4n-6 decreasing as well. The SBF diet reduced C20:2n-6 
and C22:5n-6 significantly (p<0.05) in comparison to the SF and S diets, 
respectively. Overall, main effects exerted by borage oil reduced C20:2n-6 
content (p<0.01), whereas fish oil reduced C22:5n-6 content (p<0.05). 
 
RBC PC (%): No significant fish/borage interaction affected the total n-6. The 
SF diet tended to increase C18:2n-6 and decrease C20:3n-6, C20:4n-6, 
C22:4n-6 and C22:5n-6 compared to the S diet. The SB diet tended to 
increase the total n-6 PUFA, and C20:4n-6. With the SBF diet, C20:3n-6 was 
increased due to SB diet countering the reducing effects of the SF diet. An 
opposite effect was noticed when considering the C20:4n-6 level. Overall, 
significant main effects exerted by fish oil reduced (p<0.01) C20:4n-6 and 
C22:5n-6, whereas borage oil increased (p<0.01) C20:4n-6.  
 
RBC PC (μg): No significant fish/borage oil interactions were noted. The SF 
diet tended to increase the total n-6 PUFA while the SB diet tended to increase 
C20:4n-6 which was also reflected with the SBF diet. Overall, fish oil main 
effects significantly increased (p<0.05) total n-6 PUFA content, while borage oil 
increased (p<0.05) C20:4n-6. 
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Table 5: Polyunsaturated fatty acid (n-6) composition (% total fatty acids and μg fatty acid/mg protein) of the         
               membrane phospholipids PC and PE in rat colon mucosa and red blood cell membranes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means (n = 4-9) ± SD of the qualitative (%) and quantitative (μg FA/mg protein) fatty acid content of rat colon mucosa and RBC membranes. Diets: S = sunflower oil only; SF = 
sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil; PC=phosphatidylcholine; PE = phosphatidylethanolamine; PUFA=polyunsaturated fatty 
acids.  Significant fish/borage oil interaction indicated by significant differences between2 dietary groups at p<0.05 (superscript) as shown by the same letters.  Main effects due to the 
presence of the fish oil (F) or  borage oil (B) indicated by: increase =↑, decrease =↓, no effect –. Significant main effects specified by * = p<0.01 and # = p<0.05. Where both F and B have 
main effects at p<0.01 or p<0.05, the value highlighted in bold has the highest main effect. 
Fatty Acids 
Qualitative (% of total fatty acids) Quantitative (μg FA/mg protein) 
S SF SB SBF Main 
effects 
S SF SB SBF Main 
effects 
Mucosa PC           
C18:2 11.00± 1.72 14.45± 1.68 9.61± 2.54 12.58± 1.36 F * ↑ 16.72± 5.89 14.59± 6.07 14.18± 9.55 22.86± 7.19 – 
C18:3 0.29± 0.07 0.23± 0.04 0.33± 0.09 0.29± 0.05 – 0.56± 0.29 0.97± 0.76 0.60± 0.41 0.53± 0.18 – 
C20:2 0.76± 0.14 1.04± 0.25 0.80± 0.09 0.77± 0.11 – 1.66± 0.64 3.75± 3.73 1.75± 0.18 1.41± 0.49 – 
C20:3 1.74± 0.32 2.28± 0.41 2.15± 0.74 2.61± 0.61 – 3.14± 2.20 3.08± 0.72 3.69± 2.29 4.85± 2.24 – 
C20:4 8.00± 0.91 7.89± 0.90 8.81± 2.47 9.59± 2.18 – 11.36± 6.61 8.05± 3.89 15.27± 8.95 20.10± 6.76 – 
C22:2 0.19± 0.06 0.21± 0.05 0.22± 0.09 0.12± 0.02 – 0.38±0.09 0.83± 0.98 0.47± 0.31 <0.01 – 
C22:4 0.64± 0.13 0.51± 0.04 0.66± 0.12 0.65± 0.13 – 1.25± 0.60 1.14± 1.12 1.04± 0.50 1.09± 0.25 – 
C22:5 0.32± 0.16 <0.01 0.16± 0.03 <0.01 – 0.67± 0.16 <0.01 0.27± 0.17 <0.01 – 
Total n-6 PUFA 22.81± 2.40 26.64± 2.95 22.63± 5.77 28.41± 1.65 F # ↑ 28.53± 15.79 21.26± 11.68 39.02± 22.04 45.97± 21.08 – 
           
Mucosa PE           
C18:2 5.30± 1.12 4.69± 1.14 4.72± 1.45 6.24± 0.62 – 7.60± 2.05 4.42± 0.68 4.38± 4.71 7.39± 1.85 – 
C18:3 0.12± 0.06 0.17± 0.13 0.58± 0.48 0.25± 0.08 – 0.16± 0.05 0.68± 0.83 0.51± 0.48 0.28± 0.12 – 
C20:2 0.69± 0.24 1.17± 0.74 0.54± 0.14 0.49± 0.06 B # ↓ 1.03± 0.43a 2.86± 0.73abc 0.37± 0.19b 0.58± 0.15c B * ↓ 
C20:3 1.93± 0.47 1.87± 0.71 2.65± 0.83 3.17± 0.37 B * ↑ 2.75± 1.24 1.75± 0.62 3.27± 1.71 3.82± 1.31 – 
C20:4 20.36± 5.44 19.69± 5.77 29.62± 4.71 30.43± 2.03 B * ↑ 25.52± 7.22 18.87± 3.05 32.23± 16.41 36.39± 11.03 – 
C22:2 0.63± 0.22 <0.01 0.79± 0.31 0.85± 0.44 B # ↓ <0.01 <0.01 0.57± 0.14 1.22± 0.64 – 
C22:4 3.31± 0.73 2.01± 0.73 4.36± 0.89 2.85± 0.42 F *↓, B * ↑ 3.67± 0.12 1.92± 0.62 2.46± 1.75 3.25± 0.63 – 
C22:5 1.51± 0.42 0.51± 0.15 1.62± 0.63 0.61± 0.09 F *↓ 2.58± 0.69abc 0.51± 0.18b 0.96± 0.48a 0.73± 0.26c F # ↓ 
Total n-6 PUFA 29.05± 9.44ab 30.76±7.20c 44.07±5.31a 44.71± 1.85bc B * ↑ 41.46± 6.50 29.69±1.26 45.16± 22.41 59.95± 9.22 – 
 
RBC PC           
C18:2 3.77±0.72 4.57±0.79 4.72±0.77 4.52±1.79 – 0.12±0.03 0.17±0.04 0.13±0.05 0.13±0.06 – 
C18:3 <0.01 <0.01 0.21±0.08 0.20±0.08 – <0.01 <0.01 0.01±0.01 <0.01 – 
C20:2 0.21±0.10 0.59±0.05 0.45±0.34 1.76±2.19 – 0.04±.0.01 0.02±0.01 <0.01 0.09±0.10 – 
C20:3 0.32±0.15 0.19±0.03 0.22±0.04 0.29±0.10 – 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01 – 
C20:4 4.69±1.50 4.11±0.39 7.36±1.44 4.94±1.74 F *↓, B * ↑ 0.13±0.04 0.16±0.03 0.19±0.05 0.25±0.15 B # ↑ 
C22:2 <0.01 <0.01 <0.01 <0.01 – <0.01 <0.01 0.01±0.01 <0.01 – 
C22:4 0.41±0.08 0.26±0.10 0.44±0.07 0.42±0.42 – 0.02±0.01 0.01±0.01 0.02±0.01 0.02±0.01 – 
C22:5 0.56±0.22 0.09±0.06 0.39±0.12 0.10±0.03 F * ↓ 0.02±0.02 <0.01 0.01±0.01 <0.01 – 
Total n-6 PUFA 9.24±2.63 10.04±1.56 12.88±2.14 10.53±3.72 – 0.32±0.09 0.40±0.08 0.29±0.06 0.39±0.08 F # ↑ 
           
RBC PE           
C18:2 1.81±0.35 1.85±0.46 1.78±0.15 1.38±0.54 – 0.03±0.02 0.03±0.01 0.02±0.01 0.03±0.01 – 
C18:3 6.66±4.81 <0.01 0.23±0.06 0.23±0.07 – <0.01 <0.01 <0.01 <0.01 – 
C20:2 0.39±0.09 1.52±1.08 0.52±0.31 1.11±0.61 F # ↑ <0.01 0.02±0.02 <0.01 0.02±0.01 – 
C20:3 0.88±0.13abc 0.25±0.16b 0.19±0.07a 0.33±0.13c B# ↓ 0.01±0.01 <0.01 <0.01 0.01±0.01 – 
C20:4 8.45±0.60 7.11±2.17 9.50±2.18a 5.87±1.20a – 0.10±0.02 0.11±0.03 0.12±0.03 0.09±0.03 – 
C22:2 <0.01 <0.01 <0.01 <0.01 – <0.01 <0.01 <0.01 <0.01 – 
C22:4 3.39±0.57ab 2.08±0.94ac 4.07±0.96cd 1.13±0.41bd F * ↓ 0.05±0.01 0.03±0.01 0.06±0.05 0.06±0.05 – 
C22:5 0.75±0.20 0.63±0.21 1.02±0.45 0.40±0.25 F * ↓ 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01 – 
Total n-6 PUFA 14.48±3.59 11.89±4.14 15.24±3.92 9.85±1.30 F * ↓ 0.20±0.05 0.20±0.03 0.20±0.06 0.19±0.10 – 
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RBC PE (%): Significant fish/borage oil interaction modulated C20:3n-6, 
C20:4n-6 and C22:4n-6. The SF diet decreased C20:3n-6 and C22:4n-6 
significantly (p<0.05) compared to the S diet, while the SB diet decreased 
(p<0.05) C20:3n-6. Compared to the SB diet, the SBF diet significantly 
reduced (p<0.05) C20:4n-6 and C22:4n-6 due to the countering effect of SF. 
Overall, fish oil significantly reduced (p<0.01) total n-6 PUFA, C22:4n-6 and 
C22:5n-6, while increasing C20:2n-6 (p<0.05). C20:3n-6 was reduced 
significantly (p<0.05) due to a borage oil main effect. 
 
RBC PE (μg): No significant fish/borage oil interaction was observed nor any 
main effects on the total n-6 content in the RBC membrane phospholipids. 
 
(b) n-3 PUFA (Table 6) 
Mucosa PC (%): No significant fish/borage interaction was noted. The SF and 
SB tended to increase C18:3n-3, C20:5n-3, C22:5n-3 and C22:6n-3 in 
comparison to the S diet. The SBF diet tended to further increase C20:5n-3, 
C22:5n-3 and C22:6n-3. Overall, fish oil had a significant main effect by 
increasing total n-3 PUFA, 20:5n-3 and C22:6n-3, while borage oil resulted in 
a significant increase (p<0.05 and p<0.01, respectively) in C20:5n-3 and total 
n-3 PUFA. 
 
Mucosa PC (μg): No significant fish/borage oil interaction was observed. The 
results indicate that the SF diet tended to increase total n-3 PUFA, C18:3n-3, 
C20:5n-3, C22:5n-3 and C22:6n-3 compared to the S diet. The SB diet tended 
to decrease total n-3 PUFA, due to a decrease in C22:5n-3. The SBF diet had 
a similar effect than the S diet implying that the SB diet countered the effect of 
SF. Only fish oil had a significant overall main effect that resulted in an 
increase (p<0.05) in total n-3 fatty acid levels. 
 
Mucosa PE (%): No significant fish/borage oil interaction affected the n-3 
levels. Significant fish oil main effects include an increased (p<0.01) total n-3 
PUFA as a result of increased levels of C20:5n-3 and C22:6n-3. Borage oil 
increased (p<0.01) the total n-3 PUFA, due to a significant increase (p<0.05) 
in C20:5n-3. 
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Table 6: Polyunsaturated fatty acid (n-3) composition (% total fatty acids and μg fatty acid/mg protein) of the membrane  
               phospholipids PC and PE in rat colon and mucosa and red blood cell membranes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means (n = 4-9) ± SD of the qualitative (%) and quantitative (μg FA/mg protein) fatty acid content of rat colon mucosa and RBC membranes. Diets: S =sunflower oil only;  
SF = sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil; PC=phosphatidylcholine; PE = phosphatidylethanolamine;  
PUFA = polyunsaturated fatty acids. Significant fish/borage oil interaction indicated by significant differences between 2 dietary groups at p<0.05 (superscript) as shown by the same letters.  
Main effects due to the presence of the fish oil (F) or borage oil (B) indicated by: increase = ↑, decrease = ↓, no effect = –. Significant main effects specified by * = p<0.01 and # = p<0.05.  
Where both F and B have main effects at p<0.01 or p<0.05, the value highlighted in bold has the highest main effect. 
 
Fatty Acids 
Qualitative (% of total fatty acids) Quantitative (μg FA/mg protein) 
S SF SB SBF Main effects S SF SB SBF Main effects 
Mucosa PC           
C18:3 0.07± 0.00 0.12± 0.03 0.19± 0.17 0.09± 0.04 – 0.17± 0.06 0.60± 0.49 0.19± 0.06 0.33± 0.01 – 
C20:5 0.09± 0.00 0.27± 0.05 0.15± 0.00 0.35± 0.09 F * ↑, B # ↑ 0.22± 0.06 1.07± 0.81 0.35± 0.01 0.70± 0.26 – 
C22:5 0.18± 0.04 0.21± 0.03 0.30± 0.20 0.37± 0.03 – 0.91± 0.61 1.78± 1.49 0.16± 0.01 1.04± 0.39 – 
C22:6 0.18± 0.01 0.36± 0.09 0.26± 0.09 0.43± 0.12 F* ↑ 0.39± 0.13 0.48± 0.14 0.42± 0.28 0.77± 0.28 – 
Total n-3 PUFA 0.31± 0.14 0.89± 0.16 0.60± 0.22 1.23± 0.30 F * ↑, B* ↑ 1.66± 0.90 3.35± 2.06 1.14± 0.87 2.50± 1.13 F # ↑ 
          
Mucosa PE           
C18:3 <0.01 0.33± 0.08 <0.01 <0.01  <0.01 0.38± 0.10 <0.01 <0.01  
C20:5 0.20± 0.06 0.69± 0.25 0.31± 0.10 1.01± 0.13 F * ↑, B #↑ 0.29± 0.17 0.57± 0.21 0.27± 0.20 1.26± 0.41 F * ↑ 
C22:5 0.76± 0.63 0.66± 0.39 0.65± 0.30 0.93± 0.17 – 1.41± 0.87 2.01±0.01 0.42± 0.25 1.06± 0.31 B # ↓ 
C22:6 1.07± 0.11 1.75± 0.26 1.22± 0.53 1.94± 0.21 F*↑ 1.51± 0.29 1.87± 0.16a 0.78± 0.60ab 2.25± 0.43b F * ↑ 
Total n-3 PUFA 2.03± 0.56 2.80± 0.66 2.39± 0.62 4.10± 0.18 F * ↑, B * ↑ 2.30± 0.73a 2.67± 0.54c 1.80± 1.12b 4.83±1.03abc F # ↑ 
           
RBC PC           
C18:3 <0.01 0.08±0.04 0.24±0.07 0.16±0.08 – <0.01 <0.01 <0.01 <0.01 – 
C20:5 <0.01 0.12±0.02 0.14±0.04 0.18±0.06 – <0.01 <0.01 <0.01 <0.01 – 
C22:5 0.21±0.12 0.31±0.07 0.44±0.31 1.23±0.96 B # ↑ 0.17±0.23AB 0.01±0.01B 0.01±0.01A 0.04±0.02 – 
C22:6 0.28±0.15 0.55±0.16 0.38±0.11 0.84±0.38 F * ↑, B # ↑ 0.04±0.05 0.02±0.01 0.02±0.01 0.02±0.01 – 
Total n-3 PUFA 0.45±0.20 1.30±0.32 1.44±0.67 1.62±0.84 F# ↑, B# ↑ 0.02±0.02 0.05±0.01 0.05±0.03 0.09±0.06 F # ↑, B # ↑ 
           
RBC PE           
C18:3 <0.01 0.32±0.05 0.10±0.01 0.30±0.16 – <0.01 <0.01 <0.01 <0.01 – 
C20:5 <0.01 0.23±0.07 <0.01 0.46±0.50 – <0.01 0.01±0.01 <0.01 0.02±0.02 – 
C22:5 1.23±0.37 2.00±0.39 0.86±0.20 1.86±0.65 F* ↑ 0.02±0.01 0.04±0.02 0.02±0.02 0.03±0.01 F * ↑ 
C22:6 <0.01 4.00±1.32 1.37±0.71 0.64±0.20 – <0.01 0.04±0.02 0.02±0.01 0.03±0.03 – 
Total n-3 PUFA 1.11±0.26a 6.64±1.52abc 2.67±0.93b 2.11±1.33c F * ↑, B # ↓ 0.01±0.01a 0.13±0.04abc 0.03±0.02b 0.05±0.02c F * ↑ 
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Mucosa PE (μg): Significant fish/borage oil interactions influenced the total 
n-3 PUFA as well as C22:6n-3. The SF diet significantly increased (p<0.05) 
C22:6n-3 in comparison to the SB diet. The SB diet significantly decreased 
(p<0.05) C22:6n-3 in comparison to the SBF diet, thus reducing the total n-3 
PUFA. With the SBF diet, total n-3 PUFA and C22:6n-3 was significantly 
increased due to the fish oil countering the reducing effects observed with the 
SB diet. Overall main effects produced by fish oil increased total n-3 PUFA 
due to the significant (p<0.01) increases in C20:5n-3 and C22:6n-3. Borage oil 
significantly decreased (p<0.05) C22:5n-3.  
 
RBC PC (%): n-3 PUFA was not influenced by any significant fish/borage oil 
interaction. Overall, fish oil main effects significantly increased total n-3 PUFA 
(p<0.05) and C22:6n-3 (p<0.01). Borage oil main effects also resulted in an 
increase (p<0.05) in total n-3 PUFA, C22:5n-3 and C22:6n-3. 
 
RBC PC (μg): Significant fish/borage oil interaction was noticed. The SF and 
SB diets significantly reduced C22:5n-3 (p<0.05) in comparison to the S diet. 
Overall fish oil and borage oil significantly increased the total n-3 PUFA.   
 
RBC PE (%): Significant fish/borage oil interaction was noticed. The SB diets 
significantly reduced (p<0.05) total n-3 PUFA in comparison to the SF diet 
mainly due to a decrease in C18:3n-3, C22:5-3 and C22:6n-3. The SB diet, 
however, tended to increase C22:6n-3 and the total  n-3 PUFA as compared 
to sunflower oil. The SBF diet significantly reduced (p<0.05) total n-3 PUFA 
below the level observed with the SF diet. Overall fish oil significantly (p<0.01) 
increased C22:5n-3 and the total  n-3 PUFA while borage oil, countered 
(p<0.05) the fish oil effect.  
 
RBC PE (μg): Significant fish/borage oil interaction was observed to increase 
the total n-3 PUFA. The SF diet significantly increased total n-3 PUFA. The 
SBF diet reduced (p<0.05) the total n-3 PUFA with SB countering the effect of 
SF. The fish oil content of the SBF diet increased the C22:6n-3 slightly above 
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that observed with SB. Overall, fish oil significantly (p<0.01) increased 
C22:5n-3 and the total n-3 PUFA.   
 
(c) Total PUFA and LCPUFA (Table 7) 
Mucosa PC (%): No significant fish/borage oil interactions were observed. 
The main effects exerted by fish oil resulted in increased (p<0.05) n-3 
LCPUFA, as well as the total PUFA. Borage oil increased (p<0.05) the total 
LCPUFA and n-3 LCPUFA. The SBF diet reflected a combined effect of the 
SF and SB regarding the increase of the different FA parameters. 
 
Mucosa PC (μg): No significant fish/borage oil interactions were noted. SF 
also tended to decrease total PUFA, LCPUFA and the n-6 LCPUFA. SBF 
closely mimicked SB with respect to the total PUFA, LCPUFA and n-6 PUFA 
and the n-3 PUFA similar to the SF diet. Main effects exerted fish oil resulted 
in a significant increase (p<0.05) n-3 LCPUFA. Borage oil containing diets 
produced significant main effects that resulting in the increase (p<0.05) in total 
PUFA and LCPUFA and n-6 LCPUFA.  
 
Mucosa PE (%): Significant fish/borage interaction modulated the total PUFA, 
LCPUFA and n-6 LCPUFA. Diets SF, SB and SBF significantly increased 
(p<0.05) total PUFA and LCPUFA in comparison to the S diet. The SBF diet 
significantly (p<0.05) increased the n-3 LCPUFA content in comparison to the 
S, SF and SB diets. Both fish and borage oil significantly, overall, increased 
the total PUFA (p<0.05) and n-3 LCPUFA (p<0.01), with fish oil having a 
greater effect. Borage oil also significantly increased (p<0.01) the total LC 
PUFA and n-6 LCPUFA.  
 
Mucosa PE (μg): Fish/borage oil interactions significantly altered (p<0.05) the 
total n-3 LCPUFA content. The SF diet tended to increase the total n-3 
LCPUFA, while the SB diet significantly (p<0.05) reduced the content. The 
SBF diet significantly increased (p<0.01) the total n-3 LCPUFA, due to the fish 
oil content countering the reducing effects of borage oil. Main effects exerted 
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by the borage oil increased (p<0.05) the total LCPUFA content largely due to 
an increase (p<0.05) in the n-6 LCPUFA. 
 
RBC PC (%): Fish/borage interactions significantly modulated the total n-6 
LCPUFA. In comparison to the SF and SBF diets, the SB diet significantly 
increased (p<0.05) n-6 LCPUFA and tended to increase the other PUFA 
parameters. SF tended to decrease and increase n-6 and n-3 LCPUFA, 
respectively. The SBF diet decreased (p<0.05) the total n-6 LCPUFA, due to 
the SF countering the SB effect. Main effects exerted by the fish oil 
significantly increased (p<0.05) n-3 LCPUFA and decreased total n-6 
LCPUFA. Borage oil main effects include an increase (p<0.05) in all the PUFA 
parameters. 
 
RBC PC (μg): No significant fish/borage oil interactions were indicated to 
have an effect on any of the parameters. However, both the SF and SB diets 
tended to increase the LCPUFA and n-3 LCPUFA. The SBF diet tended to 
increase all lipid parameters. Overall, both fish and borage oil had a significant 
(p<0.05) main effect by increasing the total n-3 LCPUFA content, with borage 
oil having the greater increasing effect. 
 
RBC PE (%): Significant fish/borage oil interactions were noticed. The SF diet 
significantly (p<0.05) increased the total n-3 LCPUFA. The SBF diet 
decreased the total LC PUFA (p<0.01) and n-3 LCPUFA (p<0.05). No overall 
main effects were observed. 
 
RBC PE (μg): Significant fish/borage oil interactions were observed. The SF 
diet significantly (p<0.05) increased the n-3 LCPUFA resulting in an increase 
in the total LCPUFA. The SB diet also tended to increase the n-3 LCPUFA. 
Overall, fish oil exerted a significant main effect that resulted in an increase 
(p<0.05) in the total LCPUFA mainly due to an increase in total n-3 LCPUFA. 
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Table 7: Total PUFA and different long chain (LC) PUFA parameters (% total fatty acids and μg fatty acid/mg protein) of the    
               membrane phospholipids PC and PE in rat colon mucosa and red blood cell membranes. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means (n = 4-9) ± SD of the qualitative (percentage) and quantitative (μg FA/mg protein) fatty acid content of rat colon mucosa and RBC membranes. Diets: S = sunflower oil only; SF = 
sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil; PC=phosphatidylcholine; PE = phosphatidylethanolamine; PUFA= polyunsaturated fatty acids; LC 
PUFA= long-chain PUFA.  Significant fish/borage oil interaction indicated by significant differences between 2 dietary groups at p<0.05 (superscript) as shown by the same letters. Main effects due to 
the presence of fish oil (F) or borage oil (B) indicated by increase =↑, decrease =↓, no effect = –. Significant main effects specified by * = p<0.01 and # = p<0.05. Where both F and B have main effects 
at p<0.01 or p<0.05, the value highlighted in bold has the highest main effect.  
 
 
 
Fatty Acid Qualitative (% of total fatty acids) Quantitative (μg FA/mg protein) 
 S SF SB SBF Main effects S SF SB SBF Main 
effects 
Mucosa PC          
 
PUFA 23.12± 2.50 27.53± 2.95 23.23± 5.67 29.64± 1.93 F # ↑ 34.77± 13.93 25.04± 13.85 50.13± 13.00 48.47± 22.00 B # ↑ 
 LC PUFA 11.80± 1.18 12.75± 1.27 13.24± 3.15 16.08± 1.49 B * ↑ 16.29± 7.48 11.40± 8.22 28.67± 7.70 24.93± 15.01 B # ↑ 
 n-6 LCPUFA 11.53± 1.12 11.96± 1.33 12.69± 3.30 14.94± 1.23 – 15.43± 7.47 11.90± 6.47 27.36± 7.72 22.57± 14.12 B # ↑ 
 n-3 LCPUFA 0.27±0.10 0.80± 0.13 0.51± 0.23 1.14± 0.28 F # ↑, B # ↑ 1.57± 0.97 2.90± 1.73 1.05± 0.86 2.80± 0.60 F # ↑ 
           
Mucosa PE         
 PUFA 31.09± 9.55abc 47.10± 5.17b 46.46± 5.39a 48.81± 1.67c F # ↑, B # ↑ 43.96± 7.98 34.45± 13.32 46.51± 22.61 65.26± 9.63 – 
 LC PUFA 29.35± 5.55abc 41.77± 4.87b 42.13± 5.00a 42.32± 2.11c B # ↑ 37.25± 8.33 29.70± 12.70 48.18± 12.73 56.64± 9.74 B # ↑ 
 n-6 LCPUFA 27.24± 5.56ab 25.50±6.50cd 39.74± 5.22ac 38.22± 2.27bd B * ↑ 34.75± 6.96 27.06± 12.62 39.50± 17.68 51.33± 9.35 B # ↑ 
 n-3 LCPUFA 2.03±0 .56a 2.67± 0.75c 2.39± 0.62b 4.09± 0.17abc F * ↑, B# ↑ 2.30±073a 2.48± 0.35c 1.80± 1.12ab 4.82± 1.05bc – 
 
RBC PC 
          
 PUFA 10.98±2.48 12.77±3.49 15.89±2.83 14.23±3.21 B * ↑ 0.34±0.11 0.38±0.05 0.41±0.13 0.84±0.63 – 
 LC PUFA 6.18±1.32 5.73±0.90 9.16±2.08 11.18±4.17 B * ↑ 0.14±0.06 0.32±0.18 0.29±0.09 0.37±0.22 – 
 n-6 LCPUFA 5.35±1.38a 5.00±0.49b 8.73±2.55abc 5.78±1.49c F # ↓, B * ↑   0.19±0.06        0.21±0.05       0.22±0.07       0.27±0.16        – 
 n-3 LCPUFA 0.53±0.17 1.25±0.33 1.38±0.66 1.88±0.74 F # ↑, B * ↑ 0.02±0.02 0.04±0.01 0.05±0.03 0.09±0.07 F # ↑, B # ↑ 
RBC PE           
 PUFA 15.85±4.16 17.33±4.00 17.50±4.87 16.21±10.39 – 0.21±0.04 0.32±0.07 0.21±0.05 0.33±0.08 – 
 LC PUFA 13.07±2.24 15.38±3.97 15.32±4.89a 8.64±3.24a – 0.18±0.04 0.35±0.15 0.19±0.04 0.20±0.11 F # ↑ 
 n-6 LCPUFA 10.31±3.44 10.11±2.96 13.29±3.71 8.18±1.43 – 0.17±0.04 0.18±0.03 0.16±0.04 0.16±0.10 – 
 n-3 LCPUFA 1.22±0.49a 5.74±2.10ab 4.08±3.78 1.00±0.71b – 0.01±0.0a   0.11±0.05a 0.07±0.01 0.04±0.03 – 
 
 
 
 
 110
3.3.5 Membrane fatty acid ratios  
(a) P/S; n-6/n-3; ∆6 S/P; C20:4n-6/C20:5n-3  (Table 8) 
 
Mucosa PC (%): A significant (p<0.05) fish/borage interaction only affected 
the C20:4n-6/C20:5n-3 ratio. The SF and SB diets significantly (p<0.05) 
decreased the C20:4n-6/C20:5n-3 ratio with the SF diet having the greater 
effect. The SBF diet decreased (p<0.05) the ratio to the same extent as the 
SF diet compared to the SB diet. Overall, fish oil decreased the n-6/n-3 
(p<0.01) and C20:4n-6/C20:5n-3 ratios while increasing, the P/S (p<0.01) and 
Δ6 S/P (p<0.05) ratios.  
 
Mucosa PC (μg): Significant fish/borage interaction only affected the 
C20:4n-6/C20:5n-3 ratio. The C20:4n-6/C20:5n-3 ratio was significantly 
decreased with both the SF and SB diets. Diet SBF decreased (p<0.05) the 
ratio significantly compared to the SB diet, while to a similar extent as the SF 
diet. Overall, the fish oil decreased the n-6/n-3 (p<0.05) and 
C20:4n-6/C20:5n-3 (p<0.01) ratios, while borage oil increased (p<0.01) the 
n-6/n-3 ratio. 
 
Mucosa PE (%): Significant (p<0.05) fish/borage oil interaction was noticed.  
The SB diet significantly (p<0.05) decreased the Δ6 S/P ratio compared to the 
SBF diet and to some extend the S diet. The SF and SBF diets decreased the 
C20:4n-6/C20:5n-3. Overall, borage oil increased (p<0.01) the P/S ratio, while 
fish oil decreased (p<0.01) the C20:4n-6/C20:5n-3 ratio.  
 
Mucosa PE (μg): No significant interactions were observed, although the SB 
diet tended to increase the n-6/n-3 and P/S ratios. Overall, fish oil decreased 
(p<0.01) the C20:4n-6/C20:5n-3 ratio, as well as the n-6/n-3 ratio (p<0.05) 
while increasing the delta 6 S/P ratio.  
 
RBC PC (%): Significant fish/borage oil interaction was observed for the 
n-6/n-3 and C20:4n-6/C20:5n-3 ratios. Both ratios were decreased (p<0.05) 
by the SF and SB with SF having the greater effect. The SBF diet mimicked 
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the effect of the SF diet. The SF diet tended to decrease the P/S ratio. 
Overall, fish oil decreased (p<0.05) the n-6/n-3 and C20:4n-6/C20:5n-3 ratios, 
but increased (p<0.05) the Δ6 S/P ratio. Borage oil, overall, increased 
(p<0.05) the P/S ratio, while decreasing the C20:4n-6/C20:5n-3 ratio. 
 
RBC PC (μg): Fish/borage oil interaction was noticed. The 
C20:4n-6/C20:5n-3 ratio was decreased (p<0.05) by the SF and SB with SF 
having the greater effect. The SBF diet mimicked the effect of the SF diet. 
Overall, fish oil decreased (p<0.05) the n-6/n-3 ratio, while borage oil 
increased the P/S (p<0.05) ratio. 
 
RBC PE (%): Significant (p<0.01) fish/borage oil interactions occurred. Both 
the SF and SB diets decreased (p<0.01) the n-6/n-3 and Δ6 S/P ratios, with a 
greater decrease effected by the SF diet.  The SBF diet closely mimics the 
reduction in both ratios obtained with the SB diet while countering the major 
reduction noticed with the SF diet.  Overall, the fish oil decreased (p<0.01) the 
n-6/n-3 and C20:4n-6/C20:5n-3 ratios, while borage oil increased (p<0.05) the 
P/S ratio. 
 
RBC PE (μg): Significant (p<0.01) fish/borage oil interactions were observed. 
Both the SF and SB diets decreased the n-6/n-3 (p<0.01) and Δ6 S/P (p<0.05) 
ratios, respectively, with a greater effected noticed by the SF diet. The SBF 
diet increased (p<0.05) the n-6/n-3 ratio similar to the SB diet. Overall, the fish 
oil decreased the n-6/n-3 (p<0.01), C20:4n-6/C20:5n-3 (p<0.01) and ∆6 S/P 
(p<0.05) ratios. 
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Table 8: Fatty acid ratios (% of total FA and μg FA/mg protein) of the PC and PE phospholipid fractions of the rat colon mucosa  
               and red blood cell membranes.  
 
Values are means (n= 4-9) ±SD of the ratios of the total fatty acid percentage and µg FA/mg protein in the Pc (phosphatidylcholine) and PE (phosphatidylethanolamine) lipid fractions of the rat colon mucosa and 
RBC membranes. Diets: S = sunflower oil only; SF = sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil. P/S = polyunsaturated/saturated fatty acid ratio; 
C20:4n-6/C20:5n-3 = arachidonic acid/eicosapentaenoic acid ratio; Δ6 S/P = delta-6 desaturase substrate/product ratio. Significant fish/borage interaction indicated by significant differences between two dietary 
groups at p<0.05 (superscript) as shown by the same letters. Main effects due to the presence of fish oil (F) or borage oil (B) on the lipid ratios indicated by: increase = ↑, decrease = ↓, no effect = –. Significant 
main effects of F/B indicated by * = p<0.01 and # = p<0.05.   
 
 
 
Qualitative (% of total fatty acids) Quantitative (μg FA/mg protein) 
S SF SB SBF Main effects S SF SB SBF Main effects 
Mucosa PC 
          
P/S 0.65±0.12 0.85±0.12 0.66±0.16 0.95±0.19 F * ↑ 0.53±0.24 0.63±0.41 1.58±1.34 0.82±0.35 – 
n-6/n-3 74.22±25.26 30.73±6.83 42.95±22.25 23.71±3.78 F * ↓ 12.09±6.03 5.42±2.82 34.11±13.94 19.86±5.77 F # ↓, B * ↑ 
∆6 S/P 16.57±6.57 21.82±4.10 12.59±3.15 18.48±4.96 F # ↑ 29.54±7.83 28.28±24.93 30.96±13.96 37.92±11.24 – 
C20:4n-6/C20:5n-3 101.51±7.29abc 29.93±3.06b 57.68±24.73ad 28.41±9.84cd F * ↓ 101.51±7.29abc 29.93±3.06b 57.68±24.73ad 28.41±9.84cd F * ↓ 
C20:4n-6 PC/PE 0.35±0.07 0.43±0.14 0.30±0.06 0.31±0.06 B # ↓ 0.42±0.13 0.51±0.07 0.47±0.19 0.54±0.01 – 
           
Mucosa PE           
P/S 1.36±0.27 1.67±0.36 2.30±0.44 1.98±0.18 B * ↑ 1.44±0.28 1.06±0.58 4.67±3.49 2.05±0.21 – 
n-6/n-3 14.97±6.21 15.97±4.91 19.55±5.74 10.93±0.92 – 15.70±7.38 11.07±4.77 23.10±4.71 11.32±0.92 F # ↓ 
∆6 S/P 3.48±0.33 2.92±0.44 2.72±0.70a 3.61±0.39a – 5.48±1.11 6.68±1.26 3.70±0.75 6.65±0.27 F * ↑ 
C20:4n-6/C20:5n-3 148.72±8.44 28.20±3.59 109.84±40.43 30.32±3.48 F *  ↓ 148.72±8.44 28.20±3.59 109.84±40.43 30.32±3.48 F *↓ 
 
RBC PC 
          
P/S 0.50±0.05 0.36±0.13 0.54±0.16 0.54±0.10 B # ↑ 0.47±0.08 0.36±0.13 0.54±0.16 0.53±0.20 B # ↑ 
n-6/n-3 17.34±5.95abc 8.10±2.83b 9.52±3.73a 9.16±3.76c F # ↓ 17.50±6.27 8.10±2.83 11.23±6.61 9.16±3.76 F # ↓ 
∆6 S/P 5.76±1.01 8.40±2.33 6.01±1.38 6.55±1.27 F # ↑ 9.66±3.45 12.93±5.43 9.95±2.43 9.20±2.53 – 
C20:4n-6/C20:5n-3 468.72±150.32abc 39.28±10.02b 50.94±22.21a 29.09±5.60c F * ↓, B # ↓ 468.72±150.32abc 39.28±10.02b 50.94±22.21a 29.09±5.60c F * ↓, B # ↓ 
C20:4n-6 PC/PE 0.58±0.22 0.66±0.13 0.78±0.38 0.66±0.21 – 1.50±0.23 1.63±0.25 1.82±0.77 2.16±0.70 – 
           
RBC PE           
P/S 1.08±0.49 0.89±0.58 1.73±0.41 2.13±2.09 B # ↑ 1.02±0.38 1.03±0.67 1.47±0.63 1.60±1.46    – 
n-6/n-3 14.65±3.13abc 1.41±059bd 6.72±1.42ad 4.97±3.93c F * ↓ 13.44±4.02abc 1.41±0.59bd 6.72±1.42Aad 4.97±3.94c    F *↓ 
∆6 S/P 7.62±1.52abc 1.91±0.63bd 2.87±098a 4.07±1.51cd – 8.67±4.18abc 4.00±2.45bd 4.73±1.41a 6.34±2.93cd F # ↓ 
C20:4n-6/C20:5n-3 657.71±229.82 34.80±4.91 881.04±270.23 31.46±15.31 F * ↓ 657.71±229.82 34.80±4.91 881.04±270.23 31.46±15.31 F * ↓ 
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(b) C20:4n-6 PC/PE ratio (Table 8) 
No significant fish/borage oil interactions for the C20:4n-6 PC/PE ratio was 
observed in any of the membranes. 
 
Mucosa (%): The C20:4n-6 PC/PE ratio tended to decrease with the SB diet. 
The SBF diet reduced the ratio to the same level observed with the SB diet. 
Overall, borage oil exerted significant main effects that resulted in a decrease 
(p<0.05) in the C20:4n-6 PC/PE ratio.  
 
Mucosa (μg): The C20:4n-6 PC/PE ratio content tended to increase with the 
SF and SBF diets. No overall main effects were observed.  
 
RBC (%): The C20:4n-6 PC/PE ratio tended to increase with all three ratio 
diets, with the SB diet exerting a greater increasing effect. No overall main 
effects were observed. 
 
RBC (μg): The C20:4n-6 PC/PE ratio tended to increase with all three ratio 
diets in the following order, SF<SB<SBF. No overall main effects were 
observed. 
 
3.3.6 Extent of lipid peroxidation (Table 9) 
Mucosa: No significant fish/borage oil interactions on the CD levels were 
observed with iron incubation. However, overall, fish oil increased (p<0.05) 
the CD level significantly. 
 
RBC: A significant fish/borage oil interaction (p<0.05) altered the oxidative 
status as determined by the conjugated dienes level (CD). Both the SF and 
SB diets significantly increased (p<0.05) the CD levels in comparison to the S 
diet, with the SF diet having the greater increasing effect. The SBF diet 
tended to increase the extent of lipid peroxidation above the levels observed 
with the individual SF and SB diets. Main effects significantly increasing the 
CD levels were caused by both fish oil (p<0.01) and borage oil (p<0.05), with 
fish oil having the greater increasing effect.  
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     Table 9:  Lipid peroxidation in rat colon mucosa and red blood cell membranes as measured by the level of conjugated dienes. 
 
Tissue 
Diets 
Main effects 
S SF SB SBF 
Mucosa 5.35±0.26 6.53±0.23 5.16±1.16 6.35±1.71 F # ↑ 
RBC 3.22±0.72abc 4.86±0.71b 4.62±0.43a 5.03±1.17c F * ↑, B # ↑ 
Values are means ± SD of the levels of conjugated dienes (measured in nmol per mg protein) in rat red blood cell membranes (n=9) and colon mucosa (n=4). Diets: S = 
sunflower oil only; SF = sunflower oil + fish oil; SB = sunflower oil + borage oil; SBF = sunflower oil + borage oil + fish oil. Significant fish/borage oil interaction indicated by 
significant differences between 2 dietary groups at p<0.05 (superscript) as shown by the same letters. Main effects due to the presence of fish oil (F) or borage oil (B) on the 
lipid profiles: increase =↑, decrease =↓. Significant main effects indicated by p<0.01 = * and p<0.05 = #. 
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3.4 Discussion  
Due to the physiological effects of dietary FA, a critical balance between n-6 
and n-3 PUFA is required to maintain normal cellular homeostasis (Sumida et 
al., 1993; Sessler and Ntambi, 1998). With dietary fat intake playing a key role 
in the supply of these FA, alterations to the ratio of n-6 and n-3 FA have the 
potential to manipulate biochemical and physiological cellular responses 
(Jump and Clark, 1999; Collett et al., 2001). These alterations may influence 
the risk of developing diseases such as cancer that have been shown to be 
associated with specific FA intakes (Nkondjock et al., 2003). The present 
study demonstrates that dietary fat intakes with specific n-6/n-3 FA ratios 
modulated the lipid profile of rat colon mucosa and red blood cell (RBC) 
membranes. 
 
Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the two 
main phospholipids in eukaryotic cells comprising 50% and 25% of the 
phospholipid mass, respectively (Henneberry et al., 2002). In normal cells, PC 
and sphingomyelin dominate the outer leaflet of the plasma membrane, 
whereas the inner leaflet contains PE and phosphatidylserine (PS) (Van 
Hoeven and Emmelot, 1972). Alterations in these lipid components have an 
impact on membrane structure and function (Hulbert et al., 2005). Thus, with 
diet being an important source of the lipid components, such as fatty acids, 
membranes phospholipids composition can readily be manipulated. Borage oil 
reduced the mucosa membrane PC content, while increasing PE, which 
resulted in a decrease in the PC/PE ratio.  Fish oil reduced PE, thereby 
increasing the mucosa PC/PE ratio. In the RBC membranes the opposite 
effect was observed with the fish oil containing diets SF and SBF increasing 
the content of both phospholipid fractions while borage oil had no effect. From 
this data it is evident that dietary FA intake played an important role in either 
the distribution of membrane phospholipid and/or the synthesis thereof which 
varies depending on the specific tissue compartment. 
 
The intestinal mucosa serves as an interface between the environment and 
mammals acquiring water, nutrients and other bioactive compounds, whilst the 
mucosa also serves as a barrier against toxins and infective agents 
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(Jankowski et al., 1994). As a result cells are constantly renewed every 2-6 
days (depending on species and intestinal site) (Lipkin, 1973) with the 
production of new cells in the crypts equal to the rate at which cells are lost 
from the villus tip by extrusion (Madara, 1990) or by apoptosis (Hall et al., 
1994). Therefore, the maintenance of homeostasis in normal tissue requires 
adequate balance and active interplay between these two regulatory 
processes. In the present study, the n-6/n-3 FA ratio diets provided a pool of 
FA that are utilized for the synthesis and distribution of membrane lipids 
thereby altering the membrane structure. In the colon mucosa, membrane 
phospholipids, PC and PE, decreased or increased depending on the n-6/n-3 
FA ratio and hence the specific oil used in the diet. Consequently, changes in 
the membrane phospholipid composition may incur different metabolic 
responses in the cell that may stimulate cell proliferation (Pajari and Mutanen, 
1999). In terms of phospholipids synthesis, cells mainly double their 
phospholipid mass in order for cell growth to occur (Jackowski, 1996). 
The membrane PE content has been linked to the control of cell proliferation, 
with reduced levels resulting in the inhibition of cell proliferation (Kano-Sueka 
and King, 1988). Similarly, PC is also an important cellular component 
required by signalling molecules that regulate cell numbers (Tercé et al., 1994; 
Cui and Houweling, 2002). Dietary fat intake is capable of modifying the 
phospholipid content in the membranes depending on the amount and type of 
fat consumed (Khuu Thi-Dinh et al., 1990; Parrish et al., 1997). Due to dietary 
modifications to the membranes phospholipid profile, the biochemical systems 
regulating cell production may be affected significantly. In a study by Anti et al. 
(1992), consumption of fish oil that is rich in the n-3 FA C20:5n-3 and 
C22:6n-3 modified the proliferative pattern of the rectal crypt epithelial cells in 
patients with sporadic adenomatous polyps. Similarly, the FA C20:5n-3 and 
C22:6n-3 has been shown to modify cell turnover in normal colonic mucosa 
(Calviello et al., 1999). These results suggest that diets with specific n-6/n-3 
FA ratios play an important role in the biosynthesis of phospholipid membrane 
constituents. 
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As mature RBC cannot synthesize lipids, they rely on a continuous exchange 
of lipids between their membranes and plasma lipoproteins (Gold and Philips, 
1990). The RBC membrane phospholipid turnover with the plasma is a 
passive process that occurs very slowly (London et al., 1949; Ganzoni et al, 
1971). Changes in plasma lipid concentration are a net result of the balance 
between two processes, firstly by both dietary intakes, as well as endogenous 
synthesis, and secondly by the utilization for energy, membrane incorporation 
and storage (Visiolo et al., 2006). In the present study, the increase in 
membrane phospholipid concentrations and distribution ratio could be a 
consequence of altered plasma lipids affected by the different n-6/n-3 FA ratio 
diets.  
 
Changes in the relative proportions of different lipid species, such as 
phospholipids, cholesterol and fatty acid saturation, modulate membrane 
permeability, rigidity and fluidity (Maxfield and Tabas, 2005). The 
cholesterol/phospholipid (chol/PL) ratio, PC/PE and polyunsaturated/saturated 
FA (P/S) ratios are lipid parameters used to monitor changes in membrane 
fluidity. Alterations in these lipid parameters illustrated that the colon mucosa 
and RBC membranes responded differently to diets with varying n-6/n-3 FA 
ratios. In the colon mucosa, changes to the phospholipid parameters did not 
significantly alter the chol/PL ratio. Only the borage oil (SB diet) tended to 
decrease the ratio due to subtle changes in PE and PC, implying that a less 
rigid membrane structure could affect membrane function. Studies illustrate 
that increased membrane fluidity plays a role in regulating plasma lipoprotein 
interactions (Fernandez and West, 2005). As a result, reduction in colon 
membranes fluidity may adversely affect critical cellular processes that are 
mediated by the membrane lipid structure. Both the fish oil and borage oil 
reduced the chol/PL ratio in the RBC membranes. Hereby RBC membrane 
fluidity was increased mainly due to an increase in phospholipid 
concentrations. The relative decrease in cholesterol as compared to the 
phospholipids will elicit an increase in the fluidity as it stabilizes the fatty acyl 
groups in the lipid bilayer (Ohvo-Rekila et al., 2002). 
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The different n-6/n-3 FA ratio diets also altered the PC/PE and P/S membrane 
ratios in both tissues. In the colon mucosa the SF and SB diets increased and 
decreased the PC/PE ratio, respectively. The SF and SBF diets increased the 
PC/PE ratio in the RBC membranes due to an increase in the PC phospholipid 
levels. A decrease in the PC/PE ratio is associated with a reduction in 
membrane fluidity while an increase elevates the viscosity of the membrane 
(Mahler et al., 1988). Variability in the PC/PE ratio between the two tissue 
types could be related to the difference in phospholipid availability and 
distribution due to the incorporation of FA (Abel et al., 1997).  
 
Fish and borage oil intake increased the total PUFA and LCPUFA content of 
PC and PE phospholipids in both tissues. As a result the P/S ratio was 
selectively elevated in the colon with fish and borage oil increasing the ratio in 
PC and PE. In the RBC membranes only borage oil increased the P/S ratio in 
both compartments. The resultant increase in the P/S ratio is known to 
enhance membrane fluidity (Zhang et al., 2007). This is ascribed to the 
presence of the double bonds that reduces the tight packaging of the lipid 
components due to a kink in the FA chain (Eyster, 2007). 
 
Alterations to membrane fluidity significantly influence the activity of certain 
enzymes and the affinity of receptors to their ligands (Tappia et al., 1997) 
while cell signal transduction pathways that are regulated by lipid-protein 
interactions are altered (Yang et al., 2005). Plasma membranes contain 
specialized lipid microdomains such as the lipid rafts and caveolae that 
influence cell signaling (Kenworthy, 2002). Incorporation of n-3 FA such as 
C20:5n-3 and C22:6n-3 into the lipid rafts of membranes has been suggested 
to have beneficial health effects (Schley et al., 2007). This is largely due to 
perturbations in membrane composition modifying the function of resident 
protein, and thus cellular responses. Therefore, alterations in the lipid FA 
contents of the microdomains may modulate their biochemical function 
significantly. With diet influencing phospholipid availability, changes in RBC 
membrane lipid composition is likely to modulate the membrane physical 
properties, hereby affecting RBC morphology, receptor activity and oxygen 
transport (Escudero et al., 1998; Vajreswari et al., 2002). As a result, 
 
 
 
 
 119
modifications to the phospholipid parameters maintaining fluidity influence 
membrane functions such as permeability and enzyme binding properties, 
oxygen transport and enzyme activities related to transmembrane transport 
(Cooper, 1977; Lande et al., 1995; Pande et al., 2005).  
 
Both the colon mucosa and RBC membrane fluidity were modulated by the 
specific n-6/n-3 FA ratio diets, and depending on the lipid fractions and tissue 
compartment it could be selectively enhanced or reduced when considering a 
specific lipid parameter (See below Fig. 5). However, when considering the 
overall effect of fish and borage oil, the membrane fluidity was increased in 
both tissue compartments. Significant differences between the two tissue 
membrane lipid compositions suggest that in relation to the main function of 
the tissues, membrane stability is altered differently with fatty acid intake.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Fish and borage oil effects on the lipid parameters influencing the membrane fluidity of 
the colon mucosa and RBC membranes. Results in brackets () indicate the phospholipids 
mainly affected by the dietary oil. 
 
Differences in the mucosa and RBC phospholipids FA content is a reflection of 
(i) the intake of specific FA associated with the diets, (ii) differences in FA 
incorporation between the two tissue types and (iii) the relative ratio of the 
specific phospholipids in the membrane. When considering the lipid 
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parameters, cholesterol, PC and PE phospholipids, PC/PE and chol/PL ratios 
in the rats receiving the sunflower diet differed significantly between the two 
cellular compartments, which reflect the differences in their proliferative and 
functional properties. In general cholesterol is higher in the mucosa, as well as 
PC and PE with a lower PC/PE ratio due to a relative high PE component. 
This is likely to be associated with an increased proliferative status of the 
colon mucosa cells. With respect to the SATS and MUFA, higher levels are 
obtained in the PC fractions, while n-3 and n-6 FA levels are higher in PE. The 
only difference, however, is that in the RBC membranes MUFA levels are 
higher in the PE fraction. With respect to FA ratios the PE fractions contains 
more n-3 FA, therefore yielding a lower n-6/n-3 ratio. The C20:4n-6 level also 
dominates in the PE fractions resulting in a higher C20:4n-6 PC/PE ratio. 
 
The incorporation of FA in a phospholipid will depend on interaction between 
n-6 and n-3 FA with respect to the substrate specificity of the ∆6-desaturase 
enzyme (Rodriguez et al., 1998) as well as the preferential incorporation of 
certain FA into phospholipids (Hatala et al., 1994). The objectives of this study 
was to determine (i) to what extend the FA patterns of the colon mucosa and 
RBC membranes would reflect the dietary FA composition, (ii) differences that 
exist between the tissue compartments and phospholipid fractions regarding 
the incorporation of specific fatty acids and (iii) the modulation of membrane 
susceptibility to oxidative damage.  
 
These aspects were investigated by modulating sunflower oil with either fish or 
borage oil or a combination of the latter to obtain dietary fats with different 
n-6/n-3 FA ratios. With the SF diet specific interaction between C18:2n-6, the 
main FA in sunflower oil, and the major FA in fish oil (C20:5n-3 and C22:6n-3), 
were evaluated. When utilising the SB diet interaction between C18:2n-6 and 
the borage oil FA (C18:3n-3 and C18:3n-6) were monitored. The combination 
(SBF) diet monitored the use of an n-6/n-3 ratio diet similar to the SF diet 
where the interaction of C18:3n-6 and C20:5n-3 on the modulation of 
∆6-desaturase activity was determined by considering the substrate/product 
FA ratios for the enzyme. The effects induced by the individual fish (SF) and 
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borage (SB) oil diets on the different FA profiles of the selected tissue are 
summarised in Fig. 6 (page 122) and Fig. 7 (page 129).  
 
In terms of the SATS composition, the fish oil content of the n-6/n-3 FA ratio 
diets exerted significant effects on the qualitative and quantitative composition 
of both tissue phospholipid fractions (see Fig. 6, page 122). The qualitative 
composition gave an indication of the percentage of total FA (%), whereas 
quantitatively defining the absolute FA levels (μg FA/mg protein) that are 
determined by the phospholipid content of the membrane. When considering 
the qualitative levels, fish oil increased, while borage oil decreased the total 
SATS in the PE fraction of the colon mucosa, respectively. This effect was 
reflected by the increase in C18:0 by fish oil and a decrease in C16:0 by 
borage oil. In contrast, fish and borage oil increased SATS in both 
phospholipid fractions in the RBC. Overall, the two tissue types exhibit distinct 
differences in terms of their levels of SATS incorporation. A similar pattern is 
noticed when considering the quantitative levels although differences do exist. 
The increased incorporation of SATS is likely to compensate for the increased 
phospholipid n-3 FA unsaturation by the fish oil in order to maintain the 
homeostatic membrane fluidity. A similar argument could be used for the 
reduction of SATS in colon PE as the level of n-3 FA is decreased by borage 
oil. In addition, it is known that PUFA decreases stearol-CoA desaturase 
(SCD) activity, a key regulator of membrane SATS and MUFA composition, 
resulting in the segregation of SATS for storage as triacylglycerols (TAG) to 
preserve the membrane physio-chemical homeostasis (Ntambi, 1999; Scaglia 
and Igal, 2005). As a result, the availability of SATS for phospholipid 
remodelling is decreased. The SATS, C16:0 and C18:0 have been implicated 
to play a role in controlling cell numbers by indirectly inducing apoptosis 
(Hardy et al., 2003; Artwohl et al., 2004). It would appear that the reducing 
effect exerted by the SB diet on membrane C16:0 and C18:0 levels may 
influence the mechanisms or signalling pathways regulating apoptosis in the 
colon. In transformed human lung fibroblasts SCD depletion strongly 
correlates with growth inhibition, thus establishing a direct relationship 
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between Δ9-desaturation, the accumulation of C16:0 and C18:0 and cell 
survival (Scaglai and Igal, 2005). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Fish and borage oil effects on the fatty acid composition of the colon mucosa and RBC 
membranes. 
 
In the RBC both fish and borage oils increased MUFA quantitatively in PE. In 
the colon borage oil increased MUFA in PC while it decreased in PE. Fish oil 
has no marked effect although it increased C18:1n-9 in PE. Alterations in the 
tissue MUFA profile were predominantly associated with the dietary 
modulation of the C18:1n-9 level. Studies have shown that diets high in PUFA, 
particularly C20:5n-3 and C22:6n-3 has an inhibitory effect on both ∆6 - and 
∆9-desaturation (Raz et al., 1997; Borgeson et al., 1989). Thus, increases in 
membrane C18:1n-9 in both tissues is likely due to dietary FA intake 
particularly with the fish oil containing diets. C18:1n-9 and C16:0 have been 
implicated to play a role in the control of cellular proliferation and apoptosis. In 
MDA-MB231 breast cancer cells the release of low levels of C18:1n-9 by 
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phospholipase A2 has been shown to stimulate cell proliferation by rapidly 
activating phosphatidylinositol 3-kinase (PI3-K) signalling pathways (Hardy et 
al., 2000). C18:1n-9 is metabolized preferentially into TAG, while it also 
promotes the incorporation of the saturated FA, C16:0, thereby decreasing the 
apoptotic effect of the latter (Hardy et al., 2003). 
 
Dietary FA intakes (i.e. mg FA/100 g BW) gave a clear indication of the 
qualitative amount of n-6 and n-3 PUFA consumed. Consequently, significant 
changes in the phospholipid n-6 and n-3 PUFA composition were observed 
due to fish and borage oil dietary FA intake. Rats consumed a high proportion 
of C20:5n-3 with the SF diet relative to the other PUFA components. Fish oil 
significantly increased C20:5n-3 in the mucosa PC and PE phospholipids 
fraction, while in the RBC membranes, it tended to increase qualitatively in 
both PC and PE. Increases in the membrane C20:5n-3 content coincided with 
an increase in C22:6n-3, which is a product of the sequential elongation and 
desaturation of C20:5n-3 (Sprecher, 2000). In all the phosholipid parameters 
of the mucosa and RBC an increase in the total n-3 LCPUFA, particularly in 
PE, was significant due to the fish oil’s supply of C20:5n-3 and C22:6n-3. 
Increases in membrane n-3 PUFA content could be a consequence of dietary 
n-3 FA being directly incorporated into the membranes rather than through the 
supply via FA metabolism (Vidgren et al., 1997). Increases in the tissue n-6 
LCPUFA, such as C20:3n-6 and C20:4n-6 was mainly elicited in response to 
borage oil increasing the membranes n-6 FA content. The SF diet, however, 
appears to have the opposite effect demonstrated with the SB diet, with the 
fish oil containing diet reducing n-6 LCPUFA content, particularly C20:4n-6 in 
the PC (%) phospholipid fraction of the RBC membranes. This is due to fish oil 
having a reducing effect on the metabolism of n-6 PUFA (Garg et al., 1990). 
 
Fish oil intake significantly influences FA metabolism due to it inhibitory effects 
on ∆6-desaturase (Garg et al., 1988). The relative (%) ∆6 S/P ratio, which 
reflects the activity of the enzyme (Raz et al., 1997), showed that the SF diet 
increased the ratio in the mucosa phospholipids. In RBC a similar pattern is 
noticed in PC and as well as a decrease in PE. This result shows that more 
∆6-desaturase substrates than products were available in the PC fraction, 
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while in PE the opposite result was in effect. Of interest is that the RBC 
membrane PC phospholipid also reflects a similar ∆6 S/P ratio pattern. As it is 
known that fish oil inhibits ∆6-desaturase, although RBC lacks the desaturases 
enzymes (Russo et al., 1997), the membrane ∆6 S/P ratio is utilized as a 
biomarker for the fish oil induced alteration of ∆6-desaturase activity (Fuhrman 
et al., 2006). Borage oil tended to decrease the ∆6-desaturase S/P ratio in PE 
and to some extent in PC implying an increase in the activity of the enzyme. 
The increased effect in PE could also be a reflection of the increased levels of 
C20:4n-6 due to the increased level of C18:3n-6 in borage oil that bypasses 
the ∆6-desaturase enzyme. It has been postulated that the increase in enzyme 
substrates may rather be a consequence of direct FA incorporation into the 
membranes rather than ∆6-desaturase products (Cho et al., 1999). 
 
Despite high intakes of C18:3n-6 with the SB diet the content in the mucosa 
and RBC membranes was not significantly altered in the PC and PE 
phospholipids fractions. However, trends suggest that borage oil increased the 
FA’s qualitative (%) and quantitative (μg) content in both the PC and PE 
phospholipid fractions of the colon mucosa. However, qualitatively the 
C20:3n-6 content increased due to borage oil’s effect on the PE phospholipid 
fraction of the mucosa. This increase in C20:3n-6 may be a consequence of 
the rapid elongation of the FA substrate C18:3n-6 (Johnson et al., 1997). With 
the increase in membrane C20:3n-6 in the mucosa, the FA is subject to 
desaturation by ∆5-desaturase (Umeda-Sawada et al., 2006). As a result, 
C20:4n-6 content tended to increase in both phospholipid fractions, with 
borage oil having a significant qualitative increasing effect in PE. In the RBC 
membrane borage oil tended to decrease the relative C20:3n-6 content in PE 
while increasing C20:4n-6 in both phospholipid fractions. The resultant 
increase in C20:4n-6 elicited by the SB diet may be a consequence of an 
increase in ∆5-desaturase activity (Engler and Engler, 1998).   
 
An important aspect of the current study was to monitor the effect of a specific 
n-6/n-3 dietary FA ratio by combining sunflower, borage and fish oil (SBF diet). 
When utilizing the SBF diet the borage oil countered the fish oil reducing effect 
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on PE resulting in a PC/PE ratio similar to the S diet in the colon mucosa 
(Table 2, page 95). In the RBC membrane the PE/PC ratio of the SBF diet 
reflects that of the SF diet. With respect to total SATS, the combination diet 
reflected the opposing effects of borage oil on fish oil (Table 3, page 97). In 
the mucosa PE (μg), the SBF diet maintained the effect observed with the fish 
oil on C18:0, while an opposite effect was noticed with C16:0. In the RBC 
membrane PC (μg) borage oil countered the increasing fish oil effect on C18:0 
and C16:0, while in PE (μg) the fish oil increasing effect on C18:0 dominates. 
Fish oil countered the reducing effect of borage oil in the combined diet when 
considering the total MUFA level, specifically of C18:1n-9 (mucosa PE μg) 
(Table 4, page 100). Borage oil dominated in PC (μg) by increasing the total 
MUFA level countering an apparent reduction by fish oil on C18:1n-9. Of 
interest is a type of “antagonistic” effect of the two oils on C22:1 (PC % and 
μg) where the combined effect reduced the level despite an increasing effect 
of the individual oils. In RBC PC (%) an opposite increased effect was noticed 
for C20:1 with the SBF diet. When considering the mucosa PC and PE n-6 
PUFA levels, a response similar to the increased SB diet effect was 
demonstrated with the SBF diet (Table 5, page 103). The increasing effect of 
fish oil in the mucosa PC (%) specifically on C18:2n-6 could be related to the 
inhibition of the ∆6-desaturase. This is further demonstrated in the RBC PE 
(%) fraction with the reducing effect of fish oil on C22:4n-6, C22:5n-6 and total 
n-6 PUFA. Of interest is the increased SBF response on C20:3n-6 and 
C20:4n6 in the mucosa PE (% and ug) which reflected the effect of borage oil. 
A similar response was noticed in C20:4n-6 RBC PC (%) and PE (%) level 
with the borage oil although the SBF diet countered the effect presumably due 
to a reducing fish oil effect. With respect to the n-3 FA, the effects of the SBF 
diet reflected the increased additive effect of borage and fish oil with the latter 
making the greatest contribution (Table 6, page 105). This increase was 
mainly obtained due to fish oil enhancing the levels of n-3 LCPUFA C20:5n-3 
and C22:6n-3 (Innis et al., 1995). The only exception is the apparent counter 
effect of borage oil with respect to the increase fish oil response on the total 
n–3 PUFA in RBC PE (%). 
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Similar type of interactions was noticed between fish and borage oil when 
considering the different FA parameters (Table 7, page 109). The SBF diet 
further enhanced the fish oil and borage oil increasing effect regarding the 
PUFA and n-3 LCPUFA in the mucosa PC and PE both qualitatively and 
quantitatively. Borage oil was more prominent in contributing to the increased 
effects of the SBF diet on LCPUFA and n-6 LCPUFA. Qualitatively the RBC 
membranes increase in n-6 LCPUFA content in PC by borage oil was 
countered by fish oil, while both oils increased the n-3 LCPUFA and PUFA 
content. Regarding the different FA ratios (Table 8, page 112) the SBF diet 
also reflects the differential effects of the dietary oils depending on the tissue 
compartment. With respect to the P/S ratio the SBF diet reflects the borage oil 
increase in the mucosa PE (%) and RBC PC (%) and PE (%) fractions thereby 
counteracting the fish decreasing effect. Both the fish and borage oils reducing 
effect contributed to the decreased n-6/n-3 ratio by the SF diet in mucosa PC 
(%) and RBC PC (%) and PE (%). A similar type of response was noticed in 
the mucosa PE (%) fraction. The borage oil tended to counteract the 
increasing effect of fish oil using the SBF diet as reflected in the ∆6-desaturase 
S/P ratio in both the mucosa and RBC PC (%) fraction. The SBF diet also 
mimics the reducing effect of fish oil on the C20:4n-6/C20:5n-3 ratio in the 
mucosa PC (%) and PE (%) as well as the RBC PC (%) and PE (%) although 
the borage oil also reduced the ratio.  
 
In order to preserve tissue homeostasis, the specific levels of certain FA in 
membranes needs to be maintained. The n-6 FA C20:4n-6 is a key regulator 
of normal cellular functions (Brash, 2001). In this study borage oil with a high 
level of 18:3n-6 resulted in an increase in the elongation product C20:3n-6, 
which is the substrate for Δ5-desaturation, thus ensuring the availability of 
C20:4n-6. High membrane levels of C20:4n-6 has however been associated 
with the development of tumours (Nicholson et al., 1991). Thus, dietary 
manipulations utilizing FA ratios containing both C20:3n-6 and C20:5n-3 has 
been proposed to modulate membrane C20:4n-6 content (Barham et al., 
2000). Such ratios ensure that sufficient levels of C20:4n-6 is available to 
mediate processes such as eicosanoid production without raising the content 
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to levels that facilitate pathological conditions. The relative proportion of these 
FA also determines their availability after phospholipase cleavage as 
substrates for cycloxygenases, and hence regulates the production of 
eicosanoids (Li et al., 1994). 
 
The C20:4n-6/C20:5n-3 and C20:4n-6 PC/PE ratios have been used as 
indicators or biomarkers to determine the class of eicosanoid produced (Li et 
al., 1994; Watkins et al., 2000). Reductions in membrane n-6/n-3 and 
C20:4n-6/C20:5n-3 ratios were illustrated in both the colon mucosa and the 
RBC membranes, with the fish oil containing diets having a prominent effect 
(Fig 7, page 129). The reduced C20:4n-6/C20:5n-3 ratio suggests that 
C20:5n-3 levels are elevated, particularly with the inclusion of fish oil in the 
diets. A study by Calviello et al. (1999) indicates that the administration of 
C20:5n-3 and C22:6n-3 does not modify the homeostasis of normal rat colonic 
mucosa. However, C20:5n-3 inhibits cell proliferation while C22:6n-3 
enhances cell differentiation and apoptosis. In addition, the increased 
availability of C20:5n-3 ensures the biosynthesis of anti-inflammatory 
eicosanoids such as the 3-series prostaglandins (Calder, 2006). Conversely 
C20:4n-6 metabolism gives rise to pro-inflammatory eicosanoids such as the 
2-series prostaglandin PGE2 which has been linked to the development of 
cancer (Chan, 2006).  
 
Barham et al. (2000) demonstrated that the production of pro-inflammatory 
eicosanoids can be reduced by supplementation with a mixture of C18:3n-6 
and C20:5n-3 rich foods. C18:3n-6 supplementation can bypass the 
pathologically defective ∆6-desaturase activity and elevate the formation of 
C20:3n-6 and subsequently the synthesis of the desirable anti-inflammatory 
1-series eicosanoids (Fan and Chapkin, 1998). An increase in tissue C20:5n-3 
level suppresses membrane C20:4n-6 levels, and subsequently the synthesis 
of 2-series eicosanoids with their potentially adverse effects (Rose and 
Connolly, 1999). C20:5n-3 also suppresses the conversion of C20:3n-6 to 
C20:4n-6, increases the ratio of C20:3n-6 to C20:4n-6 in tissue and plasma 
phospholipids (Barham et al., 2000), and hence increases the formation of 
1-series eicosanoids. Thus dietary supplementation with the proper 
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combinations of C18:3n-6 and C20:5n-3 could modulate the synthesis of 1-, 2- 
and 3-series eicosanoids that may reduce the development of cancer. As FA 
substrates compete for key metabolizing enzymes dietary manipulations of the 
eicosanoid precursors may determine which cellular responses are elicited. 
 
Borage oil had a decreasing effect on the relative C20:4n-6-PC/PE ratio in the 
colon mucosa. This implies that the PE phospholipid fraction has a higher 
C20:4n-6 content relative to PC. This finding is in accordance with a study 
indicating that C20:4n-6 is mainly localized in the PE phospholipids of the 
inner leaflet of membrane (Mahadevappa and Holub, 1987). Localization of 
C20:4n-6 in PE is important, since it has been shown that this phospholipid 
serves as a precursor for the synthesis of eicosanoids after FA cleavage by 
phospholipase A2 (Mahadevappa and Holub, 1987). This shift in membrane 
C20:4n-6 content has implications with regards to the metabolic availability of 
the FA that may affect various processes, such as prostaglandin synthesis 
and apoptosis changes of which have been associated with the promotion of 
tumour growth. 
 
An increase in membrane PUFA content is dependent on both dietary fat 
intake and endogenous FA synthesis. Therefore, the activities of the FA 
metabolizing enzymes, Δ6- and Δ5-desaturases are regulated by membranes 
FA substrate availability, feedback regulation and level of PUFA product. 
∆6-desaturase is the rate-limiting enzyme that catalyzes the first reaction of 
both n-3 and n-6 PUFA synthesis (Sprecher, 2000). In most tissues the 
Δ6-desaturase activity is low, except for in the liver, which is the primary site of 
FA metabolism (Brenner, 1989). The enzyme has a greater affinity for the n-3 
FA, with enzyme preference increasing in the order: n-9<n-6<n-3 (Brenner 
and Peluffo, 1966). With dietary intakes of LCPUFA products such as 
C20:5n-3, feedback inhibition of Δ6- desaturation is enhanced, hereby 
reducing the enzyme’s affinity for n-6 FA substrates (Brenner, 1989).  
 
Incidentally, these results agree with previous findings that indicate that fish oil 
inhibits Δ6-desaturase activity (Raz et al., 1997). The only exception was that 
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the SBF diet reduced the Δ6 S/P ratio in the PE (μg) phospholipid fraction of 
the RBC membranes. This reduction in the ratio was most likely due to the 
borage oil content of the diet countering the inhibitory effect of the fish oil on 
the enzyme activity. A study by Shimada et al. (2003) indicated that in the liver 
increases in PE FA concentration correlated significantly to a reduction in the 
level of ∆6-desaturase activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Effect of fish and borage oil on PUFA parameters and FA ratios in colon mucosa and 
RBC membranes.  
 
Dietary intakes of both fish oil and borage oil increased the mucosa and RBC 
membranes incorporation of n-6 and n-3 PUFA in the membrane 
phospholipids. The increase in membrane unsaturation, particularly with the 
n-3 LCPUFA enhances the membranes susceptibility to lipid peroxidation 
(Ando et al., 1998; Hong et al., 2002). Lipid peroxidation (LPO) is a tightly 
regulated process utilized by cellular systems to control cell numbers (Barrera 
et al., 2008). Studies have shown that changes in fat intake and dietary FA 
composition modulates the mucosal cell membrane lipid content in the rat 
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large intestine, thus influencing membrane sensitivity to LPO (Turini et al., 
1991). The incorporation of n-3 LCPUFA such as C20:5n-3 and C22:6n-3 has 
been widely attributed to increasing membrane sensitivity to free radical 
attack, therefore increasing LPO (Song et al., 2000). These FA have a 
methylene (-CH2) group between two double bonds that are susceptible to 
oxidation processes initiated by free radicals (Spiteller, 2003). These LCPUFA 
play a role in the control of cell proliferation by inhibiting cell growth and 
promoting apoptosis as a result of increased free radical damage due to LPO 
(Courtney et al., 2007). 
 
Conjugated dienes (CDs), formed from the methylene bridges of FA with 
isolated double bonds, have been widely used as an index of LPO (Kappus, 
1985). With the increase in membrane LCPUFA content, colon mucosa and 
RBC membranes were more susceptible to LPO. CD levels were more 
enhanced in the rat colon mucosa and RBC with the ratio diets containing fish 
oil (SF and SBF). The extent of LPO increased in the order of the diets 
SB<SBF<SF in the colon mucosa membranes, while increasing with the order 
SB<SF<SBF in the RBC membranes. FA incorporation into membranes 
enhances their susceptibility to lipid peroxidation, particularly with increased 
incorporation of n-3 LCPUFA such as C22:6n-3, which may have implications 
for colon cancer development by inducing free radical damage and apoptosis 
in cancer cells. 
 
In healthy cells, LPO elevates the level of oxidative stress due to the 
generation of noxious LPO products that may stimulate the apoptotic pathway 
(Kruman et al., 1997). Endogenous (GSH, SOD and catalases) as well as 
exogenous antioxidant systems (vitamin E) reduce the oxidative stress 
induced by the oxidative degradation of membrane lipid (Fang et al., 2002). 
Fish oil has been shown to up-regulate certain antioxidant genes, such as 
glutathione transferase, UCP-2 and Mn-SOD in the liver (Takahashi et al., 
2002). Presumably, this up-regulation counteracts excessive ROS production 
in normal cells and could explain the selective toxicity of PUFA to cancer cells 
(Jiang et al., 1998). Studies show that in cancer cells the level of PUFA is 
decreased while membranes contain high levels of antioxidants such as 
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vitamin E and C18:1n-9 (Cheeseman et al., 1988; Horrobin, 1990). These 
factors play a role in reducing the extent of LPO in cancer cells, thus 
propagating the continuance of damaged cells. Studies in culture demonstrate 
that cancer cells produce more peroxidation products than normal cells when 
supplemented with PUFA (Das et al., 1987; Bégin et al., 1988). Normal cells 
are well equipped to withstand LPO-mediated oxidative stress through 
controlled antioxidant systems, while tumour cells are stimulated to undergo 
apoptosis due to oxidative damage (Stoll, 2002). Thus, dietary membrane 
modulations by increasing the n-3 LCPUFA content with fish oil based diets, 
as demonstrated in this study, may serve as a chemopreventive strategy for 
cancer research due to their availability enhancing LPO induced apoptosis.  
 
3.5 Conclusions 
The observations from this study indicate that the colon mucosa and RBC 
membranes responded differently to the fish and borage oil diets. Both fish oil 
and borage oil each have a distinct FA composition. Therefore, upon dietary 
intake, both individually (diets SF and SB) and in combination (diet SBF), the 
FA content of these oils elicit specific modifications to the membranes lipid 
and FA content in the two tissue compartments (see Fig. 6, page 122 and Fig. 
7, page 129). Fish oil, while mostly having a significant effect on the level of 
membrane n-3 and n-6 PUFA, affected other lipid (i.e. cholesterol, 
phospholipids) and FA (i.e. SATS and MUFA) parameters as well. Similarly, 
borage oil modified the same parameters. These diet-induced alterations in 
membrane FA content may define or determine the specific functional 
responses related to the tissue membranes.  
 
The colon mucosa and RBC membranes lipid profile can be altered by the 
intake of fish and borage oil diets with specific n-6/n-3 FA ratios. In this study 
the dietary modifications to the mucosa tissue and RBC membranes lipid and 
FA content altered their susceptibility to LPO differently. As previously 
highlighted, the individual diets, SF and SB, either increased or decreased the 
aforementioned features. In combination, however, diet SBF had varied 
effects where the diet maintained, countered or enhanced the effects of the 
individual diets. These responses are most likely related to the direct 
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incorporation of dietary FA within the specific tissue. Membranes readily 
incorporated the FA provided by the dietary pool, however, the level of FA 
incorporation varied with tissue. This suggests that RBC, which has frequently 
been used as biomarkers for dietary fat exposure, cannot solely be used to 
determine the level of dietary FA incorporation in other cellular compartments. 
The effects exerted by the fish oil diet SF and borage oil diet SB differed 
significantly from each other in both tissue types. Enhancement of membrane 
LCPUFA content, particularly with the n-6/n-3 FA ratio diets containing fish oil, 
increased the membranes susceptibility to LPO due to the increased 
availability of n-3 FA C20:5n-3 and C22:6n-3. Increasing these FA in 
membranes sensitizes cell membranes to oxidative damage that facilitates the 
induction of apoptosis, and thus could be utilized as a chemopreventive 
strategy for cancer growth inhibition. 
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4.1 General discussion 
The continued increase in the incidence of several types of tumours in the 
Western world is of great concern (Parkin et al., 2002). Although strategies 
have been developed to detect and provide effective treatment, primary 
prevention is the most effective approach to decrease the incidences of highly 
fatal forms of cancer. Measures to prevent its occurrence can be achieved by 
identifying the factors associated with the risk of cancer development. 
Thereby, with this knowledge, strategies related to reducing the risk of cancer 
development can be adopted. 
 
Studies have illustrated that diet plays a major role in the development of 
colon cancer (Reddy and Sugie, 1988; Lund, 2006). High intake of specific 
dietary FA, in particular, is suggested to facilitate its neoplastic development 
(Zock and Katan, 1999; Nkondjock et al., 2003). The mechanisms by which 
dietary FA enhance tumour development are linked to their involvement in 
cellular functions. In cells, the FA composition of cellular membranes plays a 
key role in maintaining cellular homeostasis by regulating structure and 
function (Pan and Storlien, 1993; Jump and Clarke, 1999). FA such as the 
PUFA influence membrane fluidity, signal transductions through lipid-protein 
interactions, as well as the immune response (Broughton and Wade, 2002; 
Duan, 2006). Changes in membrane FA composition could thus have a 
significant effect on cellular homeostasis by modulating important biochemical 
events that may result in abnormal cellular function. With the availability of 
these PUFA being largely dependent on dietary fat consumption, regulated 
intake of specific FA may determine which cellular responses are elicited. 
 
Based on the principle of membrane FA composition having a significant 
effect on cellular function differences between the FA composition of cancer 
and healthy cells may be an important factor in determining their role in 
carcinogenesis. The present investigation showed that there are distinct 
differences in the membrane lipid profiles of precancerous and normal tissue 
associated with a high n-6 dietary FA intake. This dietary pattern, is 
associated with a low n-3 PUFA intake, characterizes a typical “western” diet 
associated with the development of cancer (Simopoulos, 2002). Based on 
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these findings, strategies to circumvent the occurrence of colon cancer can be 
adapted based on responses of specific dietary FA intakes. 
 
The lipid profiles between polyps and surrounding tissue were compared to 
gain a better understanding of the differences associated with colon polyp 
development. The colon polyps exhibited a distinct lipid profile that differed 
significantly from the surrounding mucosa. The PC and PE phospholipid 
concentrations were significantly increased in the polyp membranes with high 
levels of the n-6 FA incorporation, particularly C18:2n-6 and C20:4n-6. The 
concomitant increase in the membrane phospholipids PC and PE in the 
polyps could be a reflection of an increase in cell turnover (Sakai et al., 1992). 
The chemical induction of colon polyps is linked with the accumulation of 
mutations in DNA (Perše and Cerar, 2005), which when expressed may lead 
to deregulated cellular functions that include unregulated cell proliferation 
which is likely to involve an altered lipid pattern. Unregulated cell proliferation 
has been well established to be a significant feature of carcinogenesis 
(Hanahan and Weinberg, 2000).  
The fluidity of the membrane, which is determined by the membrane lipid 
composition, plays an important role in important cell regulatory processes. In 
the polyps, the results suggest that membrane fluidity was significantly 
increased due to alterations in the content of lipids such as the PC and PE 
phospholipids and cholesterol. Increased in levels of PC and PE, and low 
cholesterol have been linked to the development of colon cancer (Neugut et 
al., 1986; Dueck et al., 1996; Li et al., 2004). In the current study the 
cholesterol content decreased significantly in the polyps likely to compensate 
for the increased levels of the membrane phosholipids PC and PE in order to 
maintain the fluidity (Waheed et al., 1998). Cholesterol is known to stabilise 
fluidity in the membrane by aligning the acyl chains of FA (Petrache et al., 
2005). The reduction of cholesterol is in agreement with the apparent increase 
in polyp membrane fluidity, illustrated by the decrease in the membrane 
biomarkers of fluidity, PC/PE and chol/PL ratios and an increased polyp P/S 
ratio. It would appear that due to changes in membrane fluidity, the cellular 
processes regulating the colon mucosa physical-chemical properties may be 
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adversely altered and therefore facilitate the neoplastic process to develop 
polyps. 
Changes in the colon polyps membrane FA composition may be a key feature 
that promotes the continuance of uncharacteristic events that are usually 
absent or regulated under normal cellular conditions. Zeng et al. (2008) 
proposed that the increased levels of FA might modulate cell response to 
DNA damage, leading to defects in cell cycle checkpoints and apoptosis. 
Therefore, in terms of SATS promoting colon polyp development, it is likely 
that changes in the levels of C16:0 and C18:0 play a role in altering the 
mechanisms regulating apoptotic processes that ensure the removal of 
defective cells (Hardy et al., 2003). The altered colon polyp phenotype may 
also be promoted by an increase in MUFA such as C18:1 shown to be 
associated with the stimulation of cell proliferating pathways (Khan et al., 
1991; Nishizuka, 1995).  
 
Increases of n-6 PUFA in membranes have been indicated to enhance cellular 
processes associated with the development of cancer (Rao et al., 1996). In 
the present study the intake of the n-6 FA rich diet is likely to sustain the 
increased n-6 FA composition of PC and PE phospholipid fractions in the 
colon polyp membranes. In this regard the dietary supply of C18:2n-6 
provides the substrate for further metabolism to longer chain FA via action of 
desaturases and elongases. Hereby, the levels of n-6 LCPUFA and 
specifically C20:4n-6, were significantly elevated in the polyps, in both the PC 
and PE phospholipid fractions. When considering the ∆6 substrate/product 
(∆6 S/P) ratio, which is a reflection of ∆6-desaturase activity, it was increased 
in both PC and PE in the colon polyps, suggesting a reduced enzyme activity.  
However, when considering the high level of LCPUFA in both PC and PE it 
would appear that the activity of the ∆6-desaturase enzyme was not altered or 
impaired. This is in agreement with the high level of the n-3 and specifically 
the n-6 LCPUFA in the PC and PE phospholipid fractions. The increased 
∆6-desaturase substrate levels could also be related to negative product 
feedback regulation of the enzyme by LCPUFA products (Brenner, 1989). 
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Although the levels of n-3 PUFA increased significantly in the polyps, the 
membrane content was fairly low in comparison to the n-6 FA resulting in an 
increase in the membrane n-6/n-3 FA ratio. In this regard the increase in the 
C20:4n-6/C20:5n-3, C20:4n-6 PC/PE and C20:4n-6 polyp/surrounding ratios 
likely enhances tumour development through eicosanoid biosynthesis (e.g. 
prostaglandin PGE2) that promotes neoplastic growth. It was suggested that 
the ratio of dietary n-6/n-3 FA might be an important factor that determines the 
progression of an initiated cell into cancer. A diet, utilizing low n-6/n-3 FA 
ratio, was shown to reduce the development of hepatocyte nodules (Abel et 
al., 2004). Thus, by regulating the dietary intake of specific FA, cellular events 
associated with cancer development may potentially be modulated.  
 
Dietary modulation of membrane lipid profiles may therefore be an important 
tool in the prevention of cancer development. Information regarding the effect 
of specific dietary FA ratios on the modulation of membrane lipid profiles in 
normal colon mucosa is therefore of relevance. As FA also play a determining 
role in the oxidative status of cancer tissue and hence cell survival, the effect 
of specific dietary FA is of relevance (Abel et al., 2004). One of the objectives 
of the present study was to determine the lipid profiles of normal colon 
mucosa with respect to the intake of specific FA and the impact it has on the 
oxidative status. Red blood cell membranes were also included to assess 
whether any similarities/differences exist between the tissue compartments 
regarding changes in the lipid profiles and oxidative status. The sources of fat 
used were sunflower oil (control diet) with an n-6/n-3 FA ratio of 250:1, 
sunflower plus fish oil (SF; n-6/n-3 FA ratio of 12:1), sunflower plus borage oil 
(SB; n-6/n-3 FA ratio of 30:1) and a combination SBF diet with an n-6/n-3 FA 
ratio of 12:1.  
 
The lipid profiles between colon mucosa and RBC membranes lipid profile 
differed significantly. The RBC membrane phospholipids PC and PE content 
increased significantly, whilst the colon mucosa PE phospholipid content 
decreased with fish oil. Differences in the membrane phospholipid content 
may be indicative of the tissue type cell turnover relative to the specific 
tissue’s function. The function of RBC is to primarily serve as a vehicle for the 
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transport of oxygen to body cells (http://www.helium.com/items/763669-the-
functions-of-red-blood-cells, accessed 16 February 2009). Thus, as RBC is 
generated continuously to maintain a functional entity the fish oil diet plays a 
supportive role by increasing the PC and PE phospholipid constituents and 
PC/PE ratio. Due to the functional nature of the colon, mucosal membranes 
cells are constantly renewed to balance the removal of cells and those 
damaged by exposure to noxious elements. The PE phospholipid content and 
the PC/PE ratio of the colon mucosa was effectively reduced and increased, 
respectively, with the intake of fish oil containing diets. This is in contrast to 
the lipid content of polyps indicating that an increase in the PE phospholipid 
content relatively to PC and hence a reduced PC/PE ratio was associated with 
an increased proliferation potential and a diet high in n-6 FA. In the colon 
mucosa the PC/PE ratio is much lower compared to the RBC, which is 
indicative of the difference in proliferative status of the two cellular 
compartments. A similar response was also noticed in liver nodules, which 
was associated with an increased cell proliferative environment (Abel et al., 
2004). Of interest is that, borage oil, with relative high n-6 FA content had an 
opposite effect on the PC/PE ratio due to a marked decrease in PC and 
increase in PE. Therefore, the fish oil containing diet induced changes 
influenced the colon mucosa cell turnover, thereby minimizing the potential 
occurrence of the proliferative events associated with the continuance of 
abnormal cellular growth.   
 
As discussed for the polyps, changes in the lipid profile are likely to have a 
significant effect on the membrane fluidity of both the RBC and colon mucosa. 
The fish oil containing diets effectively increased the cholesterol content of the 
mucosal membranes, which as mentioned above is associated with a 
potentially more rigid cell structure (Petrache et al., 2005). However, this 
apparent increase in membrane rigidity was countered by a decrease in the 
chol/PL ratio an increase in the membrane unsaturation reflected by the 
increased P/S ratio and the PC/PE ratio. Changes in these parameters play a 
significant role in the regulation of critical cellular processes related to different 
cell growth parameters. In addition to the cholesterol and phospholipid 
constituents, the n-6/n-3 FA ratio diets had significant effects on the tissues 
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membrane FA composition in terms of the degree of FA incorporation into the 
PC and PE phospholipids. Fish oil increased SATS in the colon mucosa PE, 
while it was decreased by borage oil. In the RBC membranes SATS were 
increased in PC and PE by both oils. The differences in FA incorporation 
between the tissue compartments may be related to mechanisms that 
regulated membrane FA content. In this regard, fish oil increases n-3 LCPUFA 
resulting in a compensatory increase in SATS incorporation in order to 
maintain membrane fluidity. In contrast borage oil decreased SATS in the 
mucosa PE, presumably due to the preferential incorporation of the n-6 PUFA. 
Similarly to the fish oil effects, this may be a mechanism to maintain the 
homeostatic membrane fluidity. 
 
Changes to the mucosa and RBC membranes MUFA composition were 
mainly associated with the dietary oils effect on C18:1n-9. Depending on the 
phospholipid both borage oil and fish oil increased MUFA in the colon. In the 
RBC both fish and borage oils increased MUFA in PE. The decrease in 
Δ6-desaturase activity by fish oil could be responsible for the increased 
C18:1n-9 levels. As mentioned above, C18:1n-9 and C16:0 have opposite 
effects in terms of the regulation of cell proliferation and apoptosis with the 
latter promoting cell removal (Hardy et al., 2003).   
 
Changes in membrane incorporation of dietary n-6 and n-3 have a significant 
effect on the functional regulation of cellular responses (Miles and Calder, 
1998; Ng et al., 2005; Shaikh and Edidin, 2006). Fish oil significantly 
increased the n-3 PUFA content, particularly C20:5n-3, in the PC and PE 
phospholipid fractions in both membrane compartments with a concomitant 
reduction of n-6 FA. It is known that n-3 FA are preferentially incorporated into 
membranes (Hwang et al., 1987). Borage oil mainly increased the n-6 PUFA 
content, particularly C20:3n-6 and C20:4n-6, in the mucosa and RBC 
membranes due to the diet’s supply of C18:3n-6 which is rapidly metabolised 
to functional n-6 LCPUFA. The fish and borage oil diets supply of PUFA and 
their subsequent incorporation into the membranes phospholipid 
compartments significantly reduced the activity of Δ6-desaturase (Raz et al., 
1997; Engler and Engler, 1998). This effect was illustrated by the qualitative 
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(%) increase in the Δ6 S/P ratio colon the PC fraction. Dietary intake of n-6 
and n-3 PUFA thereby reduce the endogenous synthesis of these FA due to 
negative substrate feedback regulation of the Δ6-desaturase enzyme, allowing 
for direct FA incorporation into membranes phospholipids (Brenner, 1989). 
Although the individual effects of fish and borage oil were evaluated (diets SF 
and SB), the response elicited by the combination diet (SBF) was of 
significant interest. The mucosa and RBC membranes level of FA 
incorporation in response to the SBF diet illustrated that the effects of the 
individual oils were maintained, countered or enhanced. Modulation of the 
membranes FA composition by the SBF diet may therefore promote a 
condition/environment that optimizes cellular responses that regulate the cell 
cycle (Calviello et al., 1999; Latham et al., 1999). Of specific interest is the 
regulation of C20:4n-6 levels by the introduction of dietary C18:3n-6 that 
bypass the Δ6-desaturase which activity is down regulated by the n-3 FA (see 
paragraph below). 
 
The ratio of n-6 and n-3 FA in the lipid compartments of the mucosa and RBC 
membranes have a significant effect on the synthesis of eicosanoids that elicit 
important cellular responses depending on the FA. With the SF diet, 
membranes n-3 PUFA content increases significantly, whereas with the SB 
diet, the n-6 PUFA content increased. C20:4n-6 and C20:5n-3 are the 
precursory FA required for the biosynthesis of the 2- and 3- series eicosanoid, 
respectively having opposing effects regarding cell proliferation and anti-
inflammatory effects (Li et al., 1994). A high C20:4n-6/C20:5n-3 ratio elicits 
abnormal cellular responses, however, this effect can be countered by the 
incorporation of FA such as C20:5n-3 and C18:3n-6 that attenuate the effects 
C20:4n-6. This reaction can be achieved effectively by the SBF diet which 
makes provision for C20:4n-6, C20:5n-3 and C18:3n-6. Both C20:5n-3 and 
C18:3n-6 increases the availability of the anti-inflammatory eicosanoids (i.e. 3- 
and 1- series), and thus reduces the potential for persistent cell proliferation 
promoted by the C20:4n-6 derived metabolites. In the polyps the 
C20:4n-6/C20:5n-3, C20:4n-6 PC/PE and C20:4n-6 polyp/surrounding ratios 
were significantly increased which is associated with the altered growth 
patterns. The availability of C18:3n-6 makes provision for adequate C20:4n-6 
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levels required for normal cellular functions. However, the inclusion of 
C18:3n-6 and C20:5n-3 prevents the C20:4n-6 accumulation that sustains cell 
proliferation. The SBF diet may be an effective strategy against the promotion 
of colon carcinogenesis, by regulating the level of C20:4n-6 eicosanoid 
products. 
 
Changes in the oxidative status of cells have a significant effect on 
carcinogenesis (Klaunig and Kamendulis, 2004). Membranes are prime 
targets for oxidation due to the chemical structure of the LC n-6 and n-3 PUFA 
that are rich in hydrogen bonds that are highly susceptible to damage from 
free radicals resulting in lipid peroxidation (Song et al., 2000; Kokura et al., 
2002; Spitellar, 2003). In cancer cells a low oxidative status promotes the 
survival of damaged cells presumably due to high vitamin E and C18:1n-9 
levels (Horrobin, 1990). By increasing the level of oxidative stress in the 
cancer cells, pro-oxidant such ROS may be an effective mechanism to inhibit 
the continued survival of a neoplastic phenotype. ROS can initiate signal 
transductions that induce the removal of damaged and/or cancer cells via 
apoptosis (Simon et al., 2000). In the colon mucosa and RBC membranes 
intakes of the dietary n-6/n-3 FA ratios increased the membranes PUFA 
content, particularly the n-3 LCPUFA C20:5n-3 with the inclusion of fish oil in 
the diet (SF and SBF diets). Elevated levels of C20:5n-3 and C22:6n-3 
enhanced the membranes susceptibility to lipid peroxidation (LPO) and the 
level of oxidative stress within the tissue. This may be an effective way to 
reduce cancerous growth as was indicated by a recent study where enhanced 
the level of LPO in hepatocyte nodules by n-3 FA resulted in a reduction on 
growth (Abel et al. 2004). Therefore, the SF, SB and SBF diet can effectively 
increase the membrane content of n-3 LCPUFA content with concomitant 
increase in the oxidative status.  
 
Although the colon polyps displayed a similar increase in LCPUFA, 
particularly with C20:4n-6, it is likely that increases in antioxidants such as 
C18:1n-9, GSH, vitamin E, which are known to be increased in cancer cells 
(Horrobin, 1990; Valko et al., 2006), will increase resistance to free radical 
attack. Therefore, with a reduction in oxidative membrane damage, the 
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decrease in oxidative stress by may play a significant role in sustaining polyp 
development. Utilizing fish oil based diets, particularly SBF, may be an 
effective strategy to initiate LPO in cancer cells. Hereby, responses that 
control cell proliferation by inhibiting cell growth and stimulating or enhancing 
apoptosis may be induced in neoplastic lesions to circumvent their further 
development. 
 
4.2 Conclusions 
Based on the findings from the present investigation, dietary fat intake plays a 
distinctive role in modifying the lipid composition of cellular membranes. As 
membrane structure and function are dependent on the lipid composition, diet 
induced alterations would impact significantly on the associated cellular 
features/characteristics. As a result, cellular functions that diverge from the 
norm may promote abnormal cellular states, such as the process of 
carcinogenesis, which may be modulated by specific dietary constituents. The 
development of colon polyps in the cancer model illustrated that a diet high in 
n-6 PUFA may play an underlying role. This result was conveyed by the 
significant differences between the lipid profiles of the polyps and surrounding 
mucosa, which was associated with a particular high n-6 FA diet. An 
interactive role of SATS, MUFA and C20:4n-6 was highlighted as the main 
driving force to sustain the altered growth characteristics of the polyps. The 
dietary FA modulation study indicated that colon mucosa and RBC 
membranes respond differently to dietary n-6/n-3 FA ratios in relation to their 
lipid profiles. Specific n-6/n-3 FA interactions exist which differs between the 
two cellular compartments. These interactions are directly or indirectly 
influenced by the effect of the different FA on the activity of the rate limiting 
∆6-desaturase. Hence, RBC membrane lipid profiles, which have been widely 
used as a biomarker for other tissues compartments (Vidgren et al., 1997; 
Harris et al., 2005; Kuriki et al., 2006), are not a true reflection of alterations in 
the colon. 
 
The selective incorporation of n-3 LCPUFA in both membranes increased 
their susceptibly to lipid peroxidation that may selectively sensitize cell survival 
through the induction of oxidative stress resulting in apoptosis, which could be 
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a strategy to adversely affect early neoplastic lesions. Modification to cell 
membrane lipids by specific dietary FA may be an ideal strategy to circumvent 
or prevent colon carcinogenesis.  
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ADDENDUM 1 
 
Analytical parameters for TLC 
 
Solid phase Silica Gel 60 plates 10x20 cm, activated 60 minutes  
at 100 °C 
Mobile Phase Chloroform:petroleum benzene:methanol:acetic acid:boric 
acid (40:30:20:10:1.8 v/v/v/v/w), allowed to saturate tank 
atmosphere (45 min) 
Developing time 90 min 
Detection 2,5-bis-(5’tert-Butylbenzoxazoyl-[2’]-thiophene (BBot) 
added to mobile phase, detection: viewing at λ= 366 nm 
Standard mixture of PC, PI, PS, PE 
Rf values PC 0.1  
 PE 0.55 
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ADDENDUM 2 
 
Set up parameters for GC analyses 
gas chromatograph Varian 3300, Varian Chromatography 
Systems, California, USA. 
columns capillary columns, BPX-70, 30 m x 0.32 mm 
internal diameter (SGE, Texas, USA) 
column phase (0.25 µm)  70% Dicyanopropyl 30% Dimethyl 
     Polysilphenylene-siloxane 
 
 
temperature programming  initial column temperature:  160°C 
  final column temperature:  220°C 
  gradient linear at    4°C/min 
  injection temperature:  240°C 
  detector temperature:  260°C 
detector  FID (Flame Ionisation Detector) 
injection volume  1 μl 
solvent for sample/standards hexane 
standards  mixture of fatty acid methyl esters  
C12:0 to C24:1 in heptane 
internal standard   C17:0 
gas flow rates   medical air (21% O2 in N2)  250 ml/min 
N2     25 ml/min 
carrier gas H2   25 ml/min 
split ratio    20:1 
column pressure   8 Psi 
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ADDENDUM 3 
 
Gas chromatograms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. Chromatogram of a standard fatty acid mixture (C12:0 to C24:1) 
 
Instrument:   Varian 3300 Gas Chromatograph 
Column:   BPX70 (SGE, USA, cat. # 054616) 
Length:   30 m 
Internal Diameter:  0.32 mm 
Phase thickness:  0.25 μm (70% Dicyanopropyl, 30% Dimethyl 
Polysilphenylene-siloxane) 
Initial column temp.:  160°C 
Rate:    4 °C/min. 
Final column temp.:  220 °C 
Final hold time:  10 min. 
Injector temp.:   240 °C 
Detector temp.:  FID, 250 °C 
Carrier gas:   Hydrogen 
Inlet pressure:   8 PSI 
Average gas velocity:  1.85 ml/min. 
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FA calculations 
 
Percentage total FA 
                                      areaFA ⋅ 100 
%FA       =            
           areaTFA  
 
areaFA   area of individual fatty acid (e.g C14:0) 
areaTFA  sum of the total fatty acid areas 
 
FA content µg per mg protein (i.e. mFA) 
Colon polyps/mucosa 
 
                               areaFA   minternal standard[μg] ⋅ faliquot x (100/CLW) 
mFA       =            
   areainternal standard x  mcolon_protein[mg] 
 
RBC membranes 
                               areaFA   minternal standard[μg] ⋅ faliquot 
mFA       =            
   areainternal standard · Cprotein 
 
faliquot   Vtotal CMS of sample [µl]/ Valiquot of CMS extract spotted for TLC [µl] 
areaFA   area of individual fatty acid (e.g C14:0) 
areainternal standard area of internal standard (i.e. I.S = C17:0) 
minternal standard[μg] PC = 4.5 (50 µl I.S); PE = 2.25 (25 µl I.S)  
mcolon_protein[mg] mg sample protein per 100 mg colon protein dry weight 
CLW   colon lipid weight (mg) 
Cprotein  RBC protein concentration (mg per ml) 
unit:   µg FA per mg protein 
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ADDENDUM 4 
 
PHOSPHOLIPID DETERMINATION 
Adapted from Itaya and Ui (1966). Clin. Chim. Acta, 14: 361-366. 
 
Reagents 
Malachite green:  0.2% in dH2O (v/v) and filter before use 
Ammonium molbydate: 4.2% in 5 N HCl  
Tween 20:   0.5% in dH2O 
 
Ratio of working solution (MAT): 
Malachite green : Ammonium molbydate : Tween 
15   : 5    : 1 
Leave the working solution at 4°C for at 30 minutes (background colour 
changes from green to brown). 
 
 Phospholipid fractions (PC and PE) identified from TLC: 
- Scrape off into glass phospholipid tubes. 
- Add perchloric acid (i.e. PC = 400 μl, PE = 300 μl). 
- Place tubes on a 170 °C heating block for 2 hours until clear (NB: keep 
tops loosely fitted). 
- Cool to room temperature. 
- Add dH2O at a ratio of 5:1 with the perchloric acid. 
- Vortex and centrifuge at 500 rpm for 15 minutes 
 
Standards: (in duplicate) 
  1) 20 μl of standard phosphate (Pi) solution (i.e. KH2PO4) = 1 μg of Pi 
  2) 40 μl 
  3) 60 μl 
  4) 80 μl 
  5) 100 μl 
→ Evaporate standards on block (approx 20 min) 
→ Cool to room temperature; add 400 μl perchloric acid + 2ml dH2O 
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Blanks: 400 μl perchloric + 2 ml dH2O (x3) 
 
Loading of Samples:  
- Load clean dry test tubes with 1 ml working solution (MAT) 
- Add 250 μl of standard/blank/samples  
- Vortex 
- Incubate at room temperature  for 20 minutes 
- Read at 660 nm on spectrophotometer 
 
Calculation of phospholipids phosphate (CPi) content:  
Colon polyp/mucosa 
                fstandard [μg] x faliquot x fphospholipid x (100/CLW) x fHCLO4 x 
absorbancesample  
CPi  =      
                                                       mcolon_protein [mg] 
 
RBC membranes 
      fstandard [μg] ⋅ faliquot ⋅ fphospholipid ⋅ fHCLO4 ⋅ absorbancesample  
CPi  =      
                                                     Cprotein  
 
fstandard average of n values: mstandard [µg]/ absorbancestandard 
faliquot Vtotal CMS of sample [µl] / Valiquot CMS extract spotted for TLC [µl] 
fphospholipid converting factor from phospholipids to Pi using the following Mr: 
    fphospholipid  
  PC  25.4 
  PE  23.2 
CLW  colon lipid weight (mg) 
fHClO4 correction factor between dilution of standard and sample with 
perchloric acid HClO4 : Vstandard [µl] / Vsample [µl] 
mcolon_protein mg sample protein per 100 mg colon protein dry weight 
Cprotein RBC protein concentration (mg per ml) 
unit:  µg Pi per mg protein 
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ADDENDUM 5 
 
CHOLESTEROL DETERMINATION 
Adapted from  – Richmond (1973). Clin. Chem., 19: 1350-1356. 
   – Smuts et al. (1994). Cor. Art. Dis. 5: 331-338 
 
Reagents: 
(1) Cholesterol Colour Reagent: 
To one liter volumetric flask add the following: 
KH2PO4        22,1827 g 
K2HPO4.3H2O       8,4445 g 
KI         19,9212 g 
NaN3         9,7515 g 
Alkylbenzyldimethylammonium chloride     100 mg 
Ammonium molbydate      12,4 mg 
Triton X-100 (polyethylene glycol monether; peroxide free) 2 g 
 
(2) Cholesterol Reagent B: 
Cholesterol esterase  83.3 μl 
Cholesterol oxidase   125 μl 
3M NaCl    1792 μl 
 
Method: 
(1) Use 20 µl of the lipid sample from CMS extraction used for TLC 
spotting. 
(2) Add 50 µl CM, vortex. 
(3) Add 300 µl 1% Tritin-X100 (peroxide free), vortex. 
(4) Evaporate emulsion under N2, vortex until clear. 
(5) Add 1.7 ml cholesterol reagent. 
(6) Standards: - 10 µl from 4 different cholesterol standard concentrations 
- 300 µl 1% Triton-X100 
- Add 1.7 ml cholesterol reagent 
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      (7) Carry 1 ml over from (5) and (6) into small sample tubes and add 20 µl 
  cholesterol Reagent B. 
(8) Add 20 µl 3 M NaCl to original tubes from (5) and (6). 
(9) Incubate at room temperature. 
(10) Read at 365 nm with both VIS and UV bulbs on. Read each sample  
       together with its respective blank. 
 
Cholesterol content calculation: 
Colon polyps/mucosa 
 
                               fstandard  x faliquot x (100/CLW) x absorbancesample 
Ccholesterol  =            
         mcolon_protein [mg] 
 
 
RBC membranes 
                                fstandard x faliquot x absorbancesample 
Ccholesterol  =            
         Cprotein  
 
fstandard   average of n values: mstandard [µg]/ absorbancestandard 
faliquot   Vtotal CMS of sample [µl]/ Valiquot of CMS extract spotted for TLC [µl] 
CLW   colon lipid weight (mg) 
mcolon_protein [mg] mg sample protein per 100 mg colon protein dry weight 
Cprotein  RBC protein concentration (mg per ml) 
unit:   µg cholesterol per mg protein 
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ADDENDUM 6 
 
PROTEIN DETERMINATION METHODS 
 
(A) Lowry method: (colon polyps and mucosa) 
Adapted from Markwell et al. (1978), Anal. Biochem., 87: 206-210. 
 
To liquid nitrogen powdered colon polyp/mucosa sample in plastic protein 
tubes: 
- Add 5 ml of a 5% SDS + 0.5 N NaOH solution. Incubate the protein 
solution for 48 hours at 37 °C 
- Rinse content of each tube into measuring tubes with 0.5 ml 5% SDS + 
0.5 N NaOH. Repeat a further two times. 
- Centrifuge for 10 minutes at 500 rpm to remove foam. 
- Fill to a final volume of 5 ml.  
- Vortex. 
- Stores in plastic blue capped tubes (LP5) at 4 °C until analyzed. 
 
Solution 1: 5% SDS + 0.5 N NaOH  
 
Solution 2: 2% Na2CO3 + 0.16% Na-K-Tartrate 
 
Solution 3: 4% CuSO4.5H2O 
 
Solution 4: Alkaline copper reagent which consists of 100 parts of solution 2 
and 1 part of solution 3 (working solution). 
 
Solution 5: Folin –Ciocalteu reagent diluted with dH2O (1:1 v/v) 
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Table 1: Lowry protein determination method 
Standards: (i) Sample (vol) (ii) H2O (iii) Solution 1 (iv) Solution 4 
 μl μl μl ml 
Blank  200 300 1.5 
BSA (0.5 mg/ml) 25 175 300 1.5 
 50 150 300 1.5 
 75 125 300 1.5 
 100 100 300 1.5 
 150 50 300 1.5 
 200 – 300 1.5 
 
Total volume of i+ii+iii= 500 μl 
 
(colon polyps/mucosa) 
Samples:  X (100 μl)       200 μl  300 ul - X   
1.5 ml 
(done in triplicate) 
 
Do as follows: 
(i) + (ii) + (iii) → Vortex → (iv) → Vortex → (v) + 150 μl solution 5 (total volume 
2150 μl) → Vortex. Incubate at 37 °C for 45 minutes. Read absorbance at 660 
nm against water. 
 
Calculation of colon polyp/mucosa protein content:  
→ Determined from 0.5 mg/ml standard curve:  y = mx + c 
y :  sample absorbance reading – blank 
m :  standard curve slope/gradient 
x : sample protein concentration (mg/ml) 
c : y-intercept 
 
i.e  x  = y – c 
     m 
units : mg protein/ml 
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Sample protein concentration (X) in 2150 ul: 
X = (x * 2150 μl)/sample volume (μl) 
units: mg protein/ml 
 
mg sample protein per 5 ml protein solution (Y): 
Y = X/5 ml 
units: mg protein 
 
mg sample protein per 100 mg colon protein dry weight (Z): 
Z = 100/(colon dry protein weight (mg) * Y)  
Note: Z value used for fatty acid μg content/mg protein content determination 
 
(B) Pierce Method: (RBC membranes) 
Adapted from Kaushal and Barnes (1986), Anal. Biochem. 157: 291-294. 
 
Solutions Required: 
(i) 2% SDS solution (containing 2% SDS 2 mM EDTA 20 mM 
NaHCO3) 
(ii) BCA protein assay reagent A 
(iii) BCA protein assay reagent B; 4% CuSO4.5H2O (Make up own 
solution) 
(iv) BSA standard 
(v) Distilled water (H2O) 
 
BSA standard:  Make up 1 mg/ml BSA stock solution and verify 
concentration on spectrophotometer 
 
NB: Dilute collected samples (RBC) with 2% SDS solution prior 
to protein determination.  
 
 
 
 
 
 
 
 
 171
Table 2: Pierce protein determination method 
 (i) (ii) (iii) (iv) (v)  
Samples BSA from 
diluted 
stock (μl) 
Volume of 
2% SDS 
(μl) 
Unknown 
sample 
volume 
(μl) 
Dist. H2O
(μl) 
Reagent 
A + B 
(μl) 
Total 
Reaction 
Volume 
(μl) 
Standards 
Blank (x3) 0 80 – 520 400 1000 
S-1 (x2) 10 80 – 510 400 1000 
S-2 (x2) 20 80 – 500 400 1000 
S-3 (x2) 40 80 – 480 400 1000 
S-4 (x2) 60 80 – 460 400 1000 
S-5 (x2) 80 80 – 440 400 1000 
S-6 (x2) 100 80 – 420 400 1000 
       
Unknown Samples 
U-1 – – 40 560 400 1000 
U-2 – – 60 540 400 1000 
U-3 – – 80 520 400 1000 
 
Reagent A + B: calculate how much is needed. Mix in a ratio 50:1 (A:B). 
Vortex samples and standards after addition of Reagent A + B mixture. 
Incubate in a water bath at 60 °C for 1 hr. 
Cool to room temperature. 
Vortex prior to reading on spectrophotometer. 
Read at 562 nm. (Can use disposable PS or PMMA semi-micro cuvettes, 
approximately 1.5 ml) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 172
Calculation of RBC membranes protein content:  
→ Determined from 0.1 mg/ml standard curve:  y = mx + c 
y :  sample absorbance reading – blank 
m :  standard curve slope/gradient 
x : sample protein concentration (mg/ml) 
c : y-intercept 
 
i.e  x  = y – c 
     m 
units : mg protein/ml 
 
Sample protein concentration (X) in 1000 μl: 
X = [(x * 1000 μl)/sample volume (μl)] * dilution factor (i.e. RBC dilution factor) 
units: mg protein/ml 
 
 
 
 
 
 
 
 
